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ABSTRACT 
 
Mitochondria are indispensable organelles of eukaryotic cells, takes part in the 
efficient generation of energy required for the cellular activities. They also converge 
to accomplish various functions such as intrinsic apoptotic pathway, fatty acid beta 
oxidation, cellular balance of reactive oxygen species (ROS), iron sulphur cluster 
biogenesis and so-forth which are necessary for the viability of the cell. 
 
Ominous diseases may arise of incompetent mitochondrial function activity, for 
example, cardiomyopathy, optic atrophy and diabetes mellitus. Mitochondrial 
disorders may emerge as a result of mutations not only in the mitochondria DNA 
(mtDNA) but also in the nuclear DNA (nDNA) encoding proteins, which forms part 
of the mitochondrial proteome. 
 
The advent of next generation sequencing (NGS) data has hugely accelerated the 
generation of millions of DNA sequences and opened up avenues to study diseases 
at a rapid pace. NGS enables transcriptome sequencing of both the normal and the 
disease samples realised by the RNA sequencing (RNA-seq) technology. This 
facilitate the measure of the gene expression in the diseases compared to their 
normal samples, in addition to the capture of disease specific mutations. In this 
thesis, workflows to extract mutation and expression data from the RNAseq samples 
using well developed bioinformatics tools have been achieved.  
 
Mitochondria encompassing crucial cellular functions are fulfilled by protein coding 
genes encoded by both mtDNA and nDNA. In this thesis, an overall model termed as 
mitochondrial model (MitoModel) is developed, which at present includes 17 
mitochondria specific processes with 659 genes further grouped into functional 
clusters. The MitoModel forms a network model with genes connected not only 
within a single function but also across functions. It is an interactive model with an 
x 
 
option to map mutation and expression data and further the MitoModel provide 
users several information including enrichment analysis of most affected 
mitochondrial function and a downloadable variants file.  
 
The usage of MitoModel has proved the efficiency of the approach to understand the 
behaviour of the mitochondria from the RNA-seq data in HCT116 5/4, RPE1 5/3 
12/3 and RPE1H2B 21/3 aneuploidy cell lines generated by collaborators. It also 
throws light on the differences in the mitochondrial metabolism and physiology in 
the extreme stress reactivity mice from the expression data. Finally, MitoModel was 
successfully used to emphasize on the representative mitochondrial genes that were 
consistently affected in the RNA-seq data of 16 samples of primary colorectal cancer 
and corresponding liver metastases samples.  
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 CHAPTER 1 
 
Introduction 
 
 
Mitochondria are ubiquitous organelles present in eukaryotic cells with the major 
function of energy production in the form of ATP through oxidative 
phosphorylation. Acquired several billion years ago by eubacterial invasion through 
symbiosis, they have immensely impacted the metabolism and homeostasis of 
eukaryotes [Dyall et al., 2004]. 
 
1.1.1 ANATOMY OF MITOCHONDRIA: 
Anatomically mitochondria are enclosed by two membranes designated as outer 
and inner mitochondrial membranes, which are separated by the so-called 
intermembrane space (Figure 1). Both the membranes have specific functions. The 
inner membrane houses the complete electron transport chain and ATP synthase 
complex for the generation of energy. The outer membrane accommodates channels 
and multi-protein translocase complexes which aid the import of molecules and 
proteins into mitochondria, respectively. In the living cells, mitochondrial shape 
varies and range from punctuate structures to tubular networks [Anesti & Scorrano, 
2006].  
 
The inner membrane forms several folds called cristae, which enclose the main 
mitochondrial area, which is referred to as the mitochondrial matrix. This matrix 
contains the mitochondrial DNA (mtDNA) and enzymes that take part in many 
critical functions of the organelle (see for instance: 
http://www.ncbi.nlm.nih.gov/books/NBK9896/ , accessed July 28, 2015).      
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Figure 1: Structure of mitochondria. Figure taken from:                 
http://biotechlearn.org.nz/themes/barcoding_life/images/diagram_of_a_mitochondrion    
accessed July 28, 2015  
 
1.1.2 MITOCHONDRIAL GENOME: 
Mitochondria have their own genome, which is composed of a single, circular DNA 
molecule. The human mitochondrial genome consists of 16569 bases. It contains 37 
genes encoding for 13 polypeptides mostly involved in oxidative phosphorylation, 
22 tRNAs and 2 rRNAs required for mitochondrial protein translation. It also 
contains two non-coding regions necessary for replication start, one for the heavy 
and one for light strand depicted as OH and OL (Figure 2). Each mitochondria 
contains several copies of its DNA enclosed into specialized structures called 
nucleoids, which form the vehicles of transmission and inheritance [Taylor & 
Turnbull, 2005].    
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Figure 2: The human mitochondrial genome. Figure adapted from [Taylor     
                  & Turnbull, 2005]. 
 
1.1.3 MITOCHONDRIA AND NUCLEAR GENOME INTERACTION: 
The mitochondrial genome encodes only few genes, which are subunits of the 
oxidative phosphorylation and translation machineries. All other proteins required 
for proper mitochondrial function are encoded in the nuclear genome and are 
imported into mitochondria [Plon et al., 1989].  
 
1.1.4 HOMOPLASMY AND HETEROPLASMY: 
The eukaryotic cell accommodates one to several thousands of mitochondria giving 
rise to an interesting phenomenon of mitochondrial genetics called homoplasmy 
and heteroplasmy.  
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Homoplasmy is referred to the presence of identical copies of the mitochondrial 
genome in a cell, whereas heteroplasmy refers to the habitation of two or more 
mitochondrial genotypes in a single eukaryotic cell. 
 
These terms are frequently used to define the mtDNA mutations leading to diseases.  
For instance, a homoplasmic mutation is present in all the copies of the genome and 
heteroplasmic mutation is present in only few copies of the mitochondrial genome. 
In case of heteroplasmic mutations, there is a minimum threshold level for the 
disease to develop and manifest clinical symptoms [Rossignol  et al., 2003].  
 
The mtDNA is inherited maternally and transmission of mtDNA mutations also 
occur maternally. Homoplasmic mtDNA mutations are transmitted to all the 
offsprings, for example patients with LEBER HEREDITARY OPTIC NEUROPATHY 
(LHON) have homoplasmic mtDNA mutations and all the offsprings inherit the 
mutation.  Even though all the offsprings inherit the mutation, only few develop the 
disease [Man et al., 2003], which points out that not only mtDNA factors but also 
nuclear genetic factors are important for the development of this disease.  
 
Transmission of a heteroplasmic mutation is more complicated due to the fact that 
there is a genetic bottleneck during development and the amount of mutated 
mtDNA transmitted to offspring is variable [Brown et al., 2001]. Hence both, nuclear 
genetic [Battersby et al., 2003] and environmental factors affect the development of 
a disease caused by a heteroplasmic, mitochondrial mutation. [Taylor & Turnbull, 
2005].   
 
1.1.5 MITOCHONDRIA AND DISEASES: 
Mitochondrial diseases are effectively disorders that result from the dysfunction of 
the electron transport chain. Furthermore, there are other crucial functions 
converging in mitochondria, such as the apoptotic pathway, fatty acid beta 
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oxidation, cellular balance of reactive oxygen species (ROS) and iron sulphur cluster 
biogenesis, which could directly or indirectly affect the efficient operational activity 
of mitochondria.  
 
Mitochondrial disorders may arise from mutations not only in the mtDNA but also in 
the nuclear DNA encoding mitochondrial proteins. For example, individuals with 
external ophthalmoplegia display a diverse variation pattern: some patients have 
large deletions in mtDNA, others have a single nucleotide variation, and still others 
have heterozygous variants of nuclear encoded, mitochondrial genes[Chinnery, 
2014].  
 
Some of the most common disorders associated either with the mtDNA encoded 
genes or nuclear encoded mitochondrial genes include ptosis, external 
ophthalmoplegia, proximal myopathy and exercise intolerance, cardiomyopathy, 
sensorineural deafness, optic atrophy, pigmentary retinopathy, and diabetes 
mellitus (see: http://www.ncbi.nlm.nih.gov/books/NBK1224/, accessed on 28 July 
2015). 
 
 
1.1.6 MITOCHONDRIA IN CANCER AND ANEUPLOIDY: 
Deriving energy by cells, from glycolysis rather than a highly efficient oxidative 
phosphorylation was termed ‘Warburg effect’ [Zheng, 2012]. This effect was 
formulated by the observation from Otto Warburg that the tumour cells yield more 
lactate in the presence of oxygen, which he termed “aerobic glycolysis“ resulting 
from impairment of the oxidative phosphorylation machinery in mitochondria. 
However, several investigation found that defects of mitochondrial OXPHOS are not 
common in spontaneous tumors and is intact in most cancers [Zheng, 2012]. 
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mtDNA mutations have been reported in a variety of cancers, including renal 
adenocarcinoma, colon cancer cells, head and neck tumours, astrocytic tumours, 
thyroid tumours, breast tumours, ovarian tumours, prostate and bladder cancer, 
neuroblastomas and oncocytomas [Wallace, 2012]. These mutations belong to two 
classes: mutations that assist the neoplastic transformation, and those that aid the 
cancer cell adaptation to the changing bioenergetic environments. Next to mutations 
in the mitochondrial genome, many mutations in the nuclear encoded mitochondrial 
genes have been observed in specific cancers [Wallace, 2012].  
 
Mitochondrial ROS are not only signalling molecules, but also potent mutagens and 
an increase in the ROS production along with dysfunctional apoptosis, could lead to 
neoplastic transformation [Wallace, 2012].  
 
Mitochondrial activity and misregulations has been observed in the Down’s 
syndrome (DS) or trisomy 21. It is one of the most common aneuploidies resulting 
in intellectual disability disorder caused by three copies of chromosome 21. 
Increased oxidative stress due to decreased regulation of several mitochondrial 
components have been observed in the DS [Coskun & Busciglio, 2012]. It was also 
suggested that mitochondrial biogenesis was up-regulated in trisomy 21: 
mitochondrial superoxide production and oxidative stress were observed to be 3 
times higher in DS fibroblasts [Coskun & Busciglio, 2012]. 
 
1.1.7 MITOCHONDRIA IN MAJOR DEPRESSION: 
Misregulations associated with mitochondrial functions in major depression (MD) 
are differences in the translation, decreased gene expression of mtDNA encoded 
genes and nuclear encoded genes, decreased complex I activity and low ATP 
production rates [Gardner & Boles, 2011].  
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Patients suffering from major depression have been reported to have dysregulations 
in the hypothalamus-pituitary-adrenocortical (HPA) axis and deficits in cognitive 
processes caused by hippocampal and prefrontal cortex (PFC) malfunction. Three 
mouse lines were selectively bred for high (HR), intermediate (IR), and low (LR) 
stress reactivity, determined by the corticosterone response to a psychological 
stressor, probing the behavioural and functional consequences of increased vs. 
decreased HPA axis reactivity on the hippocampus and PFC. The hippocampal 
proteomic analysis identified several proteins differentially expressed in HR and LR 
mice, those including proteins involved in the energy metabolism pathway 
[Knapman et al., 2012].         
 
1.1.8 GOALS OF THE THESIS: 
There are a large scale availability of sequence data for several diseases from 
various data sources, which can be utilized to generate gene expression and 
mutation data. The main aim of this study is to understand the mitochondrial 
contribution in diseases. Thus the work is aimed at the development and 
deployment of a mitochondrial model (MitoModel) that would operate in an 
inclusive manner with both mtDNA encoded and nuclear encoded mitochondrial 
genes. The mapping of the gene expression and mutation data on to the MitoModel 
will be an efficient approach to  disclose the metabolic and physiological variations 
carried by mitochondria in a disease state. 
  
GOAL-1: Functional classification of mitochondrial genes and brief annotation of 
gene function in the respective mitochondrial function [see Chapter 1.2].  
 
GOAL-2:  Development and deployment of a user-friendly, interactive MitoModel 
[see Chapter 2].  
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GOAL-3: Development of workflows to analyse RNA-sequencing data, extracting 
mutational and gene expression data in different disease types. 
 
GOAL-4: Utilising the MitoModel to understand three different disease phenotypes: 
a. Gene expression and mutation analysis using the MitoModel in three different 
aneuploidy cell lines: the HCT 116 cell line tetrasomic for chromosome 5 
(HCT116 5/4), the RPE1 cell line trisomic for chromosome 5 and 
chromosome 12 (RPE1 5/3 12/3) and finally, the RPE1H2B cell line trisomic 
for chromosome 21 (RPE1H2B 21/3) [see Chapter 3.1]. 
b. Using the MitoModel to understand the expression difference between the HR 
and LR stress reactivity mice to elucidate potential malfunctions of 
mitochondria [see chapter 3.2]. 
c. Retrieval of representative mitochondrial genes consistently afflicted in the 
MitoModel, in 16 samples of colorectal cancer and corresponding liver 
metastasis [see chapter 3.3]. 
 
1.1.9 OUTLINE OF THIS THESIS: 
Chapter 1.2 provides a brief introduction to the methodology followed by the 
collection of mitochondria-associated genes and their functional classification.  
 
Chapter 2 describes the methods utilized for the development of the analysis 
pipeline to deduce mutation and expression data; it also gives information about the 
construction and deployment of the MitoModel. 
 
Chapter 3.1 discusses the application of expression and mutation data on the 
MitoModel for the three aneuploidy cell lines to analyse a potential mitochondrial 
involvement. 
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Chapter 3.2 describes the employment of MitoModel on the two extreme stress 
reactivity (LR vs. HR) mice to elucidate the contrasting behaviour with respect to 
mitochondrial metabolism and physiology. 
 
Chapter 3.3 provides details on the application of MitoModel and extraction of the 
most representative MitoModel genes in 16 colorectal cancer samples and its 
corresponding liver metastases  
 
Chapter 4 provides conclusions and outlook onto future perspectives of this work. 
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CHAPTER 1.2 
 
Mitochondria and their functions 
 
Mitochondria are the power houses of the cell, efficiently producing ATP for cellular 
functions and activities. In addition, they are involved in diverse functions such as 
beta oxidation of fatty acids, apoptosis, biosynthesis of heme, FE-S cluster 
biosynthesis and calcium signalling. The human mitochondrial genome encodes 
only 13 polypeptides; the remaining 99% of mitochondrial proteins are synthesized 
at cytosolic ribosomes and then imported into mitochondria. Efforts to compile the 
mitochondrial proteome have been done and Pagliarini et al in 2008 came up with 
MitoCarta, a list of nearly 1100 genes coding for mouse mitochondrial genome 
[Pagliarini et al., 2008].  
 
A seemingly quarter proportion of the mouse mitochondrial proteome have no 
known biological functions [Meisinger et al., 2008]. In this chapter, an approach is 
taken to organize mitochondria associated genes, including all mtDNA- and nuclear 
encoded mitochondrial genes into groups based on their function. This is 
accomplished by a comprehensive literature survey, specifically pinpointing the role 
of a gene in mitochondria-associated functions.  
  
1.2.1 MITOCHONDRIA ASSOCIATED FUNCTIONS: 
In this section, the approach was to bring all mitochondria associated genes 
together, specifically focussing on the functions that are well defined through 
decades of experimental research. These functions included until now are briefly 
defined below and the genes with their roles and their references are catalogued in 
the Appendix C. 
    
 12 
1.2.1.1 ELECTRON TRANSPORT CHAIN: 
Situated in the inner mitochondrial membrane, the electron transport chain consists 
of a series of enzyme complexes reducing oxygen to water resulting in protons (H+) 
being pumped across the inner mitochondrial membrane from the matrix. This gives 
rise to an electrochemical proton gradient across the inner membrane which is later 
utilized by the ATP synthase complex to synthesize ATP from ADP and inorganic 
phosphate [Schaffer & Suleiman, 2010].   
 
The gene information of all the complexes involved and the gene symbols were 
downloaded from the Hugo gene nomenclature committee (HGNC) under the gene 
group.“Mitochondrial respiratory chain complexes” (available at: 
http://www.genenames.org/cgi-bin/genefamilies/set/639 , accessed August 4, 
2015).  Respiratory chain assembly factors were also downloaded from the HGNC 
under the gene group “Mitochondrial respiratory chain complex assembly factors” 
(available at: http://www.genenames.org/cgi-bin/genefamilies/set/645 , accessed 
August 4, 2015).  There are a total of 131 genes included in the electron transport 
chain function (1 until 131 in Appendix C). 
 
1.2.1.2 GLYCOLYSIS: 
All cells crave for energy not only for their homeostasis but also for growth and 
division. The major source of cellular energy is glucose, which is assimilated by its 
breakdown via glycolysis to pyruvate. The pyruvate then enters mitochondria 
where it is further broken down by the tricarboxylic acid cycle (TCA) and oxidative 
phosphorylation to produce large amounts of ATP.  
 
Glycolysis is capable of producing ATP but to a much lesser extent as compared to 
oxidative phosphorylation in the mitochondria. Glycolytic ATP generation for a 
molecule of glucose results in only 2 ATP molecules compared to 36 ATP molecules 
generated by oxidative phosphorylation. Even though the energy generation 
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efficiency is low, the pace of energy production is faster [Lunt & Vander heiden, 
2011]. 
 
Glycolysis in its entirety takes place in the cytoplasm of the cell. Inclusion of the 
genes taking part in this process is deliberate to take into account changed 
mitochondrial functions in a disease state, which depend primarily on the glycolytic 
fuel. Furthermore, glycolysis is tighlty linked to the TCA cycle. There are in total 31 
genes catalogued in this function (132 until 163 in Appendix C).      
 
1.2.1.3 PYRUVATE TRANSFER: 
Pyruvate is formed by the breakdown of glucose in the glycolytic pathway. It is 
further taken up as a major substrate by the TCA cycle in mitochondria. The process 
of transferring pyruvate is yielded by the formation of the complex between two 
proteins Mpc1 and Mpc2 (BRP44 and BRP44L in humans) in the inner 
mitochondrial membrane [Bricker et al., 2012].  Only two genes were catalogued for 
this function (164 until 165 in Appendix C).   
   
1.2.1.4 FORMATION OF ACETYL COA: 
Irreversible conversion of pyruvate to acetyl CoA is performed before it is taken up 
by the TCA cycle. At this point the carbon atoms from the glycolysis are either 
transformed into energy or further stored as lipids. The oxidative decarboxylation of 
pyruvate to acetyl CoA is oerformed by the pyruvate dehydrogenase complex, which 
is a multi enzyme complex in the mitochondrial matrix (available at: 
http://www.ncbi.nlm.nih.gov/books/NBK22347/ , accessed on August 5, 2015). 
There were 5 genes catalogued in this section ( 166 until 170 in Appendix C). 
 
1.2.1.5 TRICARBOXYLIC ACID (TCA) CYCLE: 
Tricarboxylic acid (TCA) cycle also known as Krebs cycle or citric acid cycle takes 
place inside mitochondria. The major function of the TCA cycle is reaping high 
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energy electrons from acetyl CoA. The cycle includes a series of oxidation reduction 
reactions giving rise to two molecules of CO2 , one molecule of GTP and high energy 
electrons in the form of NADH and FADH2(available at: 
http://www.ncbi.nlm.nih.gov/books/NBK21163/, accessed on August 6, 2015). 
There were 18 genes catalogued in this function (171 until 189 in Appendix C).       
 
1.2.1.6 BETA OXIDATION OF FATTY ACIDS: 
Fatty acid metabolism is one of the major metabolic functions that play an 
important role in the energy homoeostasis of an organism. Though peroxisomes  
harbors a machinery for fatty acid metabolism, it is the mitochondrial beta oxidation 
of fatty acids, which is the primary pathway in the degradation of the fatty acids. 
Defects in fatty acid metabolism have harmful consequences that include 
hypoglycaemia, hypertrophic cardiomyopathy, myopathy and rhabdomyolysis 
[Houten & Wanders, 2010]. There are 53 genes catalogued in this function (190 
until 243 in Appendix C). 
 
1.2.1.7 ROS DEFENCE: 
Efficient energy manufacturing is conducted by the mitochondrial electron 
transport chain. Misregulations in transport activity of electrons from one to 
another complex may lead to direct interaction of the electrons with the O2, leading 
to the generation of superoxide, a free radical. These reactive oxygen species (ROS) 
can act under normal conditions as signalling molecules. In pathophysiological 
conditions, they contribute to critical disease phenotypes including cancer.  
 
The antioxidant defence machinery inside mitochondria as well as the cytoplasm 
can target ROS molecules and limit their oxidative damage capacity. A failure in 
controlling ROS by antioxidant enzymes or excessive ROS generation can 
significantly damage lipids, proteins and DNA and eventually disrupting cellular 
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functions [Sabharwal & Schumacker, 2014]. There were 23 genes catalogued in this 
function (244 until 267 in Appendix C). 
 
1.2.1.8 APOPTOSIS: 
Apoptosis is a well-orchestrated set of cellular processes that will lead to the death 
of the cell. It is as important as cell division and development due of the fact that it 
contributes to poper cellular homeostasis. In vertebrate cells, there are two 
apoptotic pathways, the extrinsic and the intrinsic pathway.  Both converge at the 
point of activating the death caspases.  
 
Mitochondria can activate the intrinsic pathway through the inception of 
mitochondrial outer membrane permeabilization. This leads to the release of 
Cytochrome C from the inter membrane space further activating caspases and in 
turn apoptosis [Tait & Green, 2010]. There were 35 genes catalogued in this 
function (268 until 303 in Appendix C). 
 
1.2.1.9 IMPORT AND SORTING: 
The endosymbiotic theory confers that mitochondria lost most of its genetic 
material to the nuclear genome. As a result  the nuclear genome encodes almost 
99% of the mitochondrial proteins that were transferred from the endosymbiont 
during eukaryotic evolution [Dolezal et al., 2006]. Mitochondria with its own 
replication, transcription and translation machinery encodes only 1% of the 
mitochondrial proteins which forms a part of the respiratory chain complexes 
[Schmidt et al., 2010].    
 
Mitochondria not only possess a central role in energy conversion, but also have 
crucial roles in multiple metabolic and signalling pathways. A well-established 
protein import machinery is necessary and is present in all eukaryotic cells, 
including the last common ancestor to all eukaryotes [Dolezal et al., 2006]. 
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Proteins entering mitochondria through the import machinery contain special 
targeting signals that are recognized by mitochondrial receptors. Depending on 
their signals and import route, they are are transported to different mitochondrial 
sub compartments. There are several types of targeting signals. The best known 
signal is the N-terminal mitochondrial targeting peptide, which is cleaved off after 
mitochondrial import. This signal targets proteins to the mitochondrial matrix. 
Several other internal targeting signals exist. Internal signals remain within the 
mature protein [Schmidt et al., 2010, Dolezal et al., 2006]. There were 32 genes 
catalogued in this function (304 until 336 in Appendix C). 
 
1.2.1.10 MITOCHONDRIAL DYNAMICS: 
In eukaryotic cells, mitochondria do not form a static organelle. They are rather 
highly dynamic and constantly change via fusion with other mitochondria or fission, 
dividing to equip cells with new mitochondria. Mitochondria thus form a highly 
interconnected network in the cell [Palmer  et al., 2011]. The viability of a cell is 
highly dependent on the proper functioning of this network and the regulation of 
the mitochondrial network depends on proper coordination between fusion and 
fission events [Hales, 2010].  
 
Fusion or joining of two mitochondria forms the fundamental process of the 
mitochondrial dynamics [Ranieri et al., 2013]. The mechanism is essential to 
maintain the organelle population in the cell homogeneously [Palmer  et al., 2011]. 
It also provides an opportunity to exchange the mitochondrial contents between the 
fused mitochondria, and aides damaged and aged mitochondria, prolonging their 
survivability [Ranieri et al., 2013].  
 
Fission or division of mitochondria in a cell is essential for many reasons: it is 
necessary to maintain sufficiently high numbers of mitochondria so that a full 
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complement of mitochondria are inherited by daughter cells during cell division; it 
is also required for segregating old and damaged mitochondria through mitophagy. 
Finally, fission is also required for the remodelling and rearrangement of the 
mitochondrial network [Palmer et al., 2011, Hales, 2010 and Ranieri et al., 2013]. 
 
Mitophagy is the autophagic clearance of the mitochondria and it is tightly linked to 
both, fusion and fission events. The selection of impaired mitochondria is 
established based on their membrane potential and the ones with reduced 
membrane potential are selected, enclosed in autophagosomes and subsequently 
broken down by lysosomes [Thomas & Gustafsson, 2013].   
 
Mitochondrial movement plays an important role in reaching the mitochondria in 
highly polarized cells such as neurons. Impaired fission and fusion dynamics have 
been suggested to reduce mitochondrial motility, though the relationship is yet to be 
established [Chen & Chan, 2009]. There were 40 genes catalogued in this function 
(583 until 623 in Appendix C).  
 
1.2.1.11 Iron Sulphur (FE-S) CLUSTER BIOSYNTHESIS: 
Fe-S cluster proteins are important cofactors involved in crucial cellular activities 
like electron transfer reactions, catalytic and regulatory processes. They serve as the 
main donors of sulphur during the biosynthesis of lipoic acid and biotin. There are 
several forms of Fe-S clusters, the simplest form being [2Fe-2S]; [4Fe-4S] and [3Fe-
4S] are more complex clusters with an additional heavy metal ion. 
 
The pathway for the synthesis for Fe-S clusters initiates in the mitochondria with a 
complex called the mitochondrial iron sulphur cluster (ISC) assembly machinery. 
The core of this machinery is not only required for the biosynthesis of Fe-S proteins 
in mitochondria but also for the maturation of the same proteins in the cytoplasm 
by the cytosolic iron-sulphur protein assembly (CIA) machinery. Defects in Fe-S 
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cluster biogenesis can severely affect other cellular functions like the electron 
transport chain, the TCA cycle and other cofactor biosynthesis processes including 
heme biosynthesis [Rouault & Tong, 2005] & [Lill, 2009]. There were 25 genes 
catalogued in this function (337 until 362 in Appendix C). 
 
1.2.1.12 REPLICATION AND TRANSCRIPTION: 
The mitochondrial genome only encodes a few polypeptides and RNA molecules 
required for mitochondrial translation processes. The genome itself is a double 
stranded circular molecule. Mitochondrial genes are devoid of introns. It also consist 
of non-coding regions on both the heavy and light strands, which are important 
blocks in the genome and contain essential elements for the transcription and 
replication.   
 
Transcription from the mitochondrial genome gives rise to polycistronic precursor 
RNAs later processed to yield mRNA, rRNA and tRNA molecules. The replication 
process and its regulation in mitochondria are complex and efforts are ongoing to 
identify enzymatic activities during the replication process. There are also intense 
debates about the models of mitochondrial replication. Currently there are two 
documented models. In the strand-asymmetric model, the transcription of the light 
strand promoter provides primers for the heavy strand replication and once the 
leading strand replication has reached two thirds of the genome, the light strand 
replication is initiated in the opposite direction resulting in new mtDNA molecules 
of both strands. In the symmetric replication model, both the leading and the lagging 
strand replicates symmetrically from multiple replication forks in the genome 
[Falkenberg et al., 2007]. There are 73 genes catalogued in this function (363 until 
435 in Appendix C). 
 
1.2.1.13 TRANSLATION: 
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Mitochondria contain their own translation machinery. The human mitochondrial 
genome itself encodes the 22 tRNAs  and 2 mitochondrial rRNAs required for 
translation. For an efficient translation process to take place, the mtDNA has to be 
transcribed and a sizable number of nuclear encoded translational regulators must 
be imported into the mitochondria.  
 
The mitochondrial translation machinery includes the mtDNA encoded tRNAs and 
rRNAs as well as nuclear encoded initiation, elongation and termination factors, 
mitochondrial ribosomal proteins, aminoacyl-tRNA synthetases and methionyl-
tRNA transformylase. The translation process includes initiation, elongation and 
termination followed by quality control and protein insertion into the inner 
mitochondrial membrane [Smits et al., 2010]. There are 146 genes catalogued in this 
function (436 until 582 in Appendix C). 
  
1.2.1.14 CALCIUM TRANSPORT: 
Calcium signalling is a process which coordinates several extracellular stimuli and 
triggers several important functions within a cell. Cells respond differentially to the 
increase or decrease of calcium concentration. It has been shown that the 
membrane potential difference generated within the mitochondria acts as a major 
driving force for calcium accumulation in mitochondria. The mitochondria are also 
in close proximity of Endoplasmic reticulum (ER) and the sarcoplasmic reticulum, 
which serves as the important intracellular calcium stores. 
 
Calcium in mitochondria regulates several crucial cellular functions. Calcium inside 
mitochondria regulates the ATP production by oxidative phosphorylation, cell death 
pathways, intrinsic apoptosis and autophagy [Rizzuto et al., 2012]. There were 15 
genes catalogued in this function (624 until 639 in Appendix C). 
 
1.2.1.15 HEME BIOSYNTHESIS: 
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Heme is a non-protein chemical compound, which becomes part of a protein by 
binding to it. For instance, it is a cofactor of crucial proteins such as haemoglobin, 
myoglobin and cytochrome proteins. Heme consists of central ferrous ion with four 
nitrogen atoms binding to it in porphyrin compounds, such as hemoproteins.  
 
Hemeproteins play a central role in the many cellular activities such as electron 
transport, apoptosis, detoxification, protection against oxygen radicals, nitrogen 
monoxide synthesis and oxygen transport [Dailey, 1997]. There are 8 genes 
catalogued in this function (640 until 648 in Appendix C). 
 
1.2.1.16 CARDIOLIPIN BIOSYNTHESIS: 
Phospholipids form the basic component of the lipid bilayer that surrounds cells as 
well as organelles present inside cells. Cardiolipin is a phospholipid, which is almost 
exclusively present in the mitochondrial inner membrane [Kiebish et al., 2008]. The 
uniqueness of the cardiolipin is its structure, which is formed by 
diphosphatidylglycerol together with four acyl chains giving it its dimeric nature. 
This dimer in turn gives rise to a highly specific conical structure favouring the 
hexagonal HII phase of the membrane and is implicated in the membrane fusion 
[Cullis et al., 1986]. 
 
By adopting the hexagonal HII phase, cardiolipin in mitochondria can form contact 
sites between the inner and outer mitochondrial membrane [Ardail et al., 1990]. 
There are 5 genes catalogued in this function (649 until 653 in Appendix C). 
 
1.2.1.17 UREA CYCLE: 
Ammonium ions are formed during the breakdown of amino acids and are used for 
the biosynthesis of nitrogen compounds. The excess free NH4⁺ ions is however toxic 
and is thus quickly converted into the more tolerable form called urea. In this form, 
it can then be secreted. The synthesis of urea is conducted through the urea cycle 
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and any defects in this cycle will result in the build-up of NH4+ in the blood in 
humans (available at: http://www.ncbi.nlm.nih.gov/books/NBK22450/ , accessed 
on August 6, 2015). There are 6 genes catalogued in this function (654 until 659 in 
Appendix C).    
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CHAPTER 2 
 
Methods And Implementation 
 
 
Sequencing is a technique to capture the whole array of nucleotides present in a 
DNA or RNA molecule. One of the major achievement of the sequencing technology 
is the human genome sequencing project, concluded in 2003 [Grada & Weinbrecht, 
2013]. The human genome project was realized by the first generation sequencing 
technology, dominated by Sanger sequencing [Sanger et al., 1977].   
 
With the availability of the human genome, the demand for faster and much cheaper 
alternatives lead to the development of second or next generation sequencing (NGS) 
technology. The major advancements in NGS compared to its predecessor are the 
higher pace and the lower cost of sequencing. There are a number of NGS platforms 
which deliver low cost, high throughput data such as Illumina, Roche 454, Ion 
torrent and SOLiD sequencing [Grada & Weinbrecht, 2013]. In this thesis, the 
sequencing data used for the analysis was RNA-sequencing generated by the 
Illumina sequencing technology.  
 
2.1 RNA-SEQUENCING (RNA-seq):  
Transcriptome analysis reveals a thorough understanding of functional elements of 
the genome and is an effective approach to recognize transcriptional changes during 
development and diseases. It provides an insight into the complete set of 
transcripts, transcriptional structures of the genes and the changing expression 
levels of the transcripts under different conditions. The NGS based approach to 
determine the complete transcriptome, termed RNA-seq, has revolutionized the 
manner in which transcriptomes are analysed.  
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In RNA-seq,  total RNA is sheared into a collection of cDNA fragments with adapters 
attached to one or both ends.  These fragments are deep sequenced to obtain either 
single end reads or paired end reads based on the protocol [Wang et al., 2009].   
 
2.2 ILLUMINA SEQUENCING: 
The Illumina sequencing technology provides a wide variety of applications in 
genomics, transcriptomics and epigenomics. Input samples to be sequenced are 
sheared into smaller sections and attached to slides using adapters.  These 
fragments are PCR-amplified on the slide, creating several copies of the same read.  
 
Single strands from the read to be sequenced are retained on the slides. In the next 
step, the slides are flooded with the fluorescently labelled nucleotides, DNA 
polymerase and a terminator to allow only a single base addition at a time. A 
fluorescent image of the slide indicating the base is recorded. In the next cycle, 
terminator and the fluorescent signal are removed and the addition of the following  
base and imaging process is further continued. Consequently, all signals of an 
Illumina run are recored on a computer and used to construct the sequence 
[available at: https://www.ebi.ac.uk/training/online/course/ebi-next-generation-
sequencing-practical-course/what-next-generation-dna-sequencing/illumina- , 
accessed August 17, 2015].        
       
2.3 BASE CALL ACCURACY:  
The base call accuracy from NGS is determined by the phred quality score, which 
determines the quality of the base call during the sequencing [Ewing & Green, 
1998]. A base call is assigned a quality value q which is logarithmically related to the 
estimated error probability p of that base call. 
                    q = -10 X log10(p) 
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If the quality score of a base is 30 then the error probability of that base call is 
1/1000. The higher the quality value, the lower is the error probability of that base 
call and vice versa.   
 
2.4 TRIM GALORE:  
Trim Galore (available at: 
http://www.bioinformatics.babraham.ac.uk/projects/trim_galore/,  accessed June 
14, 2015) accomplishes both, the removal of the adapter sequences and subsequent 
quality control of the raw RNA-seq reads in a single pass. For adapter sequence 
removal the default 13 bp standard Illumina adapters ('AGATCGGAAGAGC')  suitable 
for both single and paired end libraries are used with the option for the provision of 
other adapter sequences. Trim Galore specifically uses Cutadapt [Martin, 2011] to 
remove adapter sequences from the raw sequencing reads. It removes the reads 
that are too short after the trimming process. However for paired end reads, there is 
an option to retain the best quality partner read, if one of the reads in the read pair 
becomes too short during the trimming process. For the quality control, the phred 
quality value of the base calls can be specified. The processed raw RNA-seq reads 
are output in the form of FastQ files which are quality checked with FastQC 
(available at: http://www.bioinformatics.bbsrc.ac.uk/projects/fastqc/,  accessed 
June 21, 2015).  
 
2.5 ALIGNMENT: 
Alignment is the process of arranging the sequences of DNA, RNA, or protein to 
identify regions of similarity that may be a consequence of functional, structural, or 
evolutionary relationships between the sequences [available at: 
https://en.wikipedia.org/wiki/Sequence_alignment , accessed July 20, 2015]. With 
the advent of NGS data, aligning millions of short to long reads to the reference 
genome is the primary and critical task after the sequencing process. For RNA-seq 
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data, there are a number of aligners that are capable of aligning the reads with high 
accuracy. A brief discussion of the aligners used in this thesis are put forth below: 
    
2.5.1 BWA ALIGNER: 
Burrows-Wheeler Alignment tool (BWA) is a fast short read aligner based on 
backward search with Burrows-Wheeler Transform [Li and Durbin, 2009]. It 
supports both single and paired-end reads, and is also capable of allowing 
mismatches and gaps while aligning reads against a reference sequence.  
 
Performance is reduced with long reads because BWA seeks a global alignment from 
first to last base of the read and long reads may inherently contain structural 
variations or there might be misassemblies in the reference genome. 
 
2.5.2 STAR ALIGNER: 
Spliced Transcripts Alignment to a Reference (STAR) is an ultrafast universal RNA-
seq reads aligner [Dobin et al., 2013]. It has the ability to map both long and short 
RNA-seq reads to the reference sequences. It is provided as a C++ standalone code 
capable of running parallel threads on multicore systems. 
 
It aligns the RNA-seq reads to the genome in a twostep process: 
 
a. Seed search 
In this step, the STAR algorithm discovers for each read the longest substring 
or maximum mappable prefix (MMP) that matches exactly to one or more 
substrings in the genomic sequences. These MMPs serve as the foundations in 
the genome, where the reads are aligned to with allowed mismatches.  
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The advantage of this step is that the algorithm recognizes splice junction 
information for each read without previous information of splice junction 
location. 
 
b. Clustering, stitching and scoring:  
In this step, the algorithm takes the log of all MMPs defined for the whole 
genome in the first phase and builds alignments for the entire read sequence.  
In case of paired end reads, seeds of the mates are clustered and stitched or 
aligned concurrently.  
 
The alignment is validated by the local alignment scoring scheme, which is 
user controlled for defining the penalties for matches, mismatches, insertions, 
deletions and splice junction gaps.  
 
The ability of the STAR algorithm to identify the splice junction information for the 
entire read sequences in the first pass alignment (PASS 1) provides an option to 
accurately align the entire read sequence to the genome in the second pass 
alignment (PASS 2). Alternatively, STAR can also be provided with possible splice 
junction information from an annotation file.    
 
2.5.3 TOPHAT2 ALIGNER: 
The TopHat aligner [Trapnell et al., 2009] is one of the most popular aligners used 
for the RNA-seq experiments. TopHat2 [Kim et al., 2013] is a significant extension of 
TopHat with several important enhancements. It can align both single and also 
paired-end reads with varying lengths. TopHat2 is also enhanced to align reads 
across fusion break events occurring as a consequence of genomic translocations. 
 
Provided with transcriptome annotation file, TopHat2 aligns the reads across the 
known transcriptome with significant speed, sensitivity and accuracy. The 
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unmapped reads that remain after the mapping are realigned to identify novel exons 
and novel introns based on the known junction signals (GT-AG, GC-AG, and AT-AC). 
Some of the reads are remapped with Bowtie2 [Langmead et al., 2012] by splitting 
them into smaller non overlapping segments (25 bp each by default).    
 
2.6 MAPPING QUALITY 
Mapping quality is the post alignment probability that a read aligned belongs to its 
assigned position [Li et al., 2008]. The probability p is calculated as: 
p = 10 -q/10 
Where q is the mapping quality. If for instance, mapping quality value q = 20 then  
p = 10-20/10 
p = 10-2 = 0.01 
Which means there is 0.01 percent chance that the read aligned is erroneous.  
 
2.7 PICARD TOOLS 
The Picard tools (available at: http://broadinstitute.github.io/picard/index.html, 
accessed July 13, 2015) are a set of java command line tools used in the 
manipulation of next generation sequencing data. The tools are implemented in the 
HTSJDK (available at: http://samtools.github.io/htsjdk/ , accessed July 13, 2015) 
java library and supports both SAM and BAM formats retrieved during NGS data 
analysis.  
 
2.7.1 MARK DUPLICATES           
During the sequencing process DNA molecules are sequenced several times 
resulting in the accumulation of duplicate reads, which would distort the calling of 
putative variants during SNP analysis.  
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MarkDuplicates (available at: http://broadinstitute.github.io/picard/command-
line-overview.html#MarkDuplicates , accessed July 13, 2015) is a Picard command 
line tool which inspects the alignments to locate and subsequently flag duplicate 
reads, such that they will be ignored in downstream SNP calling steps. 
  
2.8 THE GENOME ANALYSIS TOOLKIT (GATK): 
GATK is a software package developed for the analysis of next generation DNA 
sequencing data [Mckenna et al., 2010], emphasizing principally on variant 
discovery and genotyping [Depristo et al., 2011].    
 
The toolkit maintains a stable and most upto date version of tools called “walkers”, 
that can be used individually or in combination eventuating into pipelines for the 
analysis of data. It is built to be highly generic and can be used for multiple 
organisms including humans. 
 
It is proficient in handling whole genome, exome and also RNA-seq data and for each 
kind of data, best practices recommendations for variant calling are provided and 
updated frequently [Van der Auwera, 2013].  
 
2.8.1 SPLIT’N’TRIM: 
This step includes the removal of the sequences overhanging into intronic regions. 
The process involves slicing the reads into exonic segments by hard clipping the 
part mapped to the intronic region. This is achieved by GATK’s SplitNCigarReads 
tool (available at: 
https://www.broadinstitute.org/gatk/guide/tooldocs/org_broadinstitute_gatk_tool
s_walkers_RNA-seq_SplitNCigarReads.php, accessed July 19, 2015). It is mainly 
focussed on reducing false calls generated by the reads mapping to intronic regions. 
 
2.8.2 REASSIGN MAPPING QUALITIES: 
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STAR aligner assigns a mapping quality value of 255 for good alignments, which 
technically means “UNKNOWN” and would be rejected by GATK during the variant 
calling step. 
This is circumvented by reassigning the mapping quality value of 255 to 60, which is 
acceptable by GATK. Reassigning mapping qualities is accomplished by the tool, 
ReassignOneMappingQualityFilter (available at: 
https://www.broadinstitute.org/gatk/gatkdocs/org_broadinstitute_gatk_engine_filt
ers_ReassignOneMappingQualityFilter.php, accessed July 19, 2015). 
 
2.8.3 REALIGNMENT AROUND INDELS: 
Mapping artifacts around indels often are miscalled as SNPs. To avoid this, a 
realignment process is done, which identifies the region for reads around indels to 
eliminate these artifacts.  
 
Realignment is achieved in two steps: 
a. In the first step, genomic intervals that require realignment are identified. 
This task is achieved by RealignerTargetCreator tool (available at: 
https://www.broadinstitute.org/gatk/guide/tooldocs/org_broadinstitute_gat
k_tools_walkers_indels_RealignerTargetCreator.php , accessed July 20, 2015). 
b. In the second step, realignment of reads is performed after identifying the 
optimal consensus sequence. Local realignment of reads around indels is 
performed by IndelRealigner tool (available at: 
https://www.broadinstitute.org/gatk/guide/tooldocs/org_broadinstitute_gat
k_tools_walkers_indels_IndelRealigner.php, accessed July 20, 2015 ). 
 
2.8.4 BASE RECALIBRATION: 
Variant calling algorithms use base quality score as a criteria to call variants in the 
genomic data. Quality scores assigned to individual bases in the sequencing read are 
subjected to various sources of systematic errors. These systemic errors could lead 
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to the erroneous base calls.  Base quality score recalibration adjusts the base quality 
scores in the data based on a model of covariation calculated based on a list of 
already known SNPs, such as dbSNP [Sherry et al., 2001]. This step is accomplished 
by the tool BaseRecalibrator (available at: 
https://www.broadinstitute.org/gatk/guide/tooldocs/org_broadinstitute_gatk_tool
s_walkers_bqsr_BaseRecalibrator.php, accessed July 20, 2015). 
 
2.8.5 VARIANT CALLING AND FILTERING: 
This step involves the identification of variant sites corresponding to the reference 
genome and calculates the genotypes of each sample at that site. The major 
challenge is to establish a balance between sensitivity (minimize false negatives: 
inability of the model to predict real variants) and specificity (minimize false 
positives: failure of the model to recognize false variants). This balance is achieved 
by dividing this process into two steps: 
a. The variant calling step: This step aims to maximize sensitivity by conducting 
local de-novo assembly of reads in the active region to identify SNPs and 
indels simultaneously. This is accomplished by the tool HaplotypeCaller 
(available at: 
https://www.broadinstitute.org/gatk/guide/tooldocs/org_broadinstitute_gat
k_tools_walkers_haplotypecaller_HaplotypeCaller.php . accessed July 20, 
2015). 
b. The variant filtering step: This step aims to achieve maximum specificity and 
can be customizable by users based on the data. Here the output generated by 
the HaplotypeCaller is subjected to hard filtering such as minimum base 
quality, strand bias, clustered SNPs and many more. This step is accomplished 
by the tool VariantFiltration (available at: 
https://www.broadinstitute.org/gatk/guide/tooldocs/org_broadinstitute_gat
k_tools_walkers_filters_VariantFiltration.php . accessed July 20, 2015).  
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2.9 SNPiR FILTRATION:  
To further process and minimize false positives from the filtered data obtained from 
GATK’s VariantFiltration step, several filtering steps are defined in the study 
“Reliable identification of genomic variants from RNA-seq data” [Piskol  et al., 2013]. 
These include the removal of false calls in the repetitive regions of the genome, in 
homopolymer regions, removal of variants close to splice junctions and finally 
filtering known RNA editing sites.     
 
2.10 ONCOTATOR: 
Oncotator is a tool which annotates point mutations and indels integrating cancer 
relevant information to the annotations [Ramos et al., 2015]. It is available as a web 
server [available at: http://www.broadinstitute.org/oncotator , accessed July 21, 
2015], which restricts the amount of data submission. However a standalone 
version can be used in case of large amounts of data.     
 
2.11 MITOWHEEL: 
MitoWheel is a web based visual representation of the human mitochondrial 
genome [Zsurka and Csordás, 2009]. It displays the revised Cambridge reference 
sequence and has several components to browse upon (available at: 
http://mitowheel.org/mitowheel.html . accessed July 21, 2015). 
 
The mitochondrial genome is represented in a circular manner which can be 
spinned to view specific components of the genome such as its genes. It also consists 
of a search box to specifically select a region of interest. One important feature of 
the tool is its ability to map mutations to understand the genes affected and the 
functional consequences.   
 
2.12 CUFFLINKS PACKAGE:  
 33 
Cufflinks [Trapnell et al., 2012] works with TopHat alignment files of each condition 
and is designed to address the issue of alternative splicing events in the genes. 
Cufflinks [Trapnell et al., 2012] collects a transcriptome assembly and then reports 
full length transcript fragments or transfrags, which explains all the splicing events 
in the input data. Post assembly, expression abundance of each transfrag is 
quantified in the data using a rigorous statistical model of RNA-seq and is reported 
as Fragments Per Kilobase of transcript per Million fragments mapped (FPKM) 
[Trapnell et al., 2010].   
 
2.12.1 CUFFMERGE: 
For all the samples in the experiment, Cuffmerge performs a meta assembly of the 
transfrags which were put forth by the Cufflinks process. Provided a reference 
genome annotation file, it integrates the reference transcripts into a merged 
assembly producing a single annotation file to be used for differential analysis 
[Trapnell et al., 2012]. 
 
2.12.2 CUFFDIFF: 
Cuffdiff [Trapnell et al., 2012]calculates the expression difference between two or 
more samples in an experiment and tests the statistical significance of the observed 
change in expression between them. Multiple replicates, either biological or 
technical can be provided per condition and Cuffdiff learns for each gene the 
variation among the replicates to calculate the significance of expression change 
[Trapnell et al., 2012].  
 
2.13 VARIANT DISCOVERY WORKFLOW: 
The discovery of the variants in the form of mutation sites and expression difference 
between two samples (Normal vs. Disease) is conducted by following the workflow 
depicted in the Figure 3.  
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The fasta files generated from the RNA-seq forms the input, which then proceeds 
into the mutation sites analysis workflow (see section 2.13.1) and subsequently into 
the expression analysis workflow (see section 2.13.2). Final output of this step is the 
generation of two files:  one output file contains the mutation sites and the second 
one the expression difference specific to the disease state. 
 
 
 
Figure 3: Variant discovery workflow 
 
2.13.1 MUTATION SITES ANALYSIS WORKFLOW: 
To discover mutation sites in both the nuclear and mitochondrial genomes, specific 
workflows were designed. In this section a general overview of the variants 
workflow is briefly discussed.  
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In each experiment, the workflow (Figure 4) begins with the FASTQ files of each 
sample  as the input file. Reads may be single- or paired-end depending on the 
design of the experiment. The input file then enters individually into the nuclear 
genome variant analysis workflow (see section 2.13.1.1) and mitochondrial genome 
variant analysis workflow (see section 2.13.1.2), the results of which are 
subsequently manipulated by several analytical processes. Finally, an output file 
with the list of mutations and its annotations giving information about the gene 
harboring the mutation, as well as its potential effect on the protein function is 
returned.  
 
After obtaining the mutation sites and its annotations for both samples (usually 
Normal vs. Disease), disease-specific data is extracted by comparing it with the 
normal data. 
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Figure 4: Overview of variants analysis workflow depicting the levels of data handling 
(input, manipulation and output). 
 
2.13.1.1 NUCLEAR GENOME VARIANT ANALYSIS WORKFLOW: 
For each sample in the experiment, identification of variants in RNA-seq data is 
achieved by following the best practice recommendations provided by GATK  ( 
available at: https://www.broadinstitute.org/gatk/guide/best-
practices?bpm=RNAseq . accessed on July 21, 2015). 
 
Module I. Pre-processing RNA-seq reads: 
This module pre-processes raw RNA-seq reads, which includes removal of adapter 
sequences and quality control. This is achieved by processing the raw RNA-seq 
reads using Trim Galore (see section 2.4) with selecting default adapter sequence 
for illumina reads and a quality cutoff score of 20 on phred scale. 
 
The processed FastQ reads move over to module II, and here they are mapped to the 
reference genome. 
 
Module II. Map to the Reference genome: 
This module maps pre-processed RNA-seq reads to the human genome version 19. 
This is accomplished by the STAR aligner (see section 2.5.2) using the 2-PASS 
approach, wherein the first pass (1-PASS) identifies the splice junctions and then 
guides the second pass (2-PASS) towards the final alignment.  
MarkDuplicates (see section 4.3a), a command line tool belonging to the Picard tool 
(see section 4.3) is used to remove duplicate reads.   
 
The final alignment file in BAM format further pre-processed (module III) for 
subsequent variant detection using the variant calling and filtering module (module 
IV). 
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Module III.  Pre-processing alignment file: 
Module III pre-processes the alignment file for variant calling by removing 
overhanging reads in intronic regions. This is accomplished by the tool Split’N’Trim 
(see section 2.8.1) available in the GATK (see section 2.8) package. 
 
Furthermore, the mapping quality value of the alignment file is adjusted using a tool 
called ReassignOneMappingQualityFilter (see section 2.8.2) offered in the GATK 
package. 
 
Finally, local realignment around indels is performed (see section 2.8.3) and base 
score recalibration is done using the tool BaseRecalibrator (see section 2.8.4) 
provided by GATK package. 
 
The alignment file in BAM format is next submitted to varant calling and filtering 
(module IV). 
 
Module IV. Variant calling and filtering: 
In this module the critical task of variant calling (see section 2.8.5) is performed. 
Identified variants are subsequently filtered to obtain the bona fide variants present 
in a sample. 
 
Filtering of the variants is done using the SNPiR pipeline (see section 2.9). In this 
step, false calls are removed in repetitive regions of the genome, homopolymer 
regions, around splice junctions and known RNA editing sites. Finally, one is left 
with the most likely, genomic SNPs. 
 
Module V. Annotation of filtered variants: 
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The final annotation of identified variants is achieved by the Oncotator tool (see 
section 2.10).  
 
2.13.1.2 MITOCHONDRIAL GENOME VARIANT ANALYSIS: 
In this section, the prediction of variants in the form of homoplasmic or 
heteroplasmic sites in the mitochondrial genome is described. The workflow to 
decode heteroplasmic sites in mitochondrial genome was adapted from the work of 
[Goto et al., 2011] and was integrated in a Galaxy workflow [available at: 
https://usegalaxy.org/u/aun1/p/heteroplasmy, accessed on July 21, 2015], which 
is an open, web based platform to do biomedical research [Giardine et al., 2005].  
The workflow is divided into several modules as detailed below. 
 
Module I. Pre-processing RNA-seq reads:  
This module pre-processes raw RNA-seq reads, which includes removal of adapter 
sequences and quality control. Trim Galore (see section 2.4) was used with selecting 
default adapter sequence for illumina reads and a quality cutoff score of 20 on phred 
scale. 
 
The processed FastQ reads are in the next step mapped to the reference genome 
(module II). 
 
Module II. Map to the Reference genome: 
The filtered reads are mapped to the human mitochondrial revised Cambridge 
reference sequence [Andrews et al., 1999]. Since the mitochondrial genome is a 
circular molecule, the genome has to be extended on both ends by the length of the 
input reads -1. Reads are mapped to this extended genome using the BWA aligner 
(see section 2.5.1) with the default settings.  
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The alignment file in BAM format is further used for calling variant sites (module 
III).  
 
Module III. Segregating the alignment file: 
In this module reads mapped to the plus strand are separated from reads mapped to 
the minus strand of the genome.  
 
Both resulting read files are investigated for variant sites with a minimum coverage 
of 100 reads and the base quality value of 20. Only variant sites passing this filter 
are retained for further processing. 
 
Module IV. Applying conservative filter settings:   
For mitochondrial variant calling, a conservative variant detection setting of at least 
5 % coverage a and base quality value of 20 on the phred scale is applied to call the 
variants. Variant calling is done for all reads in plus and minus direction separately.  
 
 Module V. Calling variant sites:  
Variants present in the plus and minus strand files are merged and those sites which 
are common to both the files are chosen and retained as bona fide variant sites. This 
process eliminates the variants present on only strand, which are moste likely due 
to technical issues during sequencing. 
 
The variant sites are further manually analysed for their hetero- and homoplasmic 
nature. Further annotation information is extracted for the variants by mapping 
them on MitoWheel (see section 2.11).    
 
2.13.2 EXPRESSION ANALYSIS WORKFLOW: 
Differential gene expression analysis for two conditions (Normal and Disease) is 
done in a workflow described below:  
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Module I. Pre-processing RNA-seq reads: 
Pre-processing of reads is done as described in section 2.13.1.1 Module I, 
 
Module II. Map to the Reference genome:  
Pre-processed RNA-seq reads for the 2 conditions to be compared are individually 
mapped to the reference genome using TopHat2 (see section 2.5.3) with default 
settings. The alignment files is then submitted to transcriptome assembly and 
merging (module III).  
 
Module III. Transcriptome assembly and merging: 
For both conditions, Cufflinks assembles full length transcripts for all the genes 
expressed and provides an expression value in form of a metric called FPKM (see 
section 2.12).   
 
The transcriptomes of both conditions are merged by Cuffmerge (see section 2.12.1) 
and further annotated using a provided annotation file.  
 
Module IV. Differential expression of genes: 
Keeping the merged transcriptomes as background gene models, Cuffdiff (see 
section 2.12.2) calculates the expression difference between two conditions and 
provides the statistical significance of the expression change between two samples. 
 
2.14 MITOCHONDRIAL MODEL (MitoModel): 
The MitoModel is a web-based application that was developed for analysing 
mitochondrial contributions in diseases. The main aim is to map analysed 
expression and/or mutation data from NGS studies onto MitoModel. By this, we can 
identify the mitochondria specific metabolic and physiological changes in the 
disease state compared to the normal condition. 
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2.14.1 MITOMODEL CONSTRUCTION:   
MitoModel is an amalgamation consisting of 659 human genes, which are 
functionally associated with mitochondria (see Appendix C). It represents a closely 
connected network, with interactions among 659 genes being fetched from string 
database [Szklarczyk et al. 2015] with a medium confidence score of 0.40 and above 
for each interaction. In summary, the human and mouse MitoModel illustrates 659 
genes with 10985 and 12571 interactions among them respectively.     
A similar MitoModel for mouse was constructed by deriving 659 mouse orthologous 
genes from the human gene set, using the HCOP’s human orthology prediction [Eyre 
et al., 2007]. MitoModel is classified in 17 mitochondria-specific processes (Figure 
5).  
 
MitoModel considers the following parameters for the differentially expressed 
genes: A gene is observed as up-regulated if its log2fold change is greater than 1.5 
and second, p-value is less than 0.05. A gene is observed as a down-regulated gene if  
its log2fold change less than -1.5 and its p-value is less than 0.05. 
 
MitoModel uses different visual cues for displaying gene expression. A ciruclar node 
corresponds to a gene that is neither up- or down-regulated. An up-triangle and 
down-triangle nodes correspond to genes, which are up-regulated or down-
regulated, respectively. Mutation sites mapped on the MitoModel are depicted as 
cross nodes and finally a diamond-shaped node represents a gene that is mis-
regulated (up- or down-regulated) and also harbors a mutation.  
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Figure 5: Visual representation of MitoModel with functions as clusters annotated with 
their names   
 
One of the major advantage of the MitoModel is the fact that it is highly interactive.  
If the cursor moves on to a single node, a small window pops up with information on 
the selected gene, such as its name, function, expression values of the normal and 
disease samples, its p-value and finally, information on observed mutations in the 
samples (Figure 6).  In addition to gene-relevant information, all interactions of the 
gene to partners within and across functions are shown.  
 
The design and concept of the MitoModel was derived from the work developed by 
Jim Vallandingham (available at: http://flowingdata.com/2012/08/02/how-to-
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make-an-interactive-network-visualization/, accessed July 23, 2015) and 
restructured by us to fulfil our specific requirements. 
 
The MitoModel is complemented by an enrichment analysis, identifying the most 
affected functions based on the percentage changed genes [Percentage = (number of 
affected genes in the function / total genes in the function) X 100].  
Analysed functional categories are represented as clusters, whereby each node 
corresponds to a gene (Figure 7). The size of the node corresponds to the log2fold 
change value, where higher log2fold change corresponds to bigger circle and vice 
versa. The colour corresponds to the gene regulation, where blue corresponds to 
up-regulation, green corresponds to no differential regulation and red corresponds 
to down-regulation. The nodes with dark borders represents genes containing 
mutations.  
 
Differentially regulated genes in MitoModel (Figure 8) are also displayed as a graph 
briefly described below: two horizontal lines describe log2fold change cutoff values 
(up: 1.50 and down: -1.50) and a vertical line describes the p-value cutoff (0.05).  
The overall expression pattern is printed, giving an idea about the number of up-
regulated and down-regulated genes. In Figure 9, for example, there is a higher 
number of down-regulated genes compared to up-regulated genes. 
 
The design and concept, for the display of enrichment analysis were adapted from 
the work by Shan Carter (available at: 
http://www.nytimes.com/interactive/2012/02/13/us/politics/2013-budget-
proposal-graphic.html , accessed July 23, 2015) and restructured (kindly provided 
by José Villaveces, Computational Biology group, Max Planck Institute of 
Biochemistry) to our specific needs. 
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Figure 6: A simple depiction of the interactive ability brandished by the MitoModel 
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Figure 7: An instance of Percentage (%) affected functions observed on the MitoModel  
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Figure 8: Graphical visualization of overall expression changes in MitoModel 
 
 
 
Figure 9: A further graphical representaiton of the MitoModel’s overall expression pattern 
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2.14.2 MITOMODEL IMPLEMENTATION: 
MitoModel is implemented in the form of a web-server, which can be accessed by 
users for analysing their own data. An overview of the architecture is shown in 
Figure 10. The interaction between the users and the web-server takes place in 
three simple steps. 
 
 
Figure 10:  An overview of the interaction architecture between user and MitoModel 
server 
 
Step 1. User submission of input data: 
The MitoModel server is designed to accept both, expression and the mutation data 
at once and map them on to MitoModel simultaneously. Users with only expression 
or mutation data can also submit these data individually to obtain mapped results 
on MitoModel. Both the expression (Table 1) and the mutation (Table 2) input files 
are accepted as tab-separated files.   
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Gene Name Condition 1 Condition 2 Log2fold p-value 
SlC25A34 5.14185 0.525591 -3.29027 0.04165 
EPHB2  21.6398 77.9794 1.84941 0.03615 
CD52 113.979 24.01 -2.24706 0.14155 
MFSD2A 2.671 16.7198 2.64611 0.0318 
 
Table 1: An example of a tab-seperated expression input file  
 
The expression input file has 5 columns, including gene name in form of the official 
gene symbol (presently only NCBI gene symbols are recognized), condition 1 with = 
expression values of the control (normal) condition, condition 2 with expression 
values of the disease state, the Log2fold with the log2fold changes observed 
between condition 1 and 2 and finally the p-value stating the statistical significance 
of the observed differential expression.     
 
Gene Name Chromosome Position Reference allele Variant allele Mutation type Consequence 
MT-CO2 M 8159 T C SNP Missense 
AGO1 1 36391661 TGAA T DEL 3'UTR 
ITIH1 3 52825585 T C SNP Silent 
GPR35 2 241566012 G A SNP Intron 
 
Table 2: An example of a tab-seperated mutation input file 
 
The mutation input file has 7 columns, which are Gene Name (again the official gene 
symbol offered by NCBI), Chromosome, giving the chromosome number the 
mutated gene is located on, position with the chromosomal position of the mutation, 
reference allele with the base observed in the reference genome, variant allele with 
the observed mutation from the dataset, mutation type, interpreted as the type of 
mutation, and finally consequence, predicting the functional consequence of the 
mutation in the specific gene.  
 
Step 2. Web-server interaction: 
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Once the data is submitted, a unique session-string is created, which represents the 
input data of the user and will keep the session exclusive for that user.  
 
The MitoModel server comprises a database layer which is created using MySQL 
(available at: http://www.mysql.com/ . accessed July 26, 2015) database. It includes 
two components, mitochondrial genes and their function layers and the interaction 
among the mitochondria genes.  
 
Immediately after the input data is received by the MitoModel server, the expression 
or mutation data or both are extracted and mapped to the genes that are present in 
the mitochondria gene and function layer from the database. The integrated data 
along with all the interactions from the interaction layer are bound together as a 
JSON file (available at: http://www.json.org/, accessed July 26, 2015) to be 
displayed on the webpage.  
 
Step3. MitoModel server output: 
The MitoModel server output consists of two elements. The first one is the 
interactive webpage, which gives the user a glimpse of the mapped MitoModel, 
including a brief information of the gene function, its interactors, expression related 
values and mutation information. In addition to the visual enrichment analysis 
described above, the user can also download a tab-separated file with (Table 3) 
information about the up-regulated, down-regulated and mutated genes, all 
clustered according to their respective mitochondrial processes.     
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Table 3: An example of MitoModel variant output file 
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CHAPTER 3 
 
RESULTS 
 
 3.1 Gene expression and mutation analysis using 
MitoModel in three different aneuploidy cell lines 
 
 
Aneuploidy refers to an abnormal chromosome count in a cell, whose chromosome 
numbers are either greater or smaller than its wild type on the level of the whole 
genome or part of it [Griffiths et al., 2000]. These extra copies of chromosomes are 
detrimental to eukaryotic cells. In humans, chromosomal abnormalities are often 
detected in cancer [Gordon et al., 2012], developmental growth, mental retardation 
and multiple congenital malformations. The elementary process of how aneuploidy 
is formed and what its consequences are to the cell remain illusive to date [Biancotti 
& Benvenisty, 2011].   
 
To further our knowledge on the underlying mechanisms of aneuploidy, aneuploid 
cell lines were created in the lab of Zuzana Storchova. Three cell lines were created 
in this project: tetrasomic derivatives of HCT116 carrying 4 additional copies of 
chromosome 5 (HCT116 5/4), trisomic derivatives of RPE1 carrying 3 additional 
copies of chromosome 5 and 12  (RPE1 5/3 12/3) and trisomic derivatives of  RPE1 
carrying 3 additional copies of chromosome 21 (RPE1H2B 21/3) [Stingele et al., 
2012]. Cell lines were further investigated by Dürrbaum et al in 2014, revealing that 
complex aneuploidy exhibits the same pathway changes as simple trisomy and 
tetrasomy [Dürrbaum et al., 2014]. 
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3.1.1 TASK DESCRIPTION:  
The data used for this task was generated at Max Planck institute of Biochemistry by   
Milena Dürrbaum and Zuzana Storchová and provided for us for further analysis of 
mitochondrial functions. The data included RNA-seq samples of  HCT116 5/4, RPE1 
5/3 12/3 and RPE1H2B 21/3 with their corresponding wild types. All sample were 
provided with 3 biological replicates.    
 
Our task was to deduce the differential expression and the mutation data specific for 
each cell line and map them on to MitoModel to identify mitochondrial variations in 
each cell line.  
 
3.1.2 DATA ANALYSIS: 
The mutation and expression data for each cell line and for each replicate were 
generated by comparing aneuploidy cell lines with their wild type cell lines by 
following the workflow defined in the section 2.13. Subsequently, only aneuploidy 
specific variants were recorded and input files specifics for MitoModel were 
prepared. The input files were prepared following the MitoModel format 
specification described in the section 2.14.2. 
 
The MitoModel input files for each cell line were then mapped to the MitoModel to 
obtain individual MitoModels for each cell line.  
 
3.1.3 MitoModel of the HCT116 5/4 cell line: 
A simple depiction of the HCT116 5/4 MitoModel, after mapping the mutation and 
expression input files, describes the nodes with mutations, as well as nodes, which 
were up-regulated and down-regulated in respective functions (Figure 11).  
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Figure 11: Visual display of the HCT 116 5/4 MitoModel 
 
Crucial functions that were observed to be affected based on the percentage are: 
Pyruvate transfer with 50%; Cardiolipin biosynthesis with 40%; Fe-S cluster 
biosynthesis with 34.48%; Heme biosynthesis with 33.33%, and so on (Figure 12). 
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Figure 12: Percentage (%) of affected functions observed on the HCT116 5/4 MitoModel 
 
To understand the role of variant genes, each function and the roles of the variant 
genes in them were further studied. 
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Electron transport chain and energy production 
Seven genes were up-regulated (Table 4), fifteen genes were down-regulated (Table 
5) and three genes were mutated (Table 6) in the electron transport function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
NDUFA2 0.850331 0.00025  
Nuclear encoded essential components of complex 
I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
NDUFS4 0.961887 0.00005 
NDUFS8 0.424532 0.0305 
UQCRC2 0.376153 0.0433 Nuclear encoded essential components of complex 
III,  transfers electrons from ubiquinol to 
cytochrome c UQCRQ 1.00534 0.00005 
COX7C 0.668317 0.00005 
Nuclear encoded cytochrome c oxidase subunits, 
essential components of complex IV, catalyses the 
reduction of oxygen to water by cytochrome c 
COX20 1.09111 0.02635 Assembly factor of complex IV 
 
Table 4: Up-regulated genes in the electron transport chain function of HCT116 5/4 cell 
line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
NDUFA5 -0.46989 0.0244  
Nuclear encoded essential components of complex 
I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
NDUFB9 -0.461298 0.0151 
NDUFS5 -0.523087 0.00515 
NDUFAF2 -0.499981 0.03065 Assembly factor of complex I 
NDUFAF4 -0.780722 0.00085 Assembly factor of complex I 
C8orf38 -0.526286 0.0299 Complex I assembly factor 
SDHAF1 -0.69955 0.00405 Complex II specific assembly factor 
UQCR10 -0.495375 0.01375 
Nuclear encoded essential components of complex 
III,  transfers electrons from ubiquinol to 
cytochrome c 
PTCD2 -0.463894 0.0383 
Complex III assembly factor, process RNA 
transcripts involving cytochrome b 
CHCHD8 -0.656802 0.0018 Complex IV assembly factor 
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C1orf31 -0.544031 0.01835 Required for the stability of complex IV subunit 
SELRC1 -0.920491 0.00005 Complex IV assembly factor 
COX11 -0.75564 0.0388 Complex IV assembly factor 
ATP5G1 -0.776189 0.00015 
Nuclear encoded ATP synthase subunits, essential 
components of complex V, reversible pump of 
protons into matrix with formation of ATP 
ATPIF1 -0.598401 0.0028 
Endogenous inhibitor subunit of ATP synthase, 
essential component of complex V 
 
Table 5: Down-regulated genes in the electron transport chain function of HCT116 5/4 cell 
line 
 
GENE NAME CHROMOSOME VARIANT 
DESCRIPTION 
ROLE 
MT-ND4 M 
10827 T/C: SNP: 
Missense_Mutation 
Mitochondrially encoded NADH 
dehydrogenase, part of enzyme complex 
I, involved in the reduction of 
ubiquinone by NADH 
CYC1 8 
145151091 G/A: SNP: 
Missense Mutation 
Nuclear encoded essential components 
of complex III,  transfers electrons from 
ubiquinol to cytochrome c 
UQCRQ 5 
132203152 T/G: SNP: 
Intron 
Nuclear encoded essential components 
of complex III,  transfers electrons from 
ubiquinol to cytochrome c 
 
Table 6: Mutated genes in the electron transport chain function of HCT116 5/4 cell line 
 
We observe that several essential subunits and assembly factors of multiple 
complexes in the electron transport chain is down-regulated in the HCT116 5/4 cell 
line. For example, NDUFAF2, SDHAF1, PTCD2 and COX11, which are assembly 
factors of complex I, II, III, and IV respectively are down-regulated. There were also 
mutations in essential subunits of the complexes in the electron transport chain. 
This suggests that generation of energy by the electron transport chain might be 
lower in HCT116 5/4 cell line compared to its wild type cell line. 
  
Fatty acid beta oxidation and generation of acetyl CoA 
 57 
Seven genes were up-regulated (Table 7), seven genes were down-regulated (Table 
8) in the fatty acid beta oxidation function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
SLC25A20 0.498288 0.024 
Carnitine acylcarnitine translocase mediates 
acylcarnitine entry into mitochondria 
CRAT 1.9068 0.00005 
Free carnitine in the mitochondria is converted 
into acyl carnitine by the action of carnitine 
acetyltransferase 
ACADVL 0.839364 0.00005 
Very long chain acyl-CoAs are first catalyzed by 
long chain acyl-CoA dehydrogenase 
SLC27A6 1.24661 0.00005 
Readily converts the transported very long chain 
fatty acids to acyl-CoAs 
ACSL1 0.698046 0.0005  
Acyl-CoA synthetase activity for long chain free 
fatty acids and are also involved in the activation 
of fatty acids 
ACSL4 0.545756 0.0037 
ACSL6 3.73374 0.00005 
 
Table 7: Up-regulated genes in the fatty acid beta-oxidation function of HCT116 5/4 cell 
line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
SLC27A5 -1.37114 0.00005 
Readily converts the transported very long chain 
fatty acids to acyl-CoAs 
ACSL5 -4.37085 0.00005 
Acyl-CoA synthetase activity for long chain free 
fatty acids and are also involved in the activation 
of fatty acids 
ACSM3 -2.47286 0.0097 
Acyl-CoA synthetase activity for medium chain 
fatty acids 
ACSBG1 -1.48929 0.00075 
Acyl-CoA synthetase activity for bubblegum family 
members 
FABP5 -1.77518 0.00005 
Fatty acid binding proteins involved in the import 
and export of fatty acids 
CPT1C -3.3842 0.00005 
Carnitine palmitoyl transferase converts an acyl-
CoA into an acylcarnitine 
ACAA2 -0.755026 0.0004 Medium chain 3-ketoacyl-CoA thiolase 
 
Table 8: Down-regulated genes in the fatty acid beta-oxidation function of HCT116 5/4 cell 
line 
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We observe that carnitine acyl-CoA translocase, which mediates the transfer acyl 
carnitine into mitochondria is up-regulated. In addition ACADVL, which is involved 
in first step metabolism of very long chain fatty acids inside mitochondria is up-
regulated.  This suggests that generation of acetyl-CoA inside mitochondria might be 
higher in HR mouse line. 
 
Apoptosis  
Four genes were up-regulated (Table 9), six genes were down-regulated (Table 10) 
and three genes were mutated (Table 11) in the apoptosis function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
APAF1 0.654363 0.0017 
Binds CASP9 forming an apoptosome and 
activates it 
BCL2L1 0.762541 0.00005 Bcl-2 family member Anti-apoptotic proteins 
PMAIP1 0.761637 0.00015 Noxa Bcl-2 family member propagating apoptosis 
VDAC1 1.02475 0.00005 
Voltage dependent anion channel forms part of 
permeability transition pore 
 
Table 9: Up-regulated genes in the apoptosis function of HCT116 5/4 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
BIK -1.10509 0.00005 Bcl-2 family member propagating apoptosis 
BID -0.397959 0.0441 Bcl-2 family member propagating apoptosis 
TP53 -0.527106 0.0115 
Directly binds both BAK and BAX and activates 
them 
SLC25A5 -0.417006 0.02385 
Adenine nucleotide translocator forms part of 
permeability transition pore 
PPIF -0.782612 0.00005 
Cyclophilin D forms part of permeability 
transition pore 
ANP32A -0.509277 0.00615 Enhances APAF1 function 
 
Table 10: Down-regulated genes in the apoptosis function of HCT116 5/4 cell line 
 
GENE NAME CHROMOSOME VARIANT 
DESCRIPTION 
ROLE 
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MAPK1 22 
22117726 CT/C: 
DEL: 3'UTR 
Inhibitors of CASP9 activity 
BAX 19 
49459104 A/G: 
SNP: Intron 
Bcl-2 family member propagating 
apoptosis 
ANP32A 15 
69072241 C/A: 
SNP: 3'UTR 
Enhances APAF1 function 
 
Table 11: Mutated genes in the apoptosis function of the HCT116 5/4 cell line 
 
We observe several genes involved in propagating apoptosis are down-regulated. 
For example, BIK and BID, which propagates apoptosis are down-regulated. In 
addition, TP53, which activates apoptotic proteins is down-regulated and BCL2L1, 
which is an anti-apoptotic protein is up-regulated. Thus we hypothesize that the 
apoptosis handling by mitochondria in the HCT116 5/4 cell line is lower and the cell 
death is rather deviated.  
 
Heme biosynthesis 
One gene was up-regulated (Table 12) and two genes were down-regulated (Table 
13) in the heme biosynthesis function. 
  
GENE NAME LOG2FOLD P-VALUE ROLE 
ALAS1 0.519619 0.00555 
Catalyzes the reaction in which glycine and 
succinyl CoA from TCA cycle condenses to form 
aminolevulinate (ALA) and CO2 
 
Table 12: Up-regulated genes in the heme biosynthesis function of HCT116 5/4 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
CPOX -0.44759 0.0161 
Coproporphyrinogen III is transported to 
mitochondria and in the presence of 
coproporphyrinogen III oxidase it is oxidatively 
decarboxylated 
UROD -0.458474 0.02375 
Uroporphyrinogen III decarboxylase catalyzes 
stepwise decarboxylation of the 
Uroporphyrinogen III forming 
Coproporphyrinogen III 
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Table 13: Down-regulated genes in the heme biosynthesis function of HCT116 5/4 cell line 
 
We observe two genes involved in catalyzing the synthesis of heme are 
downregulated. For example, CPOX and UROD catalyze the consecutive steps in 
generation of heme. This suggests that synthesis of heme in the HCT116 5/4 cell line 
could be lower compared to its wild type cell line.  
 
Glycolysis 
Seven genes were up-regulated (Table 14) and three genes were down-regulated 
(Table 15) in the glycolysis function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
SLC2A1 0.432796 0.01935  
Basal glucose uptake, present in all mammalian 
tissues SLC2A3 2.87322 0.00005 
PFKP 0.582218 0.0018 
Fructose 6-phosphate is phosphorylated to 
fructose 1,6-bisphosphate, catalyzed by 
phosphofructokinase 
ALDOA 0.694506 0.00045 
Fructose 1,6-bisphosphate converted into 
glyceraldehyde 3-phosphate and 
dihydroxyacetone phosphate catalyzed by 
aldolase 
GAPDH 0.440829 0.0264 
Glyceraldehyde 3-phosphate is converted into 
1,3-bisphosphoglycerate catalyzed by 
glyceraldehyde 3-phosphate dehydrogenase 
PKM2 1.1138 0.00005 
Phosphoenolpyruvate is converted into pyruvate 
and ATP is produced, catalyzed by pyruvate 
kinase 
LDHA 0.906536 0.00005 
Pyruvate is converted to lactate catalyzed by 
lactate dehydrogenase 
 
Table 14: Up-regulated genes in the glycolytic function of HCT116 5/4 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
PFKM -0.637924 0.00065 
Fructose 6-phosphate is phosphorylated to fructose 1,6-
bisphosphate, catalyzed by phosphofructokinase 
ENO3 -0.510749 0.0458 
2-phosphoglycerate is converted into 
phosphoenolpyruvate catalyzed by enolase 
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LDHB -0.502223 0.0062 
Pyruvate is converted to lactate catalyzed by lactate 
dehydrogenase 
 
Table 15: Down-regulated genes in the glycolytic function of HCT116 5/4 cell line 
 
We observe genes catalysing several steps of the glycolysis function are up-
regulated. For example, PFKP, ALDOA and GAPDH catalysing consecutive steps are 
up-regulated. In addition PKM2, which catalyzes the conversion of 
phosphoenolpyruvate to pyruvate resulting in the generation of glycolytic ATP is 
up-regulated. Further the step in which pyruvate is converted to lactate is up-
regulated. This suggests that generation of glycolytic energy is higher in HCT116 
5/4 cell line compared to its wild type cell line. 
 
TCA cycle 
Two genes were up-regulated (Table 16) in the TCA function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
ACO2 0.711058 0.0058 
Aconitase catalyzes the interconversion of 
citrate to isocitrate 
SDHA 0.864782 0.00005 
Part of Succinate dehydrogenase complex 
in oxidative phosphorylation in TCA cycle 
it catalyzes the oxidation of succinate to 
fumarate 
 
Table 16: Up-regulated genes in the TCA cycle of HCT116 5/4 cell line 
 
Enzymes catalysing two steps in the TCA cycle were up-regulated. For instance 
SDHA, which contributes electrons to the electron transport chain is up-regulated. 
This suggests that the energy intermediates provision to the electron transport 
chain is higher in HCT116 5/4 cell line compared to its wild type cell line.     
 
Pyruvate transfer 
One gene was up-regulated (Table 17) in the pyruvate transfer function. 
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GENE NAME LOG2FOLD P-VALUE ROLE 
BRP44 0.851159 0.02225 
Involved in the transfer of pyruvate inside 
mitochondria. 
 
Table 17: Up-regulated gene in the pyruvate transfer of HCT116 5/4 cell line 
 
We observe that the pyruvate transfer is up-regulated in the HCT116 5/4 cell line. 
This suggests that there might be increased transport of pyruvate into mitochondria 
in the HCT116 5/4 cell line. 
 
Fe-S cluster biosynthesis 
Two genes were up-regulated (Table 18) and six genes were down-regulated (Table 
20) in the Fe-S cluster biosynthesis function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
LYRM4 0.620275 0.00535 Assembles with NFS1 
SLC25A28 0.495234 0.0161 Mitochondrial iron transporter 
 
Table 18: Up-regulated genes in the Fe-S cluster biosynthesis of HCT116 5/4 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
FDXR -1.10918 0.00005 
Provide reducing equivalents to electron 
transfer chain and contribute to iron-sulfur 
cluster biogenesis 
GLRX5 -0.491317 0.01235 
Fe-S cluster transfer protein directly to the 
apoprotein 
NUBP2 -0.403011 0.04425 
Required for the assembly of cytosolic iron-
sulfur proteins 
CIAPIN1 -0.563682 0.03685 Facilitates NUBP1 and NUBP2 assembly 
FAM96A -0.75034 0.00035 
Components of the cytosolic Fe/S protein 
assembly (CIA) machinery 
MMS19 -0.494624 0.01025 
Cytosolic Fe/S protein assembly targeting 
factor 
 
Table 19: Down-regulated genes in the Fe-S cluster biosynthesis of HCT116 5/4 cell line 
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We observe several genes in the Fe-S cluster biosynthesis function down-regulated. 
For example, FDXR and GLRX5 involved in providing Fe-S clusters to the 
apoproteins are down-regulated. Thus we hypothesize that the amount of Fe-S 
clusters provided to apoproteins is lower in the HCT116 5/4 cell line. 
   
Mitochondrial dynamics 
Three genes were up-regulated (Table 20), seven genes were down-regulated 
(Table 21) and a single gene is mutated (Table 22) in the mitochondrial dynamics 
function respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
PINK1 0.483554 0.01525 
Involved in the mitochondrial fusion, PINK1 
phosphorylates PARK2 and consequently 
PARK2 induced ubiquitination of mitofusins 
BNIP3L 0.718376 0.00055 
Involved in the mitophagy, cause 
permeabilization of the mitochondrial 
membrane and also regulate mitophagy 
SQSTM1 1.77694 0.00005 
Involved in the mitophagy, recruited to 
mitochondria and binds mitochondrial 
substrates on the autophagosomes 
 
Table 20: Up-regulated genes in the mitochondrial dynamics of the HCT116 5/4 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
STOML2 -0.472715 0.01355 
Involved in the mitochondrial fusion, scaffold 
proteins coordinate stability of the OPA1 
PLD6 -0.59024 0.00965 
Involved in the mitochondrial fusion, promotes 
mitofusin-mediated fusion 
TRAP1 -0.769066 0.0001 
Involved in the mitochondrial fission, known to 
regulate fission proteins DNM1L and MFF 
FIS1 -0.422012 0.0405 
Involved in the mitochondrial fission, 
facilitates binding and assembly of DNM1L 
PKIA -1.03206 0.00015 
Involved in the mitochondrial fission, is known 
to inhibit GTPase activity of DNM1L 
SYBU -1.5281 0.00005 
Involved in the mitochondrial movement, have 
a role in linking the mitochondria to KIF5B 
TRAK1 -0.521443 0.0098 
Involved in the mitochondrial movement, acts 
as an adapter linking kinesin-1 to 
mitochondria 
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Table 21: Down-regulated genes in the mitochondrial dynamics of the HCT116 5/4 cell 
line 
 
GENE NAME CHROMOSOME VARIANT 
DESCRIPTION 
ROLE 
KIF5B 10 
32300337 AT/A: DEL: 
3'UTR 
Involved in the mitochondrial movement, 
have role in the mitochondrial 
distribution in neurons 
 
Table 22: Mutated genes in the mitochondrial dynamics of HCT116 5/4 cell line 
 
We observe that the genes involved in the mitophagy are up-regulated. For example 
BNIP3L and SQSTM1, which are involved in the mitochondrial membrane 
permeabilization and binds mitochondrial substrates on the autophagosomes are 
up-regulated. Thus we hypothesize that the mitochondrial clearance is higher in the 
HCT116 cell line.  
 
Import and sorting 
Three genes were up-regulated (Table 23), seven genes were down-regulated 
(Table 24) and two genes were mutated (Table 25) in the import and sorting 
function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
TIMM17B 2.09787 0.00015 
Inner membrane translocation, might influence 
the channel activity formed by the TIMM23 
HSPA9 1.07547 0.00005 
Presequence translocase associated motor, 
binds to the preprotein and drives it into the 
matrix in association with other chaperones 
GRPEL2 0.654656 0.0014 
Presequence translocase associated motor, 
acts as a nucleotide exchange factor releasing 
the ADP from HSPA9 
 
Table 23: Up-regulated genes in the import and sorting of HCT116 5/4 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
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TOMM20 -0.414885 0.0233 
Outer membrane translocation, recognize 
presequences on the mitochondrial outer 
membrane 
TOMM40L -0.686537 0.0049 
Outer membrane translocation, forms the 
outer membrane channel forming protein 
TOMM5 -0.95617 0.00005 
Outer membrane translocation, transports 
preprotein to the import pore formed by 
TOMM40 
GRPEL1 -0.559974 0.00565 
Presequence translocase associated motor, 
acts as a nucleotide exchange factor releasing 
the ADP from HSPA9 
TIMM8A -0.540888 0.03815 
Inner membrane carrier pathway, forms 
complex with TIMM13 and also performs the 
transfer of inner membrane proteins 
TIMM13 -0.557188 0.0065 
Inner membrane carrier pathway, forms 
complex with TIMM8 and performs the 
transfer of inner membrane proteins 
IMMP2L -0.817128 0.00225 
Inner membrane peptidase that cleaves 
hydrophobic sorting signal 
 
Table 24: Down-regulated genes in the import and sorting of HCT116 5/4 cell line 
 
GENE NAME CHROMOSOME VARIANT 
DESCRIPTION 
ROLE 
HSPA9 5 
137904629 T/C: SNP: 
Missense_Mutation 
Presequence translocase associated 
motor, binds to the preprotein and drives 
it into the matrix in association with other 
chaperones 
PMPCA 9 
139318040 G/A: SNP: 
3'UTR 
Presequence of pre-proteins are removed 
by proteolytic enzyme mitochondrial 
processing peptidase 
 
Table 25: Mutated genes in the import and sorting of the HCT116 5/4 cell line 
 
The genes, which conduct outer membrane translocation and those which transfer 
of inner membrane proteins were down-regulated. This suggest that the transport 
of proteins into mitochondria might be lower in the HCT 116 5/4 cell line. In 
addition, the assembly of inner membrane proteins in HCT116 5/4 cell line might be 
lower too.  
 
Replication and transcription 
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Three genes were up-regulated (Table 26), sixteen genes were down-regulated 
(Table 27) and three genes were mutated (Table 28) in the replication and 
transcription function.   
 
GENE NAME LOG2FOLD P-VALUE ROLE 
TK2 0.558719 0.00705 
Involved in the phosphorylation of recycled 
deoxyribonucleosides in mitochondria specific 
for thymidine, cytidine and uridine 
CMPK2 1.83451 0.00005 
Phosphorylates the deoxyribonucleoside 
monophosphates specifically on dAMP 
TRMT2B 0.522388 0.0183 
Shows posttranscriptional modifications 
activity in the human mitochondrial tRNAs 
 
Table 26: Up-regulated genes in the replication and transcription of the HCT116 5/4 cell 
line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
C10orf2 -1.0818 0.00005 
Mitochondrial DNA (mtDNA) helicase 
(TWINKLE) plays an important role in the 
maintenance of mtDNA 
TERT -1.74289 0.00005 
Role in the protection of mitochondrial 
integrity with a suggested role in mtDNA 
replication and/or repair 
TFAM -0.667959 0.0012 
A key activator of mitochondrial transcription 
and also functions in replication and repair 
RMRP -1.2317 0.00875 
RNA component of mitochondrial RNA 
processing endoribonuclease cleaves 
mitochondrial RNA at the priming site of 
mitochondrial DNA replication 
APEX1 -0.692803 0.00015 
Involved in the mitochondrial DNA base 
excision repair 
POLG2 -0.807134 0.0002 
Mitochondrial DNA polymerase, and also 
shows 3' to 5' exonuclease activity and ensure 
faithful replication 
AK3 -0.425085 0.0288 
Phosphorylates the deoxyribonucleoside 
monophosphates specifically on dAMP 
SLC25A19 -1.45292 0.00005 
Transports thiamine pyrophosphates into 
mitochondria 
SLC29A1 -0.466474 0.0178 
Equilibrative nucleoside transporter 1 imports 
recycled deoxyribonucleosides from cytoplasm 
into mitochondria 
TRMT11 -0.546232 0.01295  
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TRMT1 -0.460001 0.0206  
 
 
 
Shows posttranscriptional modifications 
activity in the human mitochondrial tRNAs 
PUS1 -0.824706 0.0001 
RPUSD4 -0.614644 0.0021 
QTRT1 -0.432503 0.04655 
QTRTD1 -0.472775 0.0176 
TRIT1 -0.563625 0.00705 
 
Table 27: Down-regulated genes in the replication and transcription of the HCT116 5/4 
cell line 
 
GENE NAME CHROMOSOME VARIANT 
DESCRIPTION 
ROLE 
TK2 16 
66544965 C/T: SNP: 
3'UTR 
Involved in the phosphorylation of 
recycled deoxyribonucleosides in 
mitochondria specific for thymidine, 
cytidine and uridine 
AK4 1 
65696724 TA/T: DEL: 
3'UTR 
Phosphorylates the 
deoxyribonucleoside monophosphates 
specifically on dAMP 
QTRTD1 3 
113784299 A/C: SNP: 
Intron 
Shows posttranscriptional modifications 
activity in the human mitochondrial 
tRNAs 
 
Table 28: Mutated genes in the replication and transcription of the HCT116 5/4 cell line 
 
We observe several genes involved in the replication and transcription is down-
regulated in the HCT116 5/4 cell line e.g., POLG2, TFAM, TERT and C10orf2. Thus 
we hypothesize that the DNA biosynthesis might be reduced in the HCT116 5/4 cell 
line compared to its wild type cell line. 
 
Translation 
Three genes were up-regulated (Table 29), twenty nine genes were down-regulated 
(Table 30) and four genes were mutated (Table 31) in the translation function. 
 
 68 
GENE NAME LOG2FOLD P-VALUE ROLE 
FARS2 0.819286 0.0013 
Involved in the specific attachment of 
phenylalanine amino acid to its cognate tRNA 
GFM2 1.05133 0.0034 
Involved in the elongation and termination phases 
of the translation process may also be involved in 
the ribosome recycling 
MRPS30 0.834859 0.00005 
Mitoribosome which forms a part of 
mitochondrial translation machinery 
 
Table 29: Up-regulated genes in the translation function of HCT116 5/4 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
MARS2 -0.823736 0.00015 
Involved in the specific attachment of methionine 
amino acid to its cognate tRNA 
AARS2 -0.509629 0.01985 
Involved in the specific attachment of alanine 
amino acid to its cognate tRNA 
NARS2 -0.679407 0.0018 
Involved in the specific attachment of asparagine 
amino acid to its cognate tRNA 
DARS2 -0.406307 0.0474 
Involved in the specific attachment of aspartic acid 
amino acid to its cognate tRNA 
PARS2 -0.512162 0.0259 
Involved in the specific attachment of proline 
amino acid to its cognate tRNA 
MRRF -0.694552 0.0206 
Acts as a mitochondrial ribosome recycling factor 
during translation process 
PTCD3 -0.379742 0.0442 
Associates with mitochondrial small ribosomal 
subunit and regulates translation 
MRPL3 -0.456574 0.0165  
 
Mitoribosome which forms a part of 
mitochondrial translation machinary 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MRPL4 -0.466443 0.0197 
MRPL10 -0.45632 0.0178 
MRPL11 -0.542947 0.00575 
MRPL12 -1.01731 0.00005 
MRPL19 -0.39658 0.0423 
MRPL30 -0.517519 0.00755 
MRPL36 -0.603458 0.00465 
MRPL38 -0.783028 0.00005 
MRPL50 -0.691954 0.00125 
MRPS14 -0.578458 0.00845 
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MRPS15 -0.416237 0.03435 Mitoribosome which forms a part of 
mitochondrial translation machinery 
MRPS17 -0.47862 0.03125 
MRPS18B -0.381176 0.04885 
MRPS21 -0.477955 0.0225 
MRPS26 -0.688225 0.00075 
MRPS27 -0.401445 0.03325 
MRPS33 -0.540767 0.00995 
MRPS7 -0.916785 0.00255 
TACO1 -0.65952 0.00185 Translational activator of complex IV subunit 
CLPP -0.688411 0.0009 
Involved in the post translational quality control, 
has re-solubilization activity of protein aggregates 
DDX28 -0.678136 0.02055 
May be involved in the biogenesis of 
mitochondrial ribosomes 
 
Table 30: Down-regulated genes in the translation function of HCT116 5/4 cell line 
 
GENE NAME CHROMOSOME VARIANT 
DESCRIPTION 
ROLE 
LARS2 3 
45527240 G/A: 
SNP: Missense 
Mutation 
Involved in the specific attachment of leucine 
amino acid to its cognate tRNA 
MRPL45 17 
36478776 G/A: 
SNP: 3'UTR 
 
 
Mitoribosome which forms a part of 
mitochondrial translation machinary 
MRPL54 19 
3765222 C/T: 
SNP: Silent 
LRPPRC 2 
44145196 A/G: 
SNP: Missense 
Mutation 
Might play a role in the translation and 
stability of COX subunits 
 
Table 31: Mutated genes in the translation function of HCT116 5/4 cell line 
 
Several amino acyl tRNA synthetases and mitoribosomes were down-regulated in 
the HCT116 5/4 cell line. Thus we hypothesize that the amount of proteins 
produced inside mitochondria is lower in HCT116 5/4 cell line. 
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Calcium transport 
Three genes were up-regulated (Table 32) and one gene was down-regulated (Table 
33) in the calcium transport function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
CCDC109B 0.672219 0.0025 
Forms an important component of 
mitochondrial calcium uniporter with MCU 
ITPR1 0.641122 0.00285 
Component of the Inositol-1,4,5-
trisphosphate receptors channels used for 
the fluxes of Ca2+ from ER to mitochondria 
PML 0.658306 0.00355 
Regulates Inositol-1,4,5-trisphosphate 
receptor mediated Ca2+ release from the ER 
 
Table 32: Up-regulated genes in the calcium transport of the HCT116 5/4 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
SIGMAR1 -0.757161 0.00005 
Stabilises the Inositol-1,4,5-trisphosphate 
receptors and ensures proper Ca2+ fluxes 
 
Table 33: Down-regulated genes in the calcium transport of the HCT116 5/4 cell line 
 
We observe that genes which are involved in the transfer of calcium into 
mitochondria and those which regulate the transfer of calcium from ER into 
mitochondria were up-regulated. This suggests that there is an increase in the 
transfer of calcium into mitochondria in the HCT116 5/4 cell line. 
 
Cardiolipin biosynthesis 
Two genes were up-regulated (Table 34) in the cardiolipin biosynthesis function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
CDS1 -2.01287 0.00005 
Converts phosphatidic acid to cytidine 
diphosphate diacylglycerol 
PGS1 -0.529839 0.01175 
Phosphatidylglycerol synthase converts 
cytidine diphosphate diacylglycerol to 
phosphatidylglycerol phosphate 
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Table 34: Down-regulated genes in the cardiolipin biosynthesis function of the HCT116 
5/4 cell line 
 
We observe that two steps in the cardiolipin biosynthesis function is up-regulated in 
the HCT116 5/4 cell line. This suggests that there is increase in the availability of 
cardiolipin in the HCT116 5/4 cell line. 
 
ROS defence 
Two genes were up-regulated (Table 35) and four genes were down-regulated 
(Table 36) in the ROS defence function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
GCLM 1.15434 0.00005 
Catalyzes the first step reaction which 
combines cysteine and glutamate to form 
glutamylcysteine 
SHC1 0.931169 0.00005 
Could be involved in the generation of the 
hydrogen peroxide independent of 
superoxides in mitochondria 
 
Table 35: Up-regulated genes in the ROS defence of the HCT116 5/4 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
GSR -0.504019 0.00795 
Reduces oxidized glutathione which can be re 
utilized by GPX1 
GLRX2 -1.43993 0.00005 
Involved in the control of mitochondrial 
protein glutathionylation 
GSTA1 -2.89425 0.00835 Mitochondrial glutathione-S-transferases 
through glutathione conjugation or peroxide 
reduction detoxify harmful by-products GSTA2 -2.34913 0.00155 
 
Table 36: Down-regulated genes in the ROS defence of the HCT116 5/4 cell line 
 
We observe that GSR, which reduces oxidized glutathione and glutathione-S-
transferases, which detoxify harmful by-products are down-regulated. Thus we 
hypothesize that there is a build up of ROS in the mitochondria in the HCT116 5/4 
cell line.    
 72 
 
3.1.3.1 Summary for HCT116 5/4 MitoModel 
In total, there were 16 function that were observed to be affected in the HCT116 5/4 
cell line. Further we observe that the MitoModel had more down- (102) compared 
to up-regulated genes (49). Most number of down-regulated genes were present in 
the translation function with 29 genes affected. We also observed several (22) genes 
with mutations HCT116 5/4 MitoModel (Figure 13).   
  
 
 
Figure 13: Number of affected genes observed on all the functions of HCT116 5/4 MitoModel 
 
3.1.4 MitoModel of the RPE1 5/3 12/3 cell line: 
After mapping the input mutation and expression files, the visual representation of 
the RPE1 5/3 12/3 MitoModel (Figure 14), displays the genes which are up-
regulated, down-regulated and mutated.  
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Figure 14: Visual display of the RPE1 5/3 12/3 MitoModel 
 
Principal functions were observed to be misregulated (Figure 15) based on the 
percentage, and they are: Heme biosynthesis with 44% genes affected; glycolysis 
with 34% genes impaired; Apoptosis with 33% genes inflicted; Calcium transport 
with 31% genes defective, and so on.   
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Figure 15: Percentage (%) of affected functions observed on the RPE1 5/3 12/3 
MitoModel 
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To further explore the roles of the variant genes, each function was studied for the 
variant genes and its roles. 
 
Electron transport chain and energy production 
Twenty four genes were up-regulated (Table 37) and a single gene was down-
regulated (Table 38) in the electron transport chain function.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
NDUFA2 0.847609 0.00005 
 
 
 
Nuclear encoded essential components of complex 
I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
NDUFA9 0.697875 0.00005 
NDUFA12 0.571784 0.0009 
NDUFB4 0.330836 0.0442 
NDUFS4 0.796412 0.00005 
NDUFS6 0.887836 0.00005 
NDUFS8 0.507377 0.00305 
NDUFV1 0.573347 0.001 
FOXRED1 0.824873 0.00005 
 
Complex I assembly factors 
NDUFAF2 0.639314 0.00085 
TMEM126B 0.616229 0.00065 
UQCRQ 0.686108 0.00005 
Nuclear encoded essential component of complex 
III,  transfers electrons from ubiquinol to 
cytochrome c 
COX5A 0.3649 0.02995 
 
 
Nuclear encoded cytochrome c oxidase subunits, 
essential components of complex IV, catalyses the 
reduction of oxygen to water by cytochrome c 
COX6A1 0.636835 0.0001 
COX7C 0.722798 0.00005 
COX8A 0.583068 0.00045 
C7orf44 0.448529 0.0107 
 
 
 
Complex IV assembly factor 
CHCHD8 0.595943 0.00085 
COX14 0.553737 0.00275 
COX17 0.522548 0.008 
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SURF1 0.361213 0.0482 
ATP5B 0.645664 0.00045 
 
Nuclear encoded ATP synthase subunits, essential 
components of complex V, reversible pump of 
protons into matrix with formation of ATP 
ATP5G2 0.855464 0.00005 
ATP5L 0.647057 0.0066 
 
Table 37: Up-regulated genes in the electron transport chain of RPE1 5/3 12/3 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
NUBPL -0.389781 0.0426 Complex I assembly factor 
 
Table 38: Down-regulated gene in the electron transport chain function of RPE1 5/3 12/3 
cell line 
 
We observe that several genes involved in the complex I, III, IV and V are up-
regulated in the RPE1 5/3 12/3 cell line. Further assembly factors of complex I and 
IV are up-regulated. This suggests that there might be an increased stress for energy 
production by electron transport chain in the RPE1 5/3 12/3 cell line. 
 
Fatty acid beta oxidation and generation of acetyl CoA 
Six genes were up-regulated (Table 39) and four genes were down-regulated (Table 
40) in the fatty acid beta oxidation function. 
 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
SLC27A3 0.675558 0.0193 
Readily converts the transported very long chain 
fatty acids to acyl-CoAs 
ACSL5 3.99654 0.00005 
Acyl-CoA synthetase activity for long chain free 
fatty acids and are also involved in the activation 
of fatty acids 
ACSS3 2.46516 0.00005 
Acyl-CoA synthetase activity for short chain fatty 
acids 
FABP5 0.682189 0.0001 
Fatty acid binding proteins involved in the import 
and export of fatty acids 
ACAD8 0.665542 0.0004 Involved in the catabolism of fatty acids 
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ACAD10 0.8601 0.00005 
Involved in the catabolism of fatty acids with 
significant activity towards branched chains 
  
Table 39: Up-regulated genes in the fatty acid beta oxidation function of RPE1 5/3 12/3 
cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
ACSL1 -0.518211 0.0031 
Acyl-CoA synthetase activity for long chain free 
fatty acids and are also involved in the activation 
of fatty acids 
CPT1C -2.98183 0.00005 
Carnitine palmitoyl transferase converts an acyl-
CoA into an acylcarnitine 
SLC25A20 -0.474659 0.0271 
Carnitine acylcarnitine translocase mediates 
acylcarnitine entry into mitochondria 
ACAA2 -0.980128 0.00005 Medium chain 3-ketoacyl-CoA thiolase 
 
Table 40: Down-regulated genes in the fatty acid beta oxidation function of RPE1 5/3 12/3 
cell line 
 
We observe that several crucial genes are down-regulated in the RPE1 5/3 12/3 cell 
line. For example, Carnitine palmitoyl transferase (CPT1C), which converts acyl-CoA 
to acylcarnitine, SLC25A20, which mediates acylcarnitine entry into mitochondria. 
Further ACAA2, involved in the last step of beta-oxidation inside mitochondria is 
down-regulated. This suggests that the acetyl-CoA generation inside mitochondria 
by the beta-oxidation of fatty acids might be lower in RPE1 5/3 12/3 cell line 
compared to its wild type cell line. 
 
Apoptosis 
Nine genes were up-regulated (Table 41) and three genes were down-regulated 
(Table 42) in the apoptosis function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
APAF1 0.359293 0.04345 
Binds CASP9 forming an apoptosome and 
activates it 
DIABLO 0.532655 0.00165 
Acts as caspase activator by inhibiting the 
inhibitors of apoptotic proteins 
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BAD 0.461006 0.04085 Bcl-2 family member propagating apoptosis 
BCL2L11 1.50067 0.00005 Bim Bcl-2 family member propagating apoptosis 
PMAIP1 0.729481 0.0002 Noxa Bcl-2 family member propagating apoptosis 
BBC3 0.571182 0.0134 Puma Bcl-2 family member propagating apoptosis 
VDAC1 0.678414 0.0001 
Voltage dependent anion channel forms part of 
permeability transition pore 
SLC25A5 0.423884 0.01255 
Adenine nucleotide translocator forms part of 
permeability transition pore 
EIF3M 0.531998 0.0027 
PCI domain containing protein 1 can negatively 
regulate CASP9 activity 
 
Table 41: Up-regulated genes in the apoptosis function of RPE1 5/3 12/3 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
BAK1 -0.706554 0.0004 
Bcl-2 family member propagating apoptosis 
 
SLC25A4 -0.509158 0.00335 
Adenine nucleotide translocator forms part of 
permeability transition pore 
DNM1 -1.24561 0.0267 
Recruited to mitochondria can induce cristae 
remodelling to release cytochrome c and 
subsequent apoptosis 
 
Table 42: Down-regulated genes in the apoptosis function of RPE1 5/3 12/3 cell line 
 
We observe several genes coding for pro-apoptotic proteins are up-regulated. In 
addition, gene coding for voltage dependent anion channel, which control the 
release of cytochrome c from mitochondria is up-regulated. This suggests that there 
is an increase in the mitochondrial handling of apoptosis in the RPE1 5/3 12/3 cell 
line compared to its wild type cell line. 
 
Heme biosynthesis 
Two genes were up-regulated (Table 43) and two genes were down-regulated 
(Table 44) in the heme biosynthesis function. 
  
GENE NAME LOG2FOLD P-VALUE ROLE 
ALAS1 0.382534 0.03435 
Catalyzes the reaction in which glycine and 
succinyl CoA from TCA cycle condenses to form 
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aminolevulinate (ALA) and CO2 
HMBS 0.440116 0.01605 
Hydroxymethylbilane synthase catalyzes head to 
tail condensation of four PBG and subsequent 
deamination to form a linear tetrapyrrole, 
Hydroxymethylbilane 
 
Table 43: Up-regulated genes in the heme biosynthesis function of RPE1 5/3 12/3 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
FECH -0.423414 0.0145 
Ferrochelatase catalyzes the step involving the 
addition of Ferrous iron into the protoporphyrin 
IX to form the protoheme IX 
CPOX -0.446662 0.0117 
Coproporphyrinogen III is transported to 
mitochondria and in the presence of 
coproporphyrinogen III oxidase it is oxidatively 
decarboxylated 
 
Table 44: Down-regulated genes in the heme biosynthesis function of RPE1 5/3 12/3 cell 
line 
 
We observe that crucial genes coding for the proteins required for the heme 
biosynthesis is down-regulated in the RPE1 5/3 12/3 cell line. For example, CPOX 
and FECH in the mitochondria are down-regulated, which play an import role in the 
heme biosynthesis. This suggests that there is a decreased synthesis of heme in the 
RPE1 5/3 12/3 cell line compared to its wild type cell line.  
 
Glycolysis 
Six genes were up-regulated (Table 45) and two genes were down-regulated (Table 
46) in the glycolysis function.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
SLC2A3 1.08432 0.00005 
Basal glucose uptake, present in all mammalian 
tissues   
PFKM 0.538878 0.0011 
Fructose 6-phosphate is phosphorylated to 
fructose 1,6-bisphosphate, catalyzed by 
phosphofructokinase 
GAPDH 0.700267 0.00455 
Glyceraldehyde 3-phosphate is converted into 1,3-
bisphosphoglycerate catalyzed by glyceraldehyde 
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3-phosphate dehydrogenase 
ENO1 0.467245 0.0223  
2-phosphoglycerate is converted into 
phosphoenolpyruvate catalyzed by enolase ENO2 0.446011 0.00905 
LDHB 0.476498 0.00725 
Pyruvate is converted to lactate catalyzed by 
lactate dehydrogenase 
 
Table 45: Up-regulated genes in the glycolysis function of RPE1 5/3 12/3 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
SLC2A1 -0.673644 0.0002 
Basal glucose uptake, present in all mammalian 
tissues   
GPI -0.667722 0.00005 
Isomerization of glucose 6-phosphate to fructose 
6-phosphate by the phosphoglucose isomerase 
PFKL -0.400993 0.0185 Fructose 6-phosphate is phosphorylated to 
fructose 1,6-bisphosphate, catalyzed by 
phosphofructokinase PFKP -0.463312 0.0062 
ALDOC -1.46654 0.00455 
Fructose 1,6-bisphosphate converted into 
glyceraldehyde 3-phosphate and 
dihydroxyacetone phosphate catalyzed by 
aldolase 
 
Table 46: Down-regulated genes in the glycolysis function of RPE1 5/3 12/3 cell line 
 
We observe two genes involved in the generation of pyruvate to be up-regulated. 
For example, ENO1 and ENO2, catalyzes the formation of phosphoenolpyruvate 
leading to the generation of pyruvate in the next step. Further, LDHB, which 
converts pyruvate to lactate is up-regulated. This suggests that the pyruvate 
generation by glycolysis in the RPE1 5/3 12/3 cell line is higher compared to its 
wild type cell line. 
 
Formation of Acetyl-CoA   
There was a single gene up-regulated (Table 47) in the formation of acetyl-CoA 
function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
DLAT 0.460836 0.0075 Component of pyruvate dehydrogenase complex, 
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catalyzes the overall conversion of pyruvate to 
acetyl CoA  
 
Table 47: Up-regulated genes in the formation in the acetyl-CoA fucntion of RPE1 5/3 12/3 
cell line 
 
We observe that the DLAT, a subunit of the pyruvate dehydrogenase complex is up-
regulated in the RPE1 5/3 12/3 cell line. This suggests that the overall conversion of 
pyruvate to acetyl-CoA is higher in the RPE1 5/3 12/3 cell line compared to its wild type 
cell line. 
 
TCA cycle 
Three genes were up-regulated (Table 48) and one gene was down-regulated (Table 
49) in the TCA cycle function. 
    
GENE NAME LOG2FOLD P-VALUE ROLE 
CS 0.441377 0.0096 
Citrate synthase catalyzes the synthesis of citrate 
from oxaloacetate and acetyl CoA 
SDHA 0.567448 0.0004 Part of Succinate dehydrogenase complex in 
oxidative phosphorylation in TCA cycle it 
catalyzes the oxidation of succinate to fumarate SDHD 0.71975 0.00005 
 
Table 48: Up-regulated genes in the TCA cycle function of RPE1 5/3 12/3 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
IDH2 
-0.728959 0.00005 Isocitrate dehydrogenase catalyze the oxidative 
decarboxylation of isocitrate to 2-oxoglutarate 
 
Table 49: Down-regulated gene in the TCA cycle function of RPE1 5/3 12/3 cell line 
 
Crucial components of the succinate dehydrogenase complex are up-regulated. For 
example, SDHA and SDHD are upregulated in the RPE1 5/3 12/3 cell line. This 
suggests that the oxidation of succinate to fumarate and electron feeding to the 
electron transport chain is higher in the RPE1 5/3 12/3 cell line compared to its 
wild type cell line. 
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Fe-S cluster biosynthesis 
4 genes were up-regulated (Table 50) in the Fe-S cluster biosynthesis function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
ISCU 0.735633 0.00005 
Iron sulfur cluster assembly enzyme, Fe-S cluster 
intermediate is formed on it 
SLC25A37 0.846412 0.00005 Functions as an essential iron importer 
FDX1 0.740183 0.00005 
Small iron-sulfur protein, transfers electrons from 
NADPH to mitochondrial cytochrome P450 
NUBP1 0.529257 0.00305 
Essential for both cytosolic iron-sulfur protein 
assembly and iron homeostasis 
 
Table 50: Up-regulated genes in the Fe-S cluster biosynthesis of RPE1 5/3 12/3 cell line 
  
We observe that several genes involved in the Fe-S cluster biosynthesis is up-
regulated. For example; SLC25A37, required for the import of iron; and ISCU, 
required for the formation of Fe-S cluster intermediates inside mitochondria are up-
regulated. This suggests that the biosynthesis of Fe-S cluster intermediates is higher 
in the RPE1 5/3 12/3 cell line compared to its wild type cell line. 
 
Mitochondrial dynamics  
Four genes were up-regulated (Table 51) and five genes were down-regulated 
(Table 52) in the mitochondiral dynamics function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
PHB2 0.546811 0.00085 
Involved in the mitochondrial fusion, scaffold 
proteins coordinate stability of the OPA1 
TRAP1 0.46533 0.0075 
Involved in the mitochondrial fission, known to 
regulate fission proteins DNM1L and MFF 
DNM1L 0.390909 0.02075 
Involved in the mitochondrial fission, mediates 
the division of mitochondria 
SQSTM1 0.999647 0.00005 
Involved in the mitophagy, recruited to 
mitochondria and binds mitochondrial substrates 
on the autophagosomes 
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Table 51: Up-regulated genes in the mitochondrial dynamics function of RPE1 5/3 12/3 
cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
OPA3 -0.48298 0.03035 
Involved in the mitochondrial fusion, interacts 
with MFN1 and involved in mitochondrial 
fragmentation 
PLD6 -1.02164 0.0005 
Involved in the mitochondrial fusion, promotes 
mitofusin-mediated fusion 
MTFP1 -0.520328 0.01475 
Involved in the mitochondrial fission, role in 
mitochondrial fragmentation and is dependent on 
DNM1L expression 
GDAP1 -0.837419 0.0002 
Involved in the mitochondrial fission, known to 
have a role in the mitochondrial fragmentation 
TRAK2 -0.47557 0.0043 
Involved in the mitochondrial movement, acts as 
an adapter linking kinesin-1 to mitochondria 
 
Table 52: Down-regulated genes in the mitochondrial dynamics function of RPE1 5/3 12/3 
cell line 
 
We observe that several crucial genes involved in the mitochondrial fusion, fission 
and movement are down-regulated. At the same time SQSTM1, which binds 
mitochondrial substrates to autophagosomes during mitophagy is up-regulated. 
This suggests that there is an increased clearing of mitochondria and deviation in 
mitochondrial dynamics of RPE1 5/3 12/3 cell line compared to its wild type cell 
line.  
 
Import and sorting 
Two genes were up-regulated (Table 53), one gene is down-regulated (Table 54) 
and one gene is mutated (Table 55) in the import and sorting function.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
HSPA9 0.544413 0.0009 
Presequence translocase associated motor, binds 
to the preprotein and drives it into the matrix in 
association with other chaperones and also 
involved in the mediation of the interaction 
between VDAC1 and Inositol-1,4,5-trisphosphate 
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receptors. 
GRPEL2 0.373354 0.04305 
Presequence translocase associated motor, acts as 
a nucleotide exchange factor releasing the ADP 
from HSPA9. 
 
Table 53: Up-regulated genes in the import and sorting function of RPE1 5/3 12/3 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
TOMM40L -0.551265 0.00795 
Outer membrane translocation, forms the outer 
membrane channel forming protein. 
 
Table 54: Down-regulated genes in the import and sorting function of RPE1 5/3 12/3 cell 
line 
 
GENE NAME CHROMOSOME VARIANT 
DESCRIPTION 
ROLE 
HSPA9 5 
137892170 G/A: 
SNP: Silent, 
 137902339 T/C: 
SNP: Silent 
Presequence translocase associated motor, binds 
to the preprotein and drives it into the matrix in 
association with other chaperones and also 
involved in the mediation of the interaction 
between VDAC1 and Inositol-1,4,5-trisphosphate 
receptors. 
 
Table 55: Mutated genes in the import and sorting function of RPE1 5/3 12/3 cell line 
 
We observe that the outer membrane channel forming protein facilitating the 
protein translocation into mitochondria is down-regulated. In addition, proteins 
involved in driving preproteins into matrix are up-regulated. This suggests that 
there might be an increased stress for proteins to enter into the mitochondria in the 
RPE1 5/3 12/3 cell line compared to its wild type cell line. 
 
Replication and transcription 
Thirteen genes were up-regulated (Table 56), three genes were down-regulated 
(Table 57) in the replication and transcription function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
TOP1MT 0.583414 0.0041 Suggested to have a role in the removal of 
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positive supercoils created by helicase activity 
TERT 2.06388 0.00005 
Role in the protection of mitochondrial integrity 
with a suggested role in mtDNA replication 
and/or repair 
RMRP 1.94861 0.00005 
RNA component of mitochondrial RNA 
processing endoribonuclease cleaves 
mitochondrial RNA at the priming site of 
mitochondrial DNA replication 
UNG 0.37312 0.0336 
Prevent mutagenesis by eliminating uracil from 
DNA molecules 
NTHL1 0.509429 0.0086 Involved in the repair of mispairs in DNA 
POLG2 0.479997 0.0385 
Acts as catalytic subunit of mitochondrial DNA 
polymerase 
TRMT112 0.814351 0.00005  
 
 
 
Shows posttranscriptional modifications activity 
in the human mitochondrial tRNAs 
 
PUS1 0.565226 0.00435 
RPUSD4 1.09897 0.00005 
OSGEPL1 0.538049 0.0167 
PUS3 1.06192 0.00005 
NSUN2 0.629669 0.0001 
SLC25A3 0.587619 0.0011 
Involved in the transport of phosphate into the 
mitochondrial matrix 
 
Table 56: Up-regulated genes in the replication and transcription function of RPE1 5/3 
12/3 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
AK4 -0.904575 0.00005 
Phosphorylates the deoxyribonucleoside 
monophosphates specifically on dAMP 
NME4 -0.344994 0.0405 
Shows mitochondrial nucleoside diphosphate 
kinase activity 
TRIT1 -0.391003 0.0405 
Shows posttranscriptional modifications activity 
in the human mitochondrial tRNAs 
 
Table 57: Down-regulated genes in the replication and transcription function of RPE1 5/3 
12/3 cell line 
 
Several genes are up-regulated in the replication and transcription function. For 
example; POLG2 and TERT which are required for the replication and repair are up-
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regulated. This suggest that there is an increase in the requirement of the 
mitochondrial DNA in the RPE1 5/3 12/3 cell line compared to its wild type cell line.  
 
Translation 
Twenty three genes were up-regulated (Table 58) and 2 genes were down-regulated 
(Table 59) in the translation function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
YARS2 0.351731 0.04695 
Involved in the specific attachment of tyrosine 
amino acid to its cognate tRNA 
HARS2 0.612305 0.0005 
Involved in the specific attachment of histidine 
amino acid to its cognate tRNA 
TSFM 0.432196 0.0234 
Involved in the elongation and termination 
phases of the translation process 
MRPL10 0.574735 0.00085  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mitoribosomes which forms a part of 
mitochondrial translation machinery 
MRPL11 0.668759 0.0001 
MRPL21 0.881521 0.00005 
MRPL22 0.781109 0.00005 
MRPL23 0.51228 0.00385 
MRPL36 0.872328 0.00005 
MRPL40 0.358002 0.0484 
MRPL42 0.464519 0.00745 
MRPL45 0.375467 0.03045 
MRPL48 0.527918 0.0049 
MRPL51 0.567403 0.00115 
MRPS18B 0.499942 0.00415 
MRPS27 0.937786 0.00005 
MRPS30 0.68526 0.0002 
MRPS31 0.448401 0.02095 
MRPS34 0.371246 0.03245 
MRPS35 0.612735 0.0003 
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MRPS36 0.917542 0.00005 
RNASEL 1.38777 0.00005 
Modulate the stability of mitochondrial mRNAs 
by interacting with MTIF2 
OXA1L 0.496889 0.0029 
May have a role in the insertion of proteins into 
inner membrane and also a complex V assembly 
factor 
 
Table 58: Up-regulated genes in the translation function of RPE1 5/3 12/3 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
RARS2 -0.35519 0.04425 
Involved in the specific attachment of arginine 
amino acid to its cognate tRNA 
MRPS21 -0.410857 0.0272 
Mitoribosomes which forms a part of 
mitochondrial translation machinery 
 
Table 59: Down-regulated genes in the translation function of RPE1 5/3 12/3 cell line 
 
Several mitoribosomes are up-regulated in the RPE1 5/3 12/3 cell line. Further 
amino acyl tRNA synthetases such as YARS2 and HARS2 are up-regulated. This 
suggests that there might be a higher production of mitochondrial polypeptides in 
the RPE1 5/3 12/3 cell line compared to its wild type cell line.   
 
Calcium transport 
Four genes were up-regulated (Table 60) and one gene was down-regulated (Table 
61) in the calcium transport function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
SLC24A6 0.582622 0.0032 
Involved in the calcium homeostasis by 
counteracting the calcium accumulation in the 
mitochondria 
ITPR2 0.601475 0.0004 
Component of the Inositol-1,4,5-trisphosphate 
receptors channels used for the fluxes of Ca2+ 
from ER to mitochondria 
TCHP 0.691381 0.0001 
Involved in the regulation of ER mitochondria 
juxtaposition 
PML 0.551688 0.0033 
Regulates Inositol-1,4,5-trisphosphate receptor 
mediated Ca2+ release from the ER 
 
Table 60: Up-regulated genes in the calcium transport function of RPE1 5/3 12/3 cell line 
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GENE NAME LOG2FOLD P-VALUE ROLE 
MCU -0.609827 0.0003 
Involved in the accumulation of calcium ions in 
the matrix through ion impermeable inner 
mitochondrial membrane 
 
Table 61: Down-regulated genes in the calcium transport function of RPE1 5/3 12/3 cell 
line 
 
We observe several genes regulating the calcium release from ER into mitochondria 
is up-regulated. This suggests that there is an increase in the calcium release from 
ER to the mitochondria in RPE1 5/3 12/3 cell line.  
 
Cardiolipin biosynthesis 
One gene was up-regulated (Table 62) in the cardiolipin biosynthesis function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
PGS1 0.365077 0.04765 
Phosphatidylglycerol synthase converts cytidine 
diphosphate diacylglycerol to 
phosphatidylglycerol phosphate 
 
Table 62: Up-regulated genes in the Cardiolipin biosynthesis function of RPE1 5/3 12/3 
cell line 
 
A single step in cardiolipin biosynthesis function is up-regulated, as a consequence 
there could more production of cardiolipin in the RPE1 5/3 12/3 cell line. 
 
ROS defence 
Three genes were up-regulated (Table 63) and two genes were down-regulated 
(Table 64) in the ROS defence function. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
GCLM 0.700054 0.00005 
Catalyzes the first step reaction which combines 
cysteine and glutamate to form glutamylcysteine 
SOD2 0.518861 0.00415 
Dismutates the superoxide generated in the 
mitochondrial matrix to hydrogen peroxide 
GSTP1 0.406851 0.019 Mitochondrial glutathione-S-transferases 
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through glutathione conjugation or peroxide 
reduction detoxify harmful byproducts 
 
Table 63: Up-regulated genes in the ROS defence function of RPE1 5/3 12/3 cell line 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
SLC25A1 -0.467231 0.0063 
May be involved in the transport of glutathione 
into the mitochondria 
GSTA4 -0.646611 0.00195 
Mitochondrial glutathione-S-transferases 
through glutathione conjugation or peroxide 
reduction detoxify harmful byproducts 
 
Table 64: Down-regulated genes in the ROS defence function of RPE1 5/3 12/3 cell line 
 
We observe that genes involved in the reducing the ROS elements in the RPE1 5/3 
12/3 cell line. For example SOD2, which reduces the superoxides generated in the 
mitochondrial matrix. Thus we hypothesize that superoxides in the mitochondria 
might be at a minimal level in RPE1 5/3 12/3 cell line.   
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3.1.4.1 Summary for RPE1 5/3 12/3 MitoModel 
In total, there were 15 functions that were observed to be affected in the RPE1 5/3 
12/3 MitoModel. Further, we observe that the MitoModel had more up- (107 genes) 
compared to down-regulated (30 genes) genes. Most number of the up-regulated 
genes were present in the electron transport chain function and translation function 
with 24 and 24 genes affected (Figure 16) respectively.  
 
 
 
Figure 16: Number of affected genes observed on all the functions of RPE1H2B 5/3 12/3 
MitoModel 
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3.1.5 MitoModel of the RPE1H2B 21/3 cell line: 
Visual display of RPE1H2B 21/3 MitoModel after mapping the expression and 
mutation input files, describes the nodes which were up- and down-regulated 
(Figure 17).  
 
 
Figure 17: A visual representation of the RPE1H2B 21/3 MitoModel 
 
Crucial functions that were observed to affected based on the percentage are: 
Glycolysis with 25%; ROS defence with 17%; Mitochondrial dynamics with 15%; 
Replication and transcription with 8%; and so on (Figure 18). 
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Figure 18: Percentage (%) of affected functions observed on the RPE1H2B 21/3 
MitoModel 
 
To further understand the affected functions, variant genes are grouped into tables 
with brief information on their roles in the function. 
 
Electron transport chain and energy production 
Two genes were up-regulated (Table 65) and no genes were down-regulated in the 
electron transport chain function.  
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GENE NAME ROLE LOG2FOLD P-VALUE 
NDUFV3 
Nuclear encoded essential components of 
complex I NADH dehydrogenase, involved in the 
reduction of ubiquinone by NADH 
0.55768 0.0172 
ATP5O 
Nuclear encoded ATP synthase subunits, 
essential components of complex V, reversible 
pump of protons into matrix with formation of 
ATP 
0.433419 0.0347 
  
Table 65: Up-regulated genes in the electron transport chain of RPE1H2B 21/3 cell line 
 
There were only two genes which were up-regulated in the electron transport chain 
function of the RPE1H2B 21/3 cell line. They are NDUFV3, which is an essential 
component of complex I NADH dehydrogenase complex. This indicate that there 
might be an increased reduction of ubiquinone and simultaneously increased 
electron leakage and ROS production in the mitochondria. 
 
Further up-regulation of the ATP50, which is an essential component of 
mitochondrial respiratory chain ATP synthase complex, might contribute to the 
imbalance in the normal subunit composition of ATP synthase complex in the 
mitochondria of RPE1H2B 21/3 cell line. 
 
Finally with only one gene in the complex I and the complex V up-regulated, it might 
suggest that the energy production function in the RPE1H2B 21/3 cell line might be 
comparable with its wild type cell line. 
 
Fatty acid beta oxidation and generation of acetyl CoA 
Two genes were down-regulated (Table 66) and none of the genes were up-
regulated in the fatty acid beta oxidation function. 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
ACSS3 
Acyl-CoA synthetase activity for short chain fatty 
acids 
-7.09682 0.0596 
ACSM5 
Acyl-CoA synthetase activity for medium chain 
fatty acids 
-6.39182 0.15815 
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Table 66: Down-regulated genes in the fatty acid beta oxidation of RPE1H2B 21/3 cell line 
 
ACSS3 and ACSM5, which shows Acyl-CoA synthetase activity for short and medium 
chain fatty acids respectively in the cytoplasm are down-regulated in the RPE1H2B 
21/3 cell line. This suggests that there might be a build-up of short and medium 
chain fatty acids in the cytoplasm. Further there are no misregulations of genes in 
any steps of the fatty acid beta-oxidation inside mitochondria. Thus the wild-type 
levels of acetyl-CoA might be generated in the RPE1H2B 21/3 cell line.  
 
Apoptosis 
A single gene was observed to be up-regulated (Table 67) and none of the genes 
were down-regulated in the apoptosis function.  
 
GENE NAME ROLE LOG2FOLD P-VALUE 
CASP3 Executioner caspases leading to apoptosis 0.448259 0.03275 
 
Table 67: Up-regulated genes in the apoptosis function of RPE1 H2B 21/3 cell line 
 
There were no misregulations of the apoptotic proteins handled by the 
mitochondria apart from the up-regulation of CASP3, which is an executioner 
caspase leading to the apoptosis. Thus we do not expect an impaired apoptotic 
handling by the mitochondria in the RPE1H2B 21/3 cell line.  
 
Glycolysis 
There were 8 genes observed to be down-regulated (Table 68) and none were up-
regulated in the glycolysis function. 
  
GENE NAME ROLE LOG2FOLD P-VALUE 
SLC2A5 Fructose transporter, present in the small intestine -2.70097 0.0016 
HK2 Glucose is phosphorylated to glucose 6-phosphate -0.589886 0.0057 
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catalysed by the hexokinase  
PFKP 
Fructose 6-phosphate is phosphorylated to fructose 
1,6-bisphosphate, catalyzed by phosphofructokinase 
-0.684619 0.00045 
ALDOA 
Fructose 1,6-bisphosphate converted into 
glyceraldehyde 3-phosphate and dihydroxyacetone 
phosphate catalyzed by aldolase 
-0.493325 0.03895 
TPI1 
Dihydroxyacetone phosphate is converted into 
glyceraldehyde 3-phosphate catalyzed by triose 
phosphate isomerase 
-0.759242 0.001 
PGK1 
1,3-bisphosphoglycerate is converted to 3-
phosphoglycerate and ATP is released, catalyzed by 
Phosphoglycerate kinase 
-0.99524 0.00005 
PGAM1 
3-phosphoglycerate is converted into 2-
phosphoglycerate catalyzed by phosphoglycerate 
mutase 
-0.600223 0.00835 
ENO2 
2-phosphoglycerate is converted into 
phosphoenolpyruvate catalyzed by enolase 
-0.427012 0.03585 
 
Table 68: Down-regulated genes in the glycolytic function of the RPE1 H2B 21/3 cell line 
 
Enzymes involved in catalysing several steps of the glycolytic pathway are down-
regulated in the RPE1H2B 21/3 cell line. In conclusion, we hypothesize that lower 
levels of pyruvate will be produced, which might have an effect on the overall 
energy production in the cells. 
 
Fe-S cluster biosynthesis 
There was a single gene observed to be up- (Table 69) and also a single gene which 
was down-regulated (Table 70) in the Fe-S cluster biosynthesis function. 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
FDXR 
Provide reducing equivalents to electron transfer 
chain and contribute to iron-sulphur cluster 
biogenesis 
0.527734 0.02135 
 
Table 69: Up-regulated gene in the Fe-S cluster biosynthesis function of the RPE1H2B 
21/3 cell line 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
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HSCB Mitochondrial iron-sulphur cluster co-chaperone -0.591209 0.02905 
 
Table 70: Down-regulated gene in the Fe-S cluster biosynthesis function of the RPE1H2B 
21/3 cell line 
 
FDXR, which mediates the transport of electrons to the mitochondrial proteins is 
up-regulated. This suggests that there is an increased need for reducing equivalents 
by the mitochondrial proteins in the RPE1H2B 21/3 cell line. 
Further down-regulation of HSCB, which is required for the biogenesis of Fe-S 
cluster implies that the Fe-S cluster biogenesis might be affected and the generation 
is reduced in the RPE1H2B 21/3 cell line.  
 
Mitochondrial dynamics 
There were 2 and 4 genes observed to be up- (Table 71) and down-regulated (Table 
72) respectively in the mitochondrial dynamics function.  
 
GENE NAME ROLE LOG2FOLD P-VALUE 
PINK1 
Involved in the mitochondrial fusion, PINK1 
phosphorylates PARK2 and consequently PARK2 
induced ubiquitination of mitofusins 
0.420517 0.0425 
SYBU 
Involved in the mitochondrial movement, have a 
role in linking the mitochondria to KIF5B 
1.0989 0.0003 
 
Table 71: Up-regulated genes in the mitochondrial dynamics of the RPE1H2B 21/3 cell line 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
MTFP1 
Involved in the mitochondrial fission, role in 
mitochondrial fragmentation and is dependent on 
DNM1L expression 
-0.832433 0.00155 
GDAP1 
Involved in the mitochondrial fission, known to 
have a role in the mitochondrial fragmentation 
-1.12083 0.0002 
BNIP3 
Involved in the mitophagy, cause permeabilization 
of the mitochondrial membrane and also acts as a 
proapoptotic factor 
-1.21804 0.00005 
MAP1LC3A 
Involved in the mitophagy, interacts with BNIP3 
and BNIP3L to remove mitochondria via autophagy 
-4.427 0.20795 
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Table 72: Down-regulated genes in the mitochondrial dynamics of the RPE1H2B 21/3 cell 
line 
 
Several genes coding for proteins, which are involved in the mitochondrial dynamics 
are up-regulated. For example, up-regulation of PINK1 which is involved in the 
mitochondria fusion. We also observe that there were several genes, which were 
down-regulated. For example, BNIP3, which causes permeabilization of the 
mitochondrial membrane during mitophagy and MAP1LC3A, which is known to 
interact with BNIP3 and BNIP3L to remove mitochondria via autophagy. This 
suggests that there could be changed mitochondrial dynamics in the RPE1H2B 21/3 
cell line. 
 
Import and sorting 
There was a single gene which was down-regulated (Table 73) and none of the 
genes were up-regulated in the import and sorting function. 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
IMMP2L 
Inner membrane peptidase that cleaves 
hydrophobic sorting signal 
-0.578531 0.0417 
 
Table 73: Down-regulated gene in the import and sorting function of the RPE1H2B 21/3 
cell line 
 
The down-regulation of IMMP2L in the RPE1H2B 21/3 cell line might suggest that 
there would be an accumulation of proteins with hydrophobic sorting signals inside 
mitochondria. As a consequence the incoming proteins with hydrophobic sorting 
signals might not be functional.  
 
Replication and transcription 
There was a single gene up-regulated (Table 74) and 5 genes down-regulated (Table 
75) in the replication and transcription function. 
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GENE NAME ROLE LOG2FOLD P-VALUE 
RRM2B 
Required for the de novo deoxyribonucleotide 
synthesis in non-proliferating cells supplying dNTPs 
to mtDNA synthesis 
0.570357 0.00775 
 
Table 74: UP-regulated gene in the replication and transcription function of the RPE1H2B 
21/3 cell line 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
TFB2M 
Essential transcription factor involved in the 
transcription of mitochondrial genes 
-0.495879 0.0371 
RMRP 
RNA component of mitochondrial RNA processing 
endoribonuclease cleaves mitochondrial RNA at the 
priming site of mitochondrial DNA replication 
-1.41059 0.00365 
AK4 
Phosphorylates the deoxyribonucleoside 
monophosphates specifically on dAMP 
-1.08976 0.00005 
NME4 
Shows mitochondrial nucleoside diphosphate 
kinase activity 
-0.428476 0.04045 
SLC25A3 Mitochondrial pyrimidine nucleotide carrier -0.641129 0.00315 
 
Table 75: Down-regulated genes in the replication and transcription function of the 
RPE1H2B 21/3 cell line 
 
Several genes involved in handling mitochondrial replication and transcription are 
down-regulated. For example, TFB2M, which is an essential transcription factor 
involved in the transcription of mitochondrial genes and RMRP, which is RNA 
component of mitochondrial RNA processing endoribonuclease. A down-regulated 
mitochondrial replication and transcription suggests that the number of 
mitochondria should not deviate from wild type in the aneuploid cells. It also 
suggests that mitochondrial function is more or less normal and that no need for 
higher levels of energy are required in this trisomic cell line.  
 
Translation 
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Only a single gene was up-regulated (Table 76) and a single gene was down-
regulated (Table 77) in the translation function. 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
RNASEL 
Modulate the stability of mitochondrial mRNAs by 
interacting with MTIF2 
0.962145 0.00155 
 
Table 76: UP-regulated gene in the translation function of the RPE1H2B 21/3 cell line 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
MRPS21 
Mitoribosome which forms a part of mitochondrial 
translation machinary 
-4.71909 0.00005 
 
Table 77: Down-regulated gene in the translation function of the RPE1H2B 21/3 cell line 
 
The up-reulation of RNASEL in the RPE1H2B 21/3 cell line might suggest that there 
could be a increase in the stability of mitochondrial mRNAs. There are only two 
genes affected in the translation function and hence suggest that translation 
function in RPE1H2B 21/3 cell line is comparable with its wild type cell line.  
    
ROS defence 
There are 2 genes which were up-regulated (Table 78) and 2 genes which were also 
down-regulated (Table 79) in the ROS defence function. 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
SOD1 
May be involved in the removal of superoxides in 
the inter membrane space of mitochondria 
0.742468 0.00015 
GPX1 
Reduces hydrogen peroxide to water by using 
reducing equivalents from glutathione 
0.563187 0.0063 
 
Table 78: UP-regulated gene in the ROS defence function of the RPE1H2B 21/3 cell line 
 
GENE NAME ROLE LOG2FOLD P-VALUE 
SOD2 
Dismutates the superoxide generated in the 
mitochondrial matrix to hydrogen peroxide 
-0.613678 0.0078 
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BCKDHA 
Involved in the catabolism of amino acids in 
mitochondria and may also be involved in the 
production of superoxides and hydrogen peroxide 
-0.455574 0.0453 
 
Table 79: Down-regulated gene in the ROS defence function of the RPE1H2B 21/3 cell line 
 
Two genes involved in balancing ROS in the mitochondria are up-regulated. These 
include SOD1, which removes superoxides in the intermembrane space of 
mitochondria and GPX1, which further reduces the hydrogen peroxide to water. In 
contrary SOD2, which removes superoxides in the matrix space of the mitochondria 
is down-regulated. This implies that there might be an increase in the build-up of 
ROS in the matrix space of the mitochondria in the RPE1H2B 21/3 cell line.   
3.1.5.1 Summary for RPE1H2B 21/3 MitoModel 
In total, there were 10 functions that were observed to be affected in the RPE1H2B 
21/3 MitoModel. Further, we observe that the MitoModel had more down- (24 
genes) compared to up-regulated (10 genes) genes. Most number of the down-
regulated genes were present in the glycolysis function with 8 genes affected 
(Figure 19).  
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Figure 19: Number of affected genes observed on all the functions of RPE1H2B 21/3 
MitoModel 
 
3.1.6 Comparison between HCT116 5/4, RPE1 5/3 12/3 and RPE1H2B 21/3 
MitoModels: 
Differentially expressed genes from five functions: Electron transport chain, 
glycolysis; translation; fatty acid beta oxidation; and replication and transcription 
were recorded and used to compare the MitoModels for each cell line (Figure 20).  
 
From Figure 20 it is clear that the differentially expression of genes is more towards 
up-regulation compared to down-reguation in translation electron transport chain 
and replication and transcription functions of RPE1 5/3 12/3 cell line when 
compared with the HCT116 5/4 cell line. Where as in RPE1H2B 21/3 cell line 
glycolysis with more differentially expressed genes tend towards dwnregulation.      
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Figure 20: Comparison of HCT116 5/4, RPE1 5/3 12/3 and RPE1H2B 21/3 MitoModels 
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CHAPTER 3.2 
 
Analysis of expression difference between LR and HR 
stress reactivity mice: impact of mitochondrial function 
 
 
 
Many studies suggest a relationship between hypothalamus-pituitary-
adrenocortical (HPA) axis dysregulation and major depression (MD) [Heinzmann et 
al., 2014]. About 60 to 80% of depressed patients are observed to have 
neuroendocrine alterations in HPA axis activity [Heinzmann et al., 2014]. Reports 
also suggest the improvement of clinical symptoms with normalisation of HPA axis 
function [Heinzmann et al., 2014]. Therefore dysregulated HPA axis as one of the 
key endophenotype of MD and may provide an opportunity to elucidate underlying 
mechanism of the disease [Heinzmann et al., 2014]. 
 
Mouse model selected for extremes in HPA axis reactivity were established by 
Touma and colleagues [Touma et al., 2008] and kindly provided for us for 
mitochondrial analysis. This ‘stress reactivity’ (SR) mouse model system consists of 
a high (HR), intermediate (IR) and low (LR) reactivity mouse line. Distinct 
differences in their corticosterone (CORT) secretion response to stressors are 
observed in these mouse line [Touma et al., 2008]. 
 
To understand the different phenotypes in the three mouse lines, differential 
expression data was generated by our collaborators generated using SAGE 
[Velculescu et al., 1995]. RNA was derived from Hippocampus tissue from brain 
from the LR and HR mice and libraries were pooled from six animals. Our aim was to 
understand the mitochondrial contribution to different stress reactivity types. 
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3.2.1 DATA ANALYSIS: 
The data we received consisted of the mouse gene symbols and expression values of 
LR pool and HR pool with log2fold change and respective p-values.  
 
In order to analyse mouse differential expression data, we generated a mouse 
MitoModel by using the orthologs of the genes present in the human MitoModel.  
 
3.2.2 LR VS. HR MITOMODEL: 
Mouse MitoModel is an amalgamation, consisting of 659 genes which are 
functionally associated with the mitochondria. The model is further classified into 
17 mitochondria specific processes grouped into clusters (Figure 21).  
 
After mapping expression data on to the mouse MitoModel, some of the crucial 
functions that were observed to be impaired, based on the percentage are: 
tricarboxylic acid cycle, which heavily affected with 84.21%  of the genes either up- 
or down-regulated (Figure 22);  cardiolipin biosynthesis, with 66.67% genes 
implicated; the electron transport chain, with 58.78% genes differentially regulated; 
Mitochondrial dynamics, with 57.5%; Glycolysis, with 56.25% affected genes. 
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Figure 21: Visual representation of LR vs. HR mouse MitoModel with functions as clusters 
annotated with their names   
 
In addition to being the most dis-regulated mitochondrial function, the TCA cycle 
also habours genes with highest log2fold change: Sdhc and Fh1 (Figure 23). In 
contrast, beta-oxidation of fatty acids exhibits the lowest log2fold change with 
Acsbg2 followed by Aars2 in the translation function.     
 
There were 313 genes that were misregulated (either up- or down-regulated) out of 
659 genes in the MitoModel. To draw a brief understanding of the biological 
functions, only top 5 up- and down-regulated genes from each function were further 
studied. 
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Figure 22: Percentage (%) of affected functions observed on the mouse MitoModel; the 
size of the node   corresponds to the log2fold change value (higher log2fold change 
corresponds to bigger circle and vice versa) and colour corresponds to gene regulation 
(Blue: Up, Green: None and Red: Down)   
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Figure 23: Graphical display of model parameters, two horizontal lines describing log2fold 
change cutoff values (up: 1.50 and down -1.50) and a vertical line describing p-value cutoff 
(0.05).  
 
Tricarboxylic acid (TCA) cycle 
Top five up-regulated and down-regulated genes in the TCA cycle with their roles 
are defined below  in the tables 80 and 81 respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Sdhc 4.41504 1,49E-16 Part of Succinate dehydrogenase complex in oxidative 
phosphorylation in TCA cycle it catalyzes the oxidation of 
succinate to fumarate 
Fh1 3.31872 5,66E-66 Fumarase catalyzes the formation of L-malate from 
fumarate 
Suclg1 1.6939 1,62E-16 Succinyl CoA synthetase catalyzes the conversion of succinyl 
CoA to succinate 
Aco2 1.28326 6,79E-16 Aconitase catalyzes the interconversion of citrate to 
isocitrate 
Suclg2 0.656476 8,58E+04 Succinyl CoA synthetase catalyzes the conversion of succinyl 
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CoA to succinate 
 
Table 80: The top 5 up-regulated genes of the TCA cycle, in the LR vs. HR comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Dld -0.412284 8,47E-17 Catalyzes the overall conversion of 2-oxoglutarate to 
succinyl-CoA and CO2 
Cs -0.225687 4,69E-30 Citrate synthase catalyzes the synthesis of citrate from 
oxaloacetate and acetyl CoA 
Ogdh -0.11583 1,15E-20 Catalyzes the overall conversion of 2-oxoglutarate to 
succinyl-CoA and CO2 
Sdhb -0.0759846 0.000276975 Part of Succinate dehydrogenase complex in oxidative 
phosphorylation in TCA cycle it catalyzes the oxidation of 
succinate to fumarate 
Idh3a -0.0372824 0.000009775 Isocitrate dehydrogenase catalyze the oxidative 
decarboxylation of isocitrate to 2-oxoglutarate 
 
Table 81: The top 5 down-regulated genes of the TCA cycle, in the LR vs. HR comparison 
 
Enzymes catalysing several steps of the TCA cycle in series are up-regulated: Suclg1 
and Suclg2, which catalyse the conversion of succinyl CoA to succinate; Sdhc, which 
catalyses the oxidation of succinate to fumarate; and finally Fh1, which catalyse the 
conversion of fumarate to malate. Consequently this suggests that three consecutive 
steps in HR mouse line, are up-regulated compared to LR mouse line. 
 
Enzymes catalysing two steps of the TCA cycle are at the same time down-regulated: 
Idh3a, which catalyses the conversion of Isocitrate into alpha-ketoglutarate; and, 
Dld and Ogdh, which catalyses the overall conversion of alpha-ketoglutarate to 
succinyl-CoA and Co2. As a consequence two continuous steps in TCA cycle are 
down-regulated in HR mouse line. 
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In conclusion the TCA cycle is massively up-regulated in the HR mouse line, which in 
turn could directly create an environment for an elevated aerobic energy production 
via the electron transport chain. 
 
Cardiolipin biosynthesis 
Up-regulated and down-regulated genes in the cardiolipin biosynthesis function are 
defined below in the tables 82 and 83 respectively.   
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Pgs1 1.54432 2,67E-03 Phosphatidylglycerol synthase converts cytidine 
diphosphate diacylglycerol to phosphatidylglycerol 
phosphate 
Cds2 0.305926 2,52E+00 Converts phosphatidic acid to cytidine diphosphate 
diacylglycerol 
 
Table 82: The top up-regulated genes of the cardiolipin biosynthesis, in the LR vs. HR 
comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Cds1 -0.439357 5,83E-06 Converts phosphatidic acid to cytidine diphosphate 
diacylglycerol 
Crls1 -0.0385575 0.0248569 Catalyzes the condensation of cytidine diphosphate 
diacylglycerol and phosphatidylglycerol forming a 
nascent cardiolipin 
 
Table 83: The top down-regulated genes of the cardiolipin biosynthesis, in the LR vs. HR 
comparison 
 
Several genes are misregulated in cardiolipin biosynthesis function. Pgs1, involved 
in the conversion of cytidine diphosphate diacylglycerol to phosphatidylglycerol 
phosphate, and Cds2, involved in the conversion of phosphatidic acid to cytidine 
diphosphate diacylglycerol are up-regulated; Cds1, on the other hand, which is 
involved in the conversion of phosphatidic acid to cytidine diphosphate 
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diacylglycerol, and Crls1, known to catalyse the formation of nascent cardiolipin are 
down-regulated in the HR mouse line.  
 
Consequently with several genes misregulated in cardiolipin biosynthesis function, 
we suggest that cardiolipin phospholipid availability in the HR mouse line is 
insufficient compared to LR mouse line. 
 
Electron transport chain (ETC) 
Top five up-regulated and down-regulated genes in the ETC function with their roles 
are defined below in the tables 84 and 85 respectively. 
  
GENE NAME LOG2FOLD P-VALUE ROLE 
Ndufb11 2.07342 6.91E-94 
Nuclear encoded essential components of complex 
I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
Atp5o 1.77797 1.13E-126 
Nuclear encoded ATP synthase subunits, essential 
components of complex V, reversible pump of 
protons into matrix with formation of ATP 
Ndufa4 1.72249 1.05E-85 
Nuclear encoded essential components of complex 
I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
Atp5h 1.67456 6.44E-111 
Nuclear encoded ATP synthase subunits, essential 
components of complex V, reversible pump of 
protons into matrix with formation of ATP 
Atp5e 1.43982 1.8E-12 
Nuclear encoded ATP synthase subunits, essential 
components of complex V, reversible pump of 
protons into matrix with formation of ATP 
 
Table 84: The top 5 up-regulated genes of the ETC, in the LR vs. HR comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Sdhaf1 -0.813245 1,85E-13 Complex II specific assembly factor 
Cox7a1 -0.578704 0.00183884 
Nuclear encoded cytochrome c oxidase subunits, 
essential components of complex IV, catalyses the 
reduction of oxygen to water by cytochrome c 
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Tmem126b -0.499571 0.000175685 Complex I assembly factor 
Cox6c -0.48796 0 Cytochrome c oxidase subunit VIc essential 
component of complex IV 
Ndufa5 -0.369577 9,43E-64 
Nuclear encoded essential components of complex 
I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
 
Table 85: The top 5 down-regulated genes of the ETC, in the LR vs. HR comparison 
 
We observe several genes coding for the complexes in the electron transport chain 
up-regulated. For example, Ndufb11 and Ndufa4, which are essential components of 
complex I and Atp5h, Atp5o and Atp5e, which are essential components of complex 
V were up-regulated.  
 
In addition several essential assembly factors of complexes were down-regulated.  
For example, Sdhaf1 and Tmem126b, which are the components required for the 
complex II and complex I assembly respectively were down-regulated. 
  
As a consequence, these misregulations could lead to a receding energy production 
capacity of the electron transport chain. In conclusion, the assembly of complexes 
and energy generation activity of electron transport chain in the HR mouse line 
could be lower compared to LR mouse line. 
 
Mitochondrial dynamics 
Top five up-regulated and down-regulated genes in the mitochondrial dynamics 
function with their roles are defined below in the tables 86 and 87 respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Sh3glb1 0.706269 0.00292318 
Involved in the mitochondrial fission, proposed 
to be involved in the lipid remodeling of the 
outer membrane during fission 
Kif1b 0.505454 0  
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Kif5b 0.617298 1,96E-33 Involved in the mitochondrial movement, have 
role in the mitochondrial distribution in neurons 
Bnip3 0.553819 0.0000017509 
Involved in the mitophagy, cause 
permeabilization of the mitochondrial 
membrane and also acts as a proapoptotic factor 
Mfn2 0.403356 3,53E-08 
Involved in the mitochondrial fusion, mitofusins 
dimerize resulting in the tethering of the outer 
membranes of the fusing mitochondria 
 
Table 86: The top 5 up-regulated genes of the mitochondrial dynamics, in the LR vs. HR 
comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Park2 -0.83335 0.000130524 Involved in the mitochondrial fusion, Park2 
induces ubiquitination of mitofusins 
Opa3 -0.238638 0.00275452 
Involved in the mitochondrial fusion, interacts 
with Mfn1 and involved in mitochondrial 
fragmentation 
Smcr7 -0.1752 0.0131032 
Involved in the mitochondrial fission, suggested to 
have roles in recruiting Dnm1l 
 
Stoml2 -0.166312 5,72E-02 
Involved in the mitochondrial fusion, scaffold 
proteins Phb2 and Stoml2 coordinate stability of 
the Opa1 
Sqstm1 -0.166026 5,15E-37 
Involved  in the mitophagy, recruited to 
mitochondria and binds mitochondrial substrates 
on the autophagosomes 
 
Table 87: The top 5 down-regulated genes of the mitochondrial dynamics, in the LR vs. HR 
comparison 
 
We observe crucial genes involved in the mitochondrial movement and distribution 
in neurons, such as Kif1b and Kif5b are up-regulated. Mfn2, known to be involved in 
the mitochondrial fusion are up-regulated. On the other hand, downregulated gene 
include Sqstm1, which binds mitochondrial substrates on to the autophagosomes 
during mitophagy.  
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In conclusion, these misregulations suggests that there could be increased 
availability of mitochondria for neuronal activity in addition to reduced clearing of 
mitochondria in HR compared to LR mouse line.   
 
Glycolysis 
Top five up-regulated and down-regulated genes in the glycolytic function with their 
roles are defined below in the tables 88 and 89 respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Slc2a4 2.11 0.0221416 Glucose transport in the muscle and fat cells 
Pgam1 1.59 0 3-phosphoglycerate is converted into 2-
phosphoglycerate catalyzed by phosphoglycerate mutase 
Hk1 0.502583 7,95E-19 Glucose is phosphorylated to glucose 6-phosphate 
catalysed by the hexokinase 
Pkm2 0.361301 3,06E-13 Phosphoenolpyruvate is converted into pyruvate and 
ATP is produced, catalyzed by pyruvate kinase 
Pfkm 0.296095 0.0109634 Fructose 6-phosphate is phosphorylated to fructose 1,6-
bisphosphate, catalyzed by phosphofructokinase 
 
Table 88: The top 5 up-regulated genes of the glycolysis, in the LR vs. HR comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Pgam2 -0.43837 0.00125861 3-phosphoglycerate is converted into 2-
phosphoglycerate catalyzed by phosphoglycerate mutase 
Tpi1 -0.258795 0 
Dihydroxyacetone phosphate is converted into 
glyceraldehyde 3-phosphate catalyzed by triose 
phosphate isomerase 
Ldha -0.251461 4,35E-30 Pyruvate is converted to lactate catalyzed by lactate 
dehydrogenase 
Gpi1 -0.186933 0 Isomerization of glucose 6-phosphate to fructose 6-
phosphate by the phosphoglucose isomerase 
Pgk1 -0.133702 1,50E-28 
1,3-bisphosphoglycerate is converted to 3-
phosphoglycerate and ATP is released, catalyzed by 
Phosphoglycerate kinase 
 
Table 89: The top 5 down-regulated genes of the glycolysis, in the LR vs. HR comparison 
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Several enzymes were identified to be misregulated in glycolytic function in HR 
compared to LR mouse line. Up-regulation of Pgam1 but down-regulation of Pgam2, 
both of which are known to catalyse the reversible reaction of 3-phosphoglycerate 
to 2-phosphoglycerate could suggest the specificity of the phenotype. Further genes 
included Slc2a4, a facilitated glucose transporter; Hk1, which phosphorylates 
glucose to glucose-6-phosphate; and Pkm2, which is known to catalyse the 
transphosphorylation of phosphoenolpyruvate into pyruvate and ATP are up-
regulated.  
 
In addition to up-regulated genes several down-regulated genes were also observed, 
including Ldha, which catalyses the interconversion of pyruvate to lactate and Gpi1, 
which interconverts glucose-6-phosphate and fructose-6-phosphate.  
 
In conclusion, the up-regulation of Pkm2 suggests that there might be a shift in the 
energy production to glycolysis with a possible impaired electron transport chain in 
HR mouse line. 
 
ROS defense 
Top five up-regulated and down-regulated genes in the ROS defence function with 
their roles are defined below in the tables 90 and 91 respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Slc25a10 1.21 0.0102904 May be involved in the transport of glutathione into the 
mitochondria 
Gclm 0.878009 5,04E-03 Catalyzes the first step reaction which combines cysteine 
and glutamate to form glutamylcysteine 
Gsta4 0.596482 2,32E-18 
Mitochondrial glutathione-S-transferases through 
glutathione conjugation or peroxide reduction detoxify 
harmful byproducts 
Sod1 0.426256 4,42E-24 May be involved in the removal of superoxides in the 
inter membrane space of mitochondria 
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Sod2 0.419814 3,74E-03 Dismutates the superoxide generated in the 
mitochondrial matrix to hydrogen peroxide 
 
Table 90: The top 5 up-regulated genes of the ROS defense, in the LR vs. HR comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Mpv17l -0.170958 3,14E-16 May have a role in the metabolism of reactive oxygen 
species 
Bckdha -0.162173 0.0290465 
Involved in the catabolism of amino acids in 
mitochondria and may also be involved in the 
production of superoxides and hydrogen peroxide 
Gstp1 -0.110822 1,49E-05 
Mitochondrial glutathione-S-transferases through 
glutathione conjugation or peroxide reduction detoxify 
harmful byproducts 
Txn2 -0.104875 0.0000420124 Mitochondrial thioredoxin reduces peroxiredoxin to 
their superoxide scavenging state 
Gstp2 -0.0918683 0.000860817 
Mitochondrial glutathione-S-transferases through 
glutathione conjugation or peroxide reduction detoxify 
harmful byproducts 
 
Table 91: The top 5 down-regulated genes of the ROS defense, in the LR vs. HR comparison 
 
Several genes involved in counter balancing the build up of ROS were misregulated 
in HR mouse line. For example Sod1 and Sod2, involved in the removal of 
superoxides in the inter membrane space and matrix of mitochondria respectively 
were observed to be up-regulated. At the same time Gstp1 and Gstp2, which are 
mitochondrial glutathione-S-transferases, involved in the detoxification of harmful 
byproducts were down-regulated.  
 
Consequently with misregulations in countering ROS balance inside mitochondria, 
there might be an elevated ROS levels inside mitochondria in the HR compared to 
LR mouse line. 
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Heme biosynthesis 
Crucial up-regulated and down-regulated genes in the heme biosynthesis function 
with their roles are defined below in the tables 92 and 93 respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Ppox 2.02 0.00000160321 Protoporphyrinogen oxidase converts 
Protoporphyrinogen IX to Protoporphyrin IX 
Alad 0.834941 2,64E-02 
ALA dehydratase catalyzes the reaction where 
two molecules of ALA condenses to form 
monopyrrole porphobilinogen (PBG) 
Fech 0.411865 0.0000419872 
Ferrochelatase catalyzes the step involving the 
addition of Ferrous iron into the 
protoporphyrin IX to form the protoheme IX 
 
Table 92: The top up-regulated genes of the heme biosynthesis, in the LR vs. HR 
comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Urod -0.1657 0.030189 
Uroporphyrinogen III decarboxylase catalyzes 
stepwise decarboxylation of the 
Uroporphyrinogen III forming 
Coproporphyrinogen III 
Cpox -0.0437044 0.0245879 
Coproporphyrinogen III is transported to 
mitochondria and in the presence of 
coproporphyrinogen III oxidase it is 
oxidatively decarboxylated 
 
Table 93: The top down-regulated genes of the heme biosynthesis, in the LR vs. HR 
comparison 
 
Out of eight steps in the biosynthetic pathway leading to the formation of heme, 
genes coding for enzymes participating in five steps were misregulated. Up-
regulated genes included Ppox and Fech, which catalyse the last two steps in the 
formation of protoheme IX. Down-regulated genes included the Urod, which 
catalyses the formation of coproporphyrinogen III and Cpox, which catalyses the 
formation of protoporphyrinogen IX. 
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In conclusion, there seems to exist an erroneous heme biosynthetic pathway in the 
HR mouse line. 
  
Apoptosis 
Top five up-regulated and down-regulated genes in the ROS defence function with 
their roles are defined below in the tables 94 and 95 respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Apaf1 1.18 4,48E-02 Binds CASP9 forming an apoptosome and 
activates it 
Bcl2l1 1.02 0.0000120163 Bcl-2 family member Anti-apoptotic proteins 
Casp7 0.812914 0.0133119 Executioner caspases leading to apoptosis 
Eif3m 0.60438 0.00210274 PCI domain containing protein 1 can negatively 
regulate CaspP9 activity 
Mapk3 0.368087 0.00313329 Inhibitors of CASP9 activity 
 
Table 94: The Top 5 up-regulated genes of the apoptosis, in the LR vs. HR comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Bbc3 -0.534657 0.000649336 Puma Bcl-2 family member propagating 
apoptosis 
Bax -0.274262 0.00104904 
Bcl-2 family member propagating 
apoptosis 
 
Cycs -0.163199 5,66E-22 
Binds to apoptosis inducing factor 1 
(Apaf1) forming a structure called 
apoptosome 
Vdac2 -0.141557 9,01E-09 
Voltage dependent anion channel forms 
part of permeability transition pore and is 
also involved in the takeup of calcium ions 
from the Endoplasmic reticulum 
2810002N01Rik -0.0676993 0.0435408 Localizes to the mitochondria and 
stimulates the release of cytochrome c 
 
Table 95: The top 5 down-regulated genes of the apoptosis, in the LR vs. HR comparison 
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The HR mouse line contains misregulations in important apoptotic genes: for 
example Apaf1, is observed to be up-regulated and Cycs, is down-regulated. Eif3m 
and Mapk3, are also up-regulated, which negatively regulate and inhibit Casp9 
activity respectively. 
 
MOMP, controlled by the Bcl-2 family members are divided into pro and anti-
apoptotic members. Bcl2l1, an anti-apoptotic member was up-regulated, while Bbc3 
and Bax were down-regulated, which are proapoptotic members.    
 
Consequently, with misregulations in crucial genes conducting mitochondria 
dependent death pathway, apoptosis  by mitochondria seems impaired in the HR 
mouse line. 
 
Pyruvate transfer 
One of out of two genes coding for the proteins to import pyruvate inside 
mitochondria is down-regulated (Table 96). 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Brp44l -0.0208261 0.000281613 Involved in the transfer of pyruvate inside 
mitochondria 
 
Table 96: The top down-regulated gene of the pyruvate transfer, in the LR vs. HR 
comparison 
 
With the observed down-regulation in the gene responsible for the transfer of 
pyruvate inside mitochondria, there might be lower levels of pyruvate available in 
the HR mouse line.  
 
Import & Sorting 
Genes up-regulated and down-regulated in the Import and sorting function with 
their roles are defined below in the tables 97 and 98 respectively.  
 
 119 
GENE NAME LOG2FOLD P-VALUE ROLE 
Timm22 0.364572 0.0263139 
Inner membrane carrier pathway, forms 
the core channel and inserts proteins into 
inner membrane 
Timm13 0.0269357 0.0373801 
Inner membrane carrier pathway, forms 
complex with Timm8 and performs the 
transfer of inner membrane proteins 
 
Table 97: The top up-regulated genes of the import and sorting, in the LR vs. HR 
comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Gfer -0.405053 0.0000127714 
Intermembrane transport and assembly, 
it is known to oxidize Chchd4 and then 
the oxidized Chchd4 acts as a receptor 
for the pre proteins and it also facilitates 
assembly of cytosolic Fe–S proteins 
Tomm40 -0.333747 3,04E-14 
Outer membrane translocation, forms 
the outer membrane channel forming 
protein 
Tomm40l -0.27109 0.0000198714 
Outer membrane translocation, forms 
the outer membrane channel forming 
protein 
Mipep -0.212018 0.000142321 
Secondary cleavage of the pre proteins 
processed by the mitochondrial 
processing peptidase 
Samm50 -0.192098 0.0116551 
Outer membrane sorting and assembly 
machinery, central component of SAMM 
complex and inserts beta barrel proteins 
into the outer membrane 
 
Table 98: The top 5 down-regulated genes of the import and sorting, in the LR vs. HR 
comparison 
 
The HR mouse line had several mis-regulated genes in the import and sorting 
pathway. These included Timm22 and Timm13, which play important roles in the 
insertion of proteins into inner membrane are up-regulated, whereas Tomm40 and 
Tomm40l, which form the outer membrane channel forming proteins are down-
regulated.  
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As a consequence, there might be a reduction in the protein import function on the 
outer membrane with a possible consequence on the insertion of inner membrane 
proteins. In conclusion, misregulations on the import and sorting function may 
impair the transport of crucial proteins inside mitochondria in HR mouse line. 
 
Fe-S cluster biosynthesis 
Top five up-regulated and down-regulated genes in the Fe-S cluster biosynthesis 
function with their roles are defined below in the tables 99 and 100 respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Nfu1 2.53 0.0000482391 Protein assembles and transfers 4Fe-4S 
clusters to target apoproteins 
Fdxr 1.88 1,80E-02 
Provide reducing equivalents to electron 
transfer chain and contribute to iron-
sulfur cluster biogenesis 
Isca1 1.36 2,91E-07 Involved in the biogenesis and assembly 
of iron-sulfur clusters 
Mms19 1.25 0.0000020733 Cytosolic Fe-S protein assembly 
targeting factor 
Iscu 0.804449 0.00072882 Iron sulfur cluster assembly enzyme, Fe-
S cluster intermediate is formed on it 
 
Table 99: Top 5 up-regulated genes of the Fe-S cluster biosynthesis, in the LR vs. HR 
comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Fdx1 -0.580097 5,66E-05 
Small iron-sulfur protein, transfers 
electrons from NADPH to mitochondrial 
cytochrome P450 
Fdx1l -0.494986 9,80E-19 Transfers electrons from NADPH to 
mitochondrial cytochrome P450 
Slc25a37 -0.368901 0.000448722 Functions as an essential iron importer 
Nubp2 -0.30274 3,08E-04 Required for the assembly of cytosolic 
iron-sulfur proteins 
Fam96b -0.155651 0.000664285 Components of the cytosolic Fe/S 
protein assembly (CIA) machinery 
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Table 100: The top 5 down-regulated genes of the Fe-S cluster biosynthesis, in the LR vs. 
HR comparison 
 
Several crucial genes involved in the Fe-S cluster biosynthesis were misregualted in 
the HR mouse line. For example, Iscu, which facilitates Fe-S cluster intermediate 
formation and Nfu1, which assembles and transfers 4Fe-4S clusters to target 
apoproteins, including succinate dehydrogenase were up-regulated, but Slc25a37, 
which functions as an mitochondrial iron importer, Fdx1 and Fdx1l,  which are 
involved in transferring electrons from NADPH to mitochondrial cytochrome P450 
were down-regulated.  
 
Consequently, we expect a consequence also for the electron transport chain, which 
contains many Fe-S proteins. In conclusion, HR mouse line exhibits an impaired Fe-S 
cluster biosynthesis function compared to the LR mouse line. 
 
Replication & transcription 
Top five up-regulated and down-regulated genes in the replication and transcription  
function with their roles are defined below in the tables 101 and 102 respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Rnaseh1 2.58 0.12614 
May have role in the removal of RNA 
primers at the origin of replication on 
heavy and light strands 
Pus1 2.05 0.000378398  
Shows posttranscriptional modifications 
activity in the human mitochondrial 
tRNAs 
 
Osgepl1 1.60 0.00144795 
Mterfd2 1.18 0.000438003 Mitochondrial transcription termination 
factor 
Nfe2l2 1.17 0.000154098 
Regulates the expression of TFB1M and 
TFB2M which are two mitochondrial 
transcription factors 
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Table 101: The top 5 up-regulated genes of the replication and transcription, in the LR vs. 
HR comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Mutyh -0.736966 0.0327108 Involved in the mitochondrial DNA base 
excision repair 
Dguok -0.376268 0.00072044 
Involved in the phosphorylation of 
recycled deoxyribonucleosides in 
mitochondria specific for guanosine, 
adenosine and inosine 
Cmpk2 -0.295153 6,16E-04 
Phosphorylates the 
deoxyribonucleoside mono phosphates 
specifically on dCMP 
Rpusd2 -0.289393 0.0225809 
Shows posttranscriptional modifications 
activity in the human mitochondrial 
tRNAs 
Trnt1 -0.281249 0.00521788 Mitochondrial CCA adding enzyme, adds 
CCA sequence to the 3' end of tRNA 
 
Table 102: The top 5 down-regulated genes of the replication and transcription, in the LR 
vs. HR comparison 
 
Genes required for the replication and transcription of the mtDNA were observed to 
be misregulated in HR mouse line. Rnaseh1, which is implicated in the removal of 
RNA primers at the origin of replication on heavy and light strands; and Mterfd2, 
which is a mitochondrial transcription termination factor are up-regulated. Mutyh, 
which is involved in the mitochondrial DNA base excision repair; and Dguok, which 
is required for the phosphorylation of recycled deoxyribonucleosides in 
mitochondria are down-regulated.  
 
As a consequence of these differential expressions, it could be that replication and 
transcription are higher with the impaired error correction mechanism in the HR 
mouse line.    
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Formation of Acetyl CoA 
Up-regulated and down-regualted genes in the formation of acetyl-CoA function 
with their roles are defined in the tables 103 and 104 respectively. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Pdha1 0.197907 0.000122616 Pyruvate dehydrogenase complex 
catalyzes the overall conversion of 
pyruvate to acetyl CoA 
 
Table 103: The up-regulated gene of the ‘formation of acetyl CoA’, in the LR vs. HR 
comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Pdhb -0.421138 0.041229 Pyruvate dehydrogenase complex 
catalyzes the overall conversion of 
pyruvate to acetyl CoA 
 
Table 104: The down-regulated gene of the ‘formation of acetyl CoA’, in the LR vs. HR 
comparison 
 
We observe two genes showing contradictory expression patterns in the pyruvate 
dehydrogenase complex, which converts pyruvate to acetyl-CoA. This suggests that 
acetyl-CoA formation in the mitochondria of HR mouse line is misregulated.  
 
Translation 
Top five up-regulated and down-regulated genes in the translation function with 
their roles are defined below in the tables 105 and 106 respectively. 
  
GENE NAME LOG2FOLD P-VALUE ROLE 
Kars 2.14 1,49E-14 Involved in the specific attachment of 
lysine aminoacid to its cognate tRNA 
Tars2 1.58 0.0431267 Involved in the specific attachment of 
threonine aminoacid to its cognate tRNA 
Mtif2 1.58 0.0000845711 Translation initiation factor could assist 
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the tRNA to bind to rRNAs 
Mrpl39 1.42 3,71E-03  
Mitoribosome which forms a part of 
mitochondrial translation machinary Mrpl42 1.42 1,22E-02 
 
Table 105: The top 5 up-regulated genes of the translation, in the LR vs. HR comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Aars2 -1.35 1,79E-07 Involved in the specific attachment of 
alanine aminoacid to its cognate tRNA 
Mrpl36 -0.58738 8,10E-03  
 
Mitoribosome which forms a part of 
mitochondrial translation machinary 
Mrpl14 -0.387381 0.000138142 
Mrpl38 -0.375404 8,84E-04 
Phb -0.400145 1,38E-23 
Involved in the post translational quality 
control, stabilizes mitochondrially 
synthesized proteins 
 
Table 106: Top 5 down-regulated genes of the translation, in the LR vs. HR comparison 
 
Aminoacyl-tRNA synthetase family members were misregulated in the HR line. Kars 
and Tars2, implicated in the specific attachment of lysine and threonine amino acids 
to its cognate tRNAs were up-regulated. Aars2, involved in the attachment of alanine 
to its cognate tRNA was down-regulated. Mitochondrial ribosomes forming part of 
mitochondrial translation machinery were misregulated. Further it was also 
observed that Phb, which is involved in the post translational quality control and 
stabilization of mitochondrially synthesized proteins is down-regulated in the HR 
mouse line.  
 
These misregulations in the translation machinery could lead to a disturbance in the 
protein translation inside mitochondria. In conclusion, HR mouse line harbours a 
defective mitochondrial translation machinery.      
 
Beta-oxidation of fatty acids 
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Top five up-regulated and down-regulated genes in the fatty acid beta-oxidation 
function with their roles are defined below in the tables 107 and 108 respectively.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Slc27a1 1.24 1,20E-18 Readily converts the transported very 
long chain fatty acids to acyl-CoAs 
Hadhb 1.20 0.0000248563 
Mitochondrial trifunctional protein 
catalyzes the Very long and long chain 
fatty acids 
Acadsb 1.10 1,98E-05 Involved in the metabolism of short 
branched chain fatty acids 
Cpt1c 0.849409 7,98E-06 
Carnitiine palmitoyl transferase 
converts an acyl-CoA into an 
acylcarnitine 
Acadl 0.575312 0.00921484 Long chain hydroxyacyl-CoA 
dehydrogenase 
 
Table 107: The top 5 up-regulated genes of the beta-oxidation of fatty acids, in the LR vs. 
HR comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Acsbg2 -1.58 0.360927 Acyl-CoA synthetase activity for 
bubblegum family members 
Acsm3 -0.531705 0.00114038 Acyl-CoA synthetase activity for medium 
chain fatty acids 
Fabp3 -0.287257 4,27E-03 
Fatty acid binding proteins are also 
involved in the import and export of 
fatty acids 
Slc27a4 -0.281893 0.00000653627 Readily converts the transported very 
long chain fatty acids to acyl-CoAs 
Fabp5 -0.274065 2,63E-38 
Fatty acid binding proteins are also 
involved in the import and export of 
fatty acids 
 
Table 108: The top 5 down-regulated genes of the beta-oxidation of fatty acids, in the LR 
vs. HR comparison 
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Several genes involved in the metabolism of fatty acids in the mitochondria were 
differentially regulated. Hadhb, which catalyses the metabolism of very-long and 
long chain fatty acids and Acadl, involved in the metabolism of long chain fatty acids 
were up-regulated. In addition, Acadsb, involved in the metabolism of short or 
branched chain fatty acids was up-regulated. Acsbg2 and Acsm3, which have acyl-
CoA synthetase activity for bubblegum family members and medium chain fatty 
acids respectively were down-regulated.  As a consequence, there might be a 
significant drift towards the consumption of very-long and long chain fatty acids and 
short or branched fatty acids as compared to medium chain fatty acids in the HR 
mouse line. 
 
Calcium transport 
Up-regulated and down-regualted genes in the calcium transport function with their 
roles are defined in the tables 109 and 110 respectively. 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Efha1 0.976153 0.0000725016 
Regulates the mitochodrial calcium 
uniporter by inhibiting and permitting 
the calcium, depending upon the 
cytosolic calcium concentrations 
1500032L24Rik 0.743222 6,26E-04 Forms a important component of 
mitochondrial calcium uniporter 
Cbara1 0.5115 0.00195838 
Regulates the mitochodrial calcium 
uniporter by inhibiting and permitting 
the calcium, depending upon the 
cytosolic calcium concentrations 
 
Table 109: The top up-regulated genes of the Calcium transport, in the LR vs. HR 
comparison 
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Efha2 -0.181187 1,58E-02 
Regulates the mitochodrial calcium 
uniporter by inhibiting and permitting 
the calcium depending upon the 
cytosolic calcium concentrations 
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Pacs2 -0.0676387 0.00525857 Involved in the control of ER 
mitochondria apposition 
 
Table 110: The top down-regulated gene of the Calcium transport, in the LR vs. HR 
comparison 
 
We observe that the genes responsible for the maintaining the balance of calcium in 
the mitochondria were up-regulated. For example Efha1 and Cbara1 were up-
regulated. In addition, a crucial component of the mitochondrial calcium uniporter 
is up-regulated. This suggests that the accumulation of calcium in the mitochondria 
is higher in HR mouse line.    
 
Urea Cycle 
A single gene was down-regulated in the urea cycle (Table 111) function.  
 
GENE NAME LOG2FOLD P-VALUE ROLE 
Arg2 -0.597902 0.00155513 
Arginase catalyzes the step where 
Arginine is hydrolyzed to form urea and 
ornithine 
 
Table 111: The top down-regulated gene of the Urea cycle, in the LR vs. HR comparison 
 
The down-regulation of Arg2 suggests that the urea synthesis in the mitochondria 
might be lower in the HR mouse line compare to the LR mouse line.  
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CHAPTER 3.3 
 
Representative MitoModel in 16 samples of primary 
colorectal cancer and liver metastases 
 
 
Colorectal cancer (CRC) is one of the most diagnosed cancer in humans, with an 
estimated death of about 600,000 to have occurred worldwide in 2008 [Jemal et al., 
2011]. CRC is primarily asymptomatic until it progresses to advanced stages and 
hence numerous patients are diagnosed, when the cancer has grown large enough to 
cause symptoms [Read & Kodner, 1999]. Liver forms a major common site of CRC 
metastases [Sheth & Clary, 2005].  
 
Sporadic genetic and /or epigenetic changes are observed in many cases of CRC. 
Nevertheless, 10% to 20% cases might be familial [Gonzalez & Cruz, 2015]. Several 
studies also highlight the diverse prognostic signatures for CRC with different 
tumour behaviors [Kim et al., 2014].  
 
Our interest was to understand the contribution of mitochondrial function on cancer 
development and progression. To this end, we used 16 RNA-seq samples of matched 
primary CRC and synchronous liver metastases histologically identified as 
adenocarcinoma in addition to normal colonic epithelium [Kim et al., 2014]. 
 
We expected a general high variation between patients. As we already observed a 
high divergence between aneuploid cell lines (Chapter 3.1.), the clonal nature of 
cancer and metastasis will typically yield a diverse set of mutations present in 
different patients. Therefore, we decided to identify representative groups of 
patients, which could give us a general idea of the mitochondrial contribution to this 
disease.  
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3.3.1 TASK DESCRIPTION: 
The task was thus to cluster  the 16 MitoModels of the primary CRC and the liver 
metastases to generate representative patient groups and identify genes that are 
consistently affected. 
 
We first retrieved the mutations and differential expression data specific to the 
primary CRC and the liver metastases as compared to the patients’ normal colonic 
epithelium. The resulting data is then mapped on to the MitoModel, resulting in the 
constitution of 16 distinct MitoModels for primary CRC and liver metastases. 
            
3.3.2 DATA ANALYSIS:  
Mutation sites and expression differences between the normal colonic epithelium 
versus primary CRC and normal colonic epithelium versus liver metastases were 
achieved by following the workflow defined in section (2.13).   
 
The obtained mutation sites and differentially expressed genes of the 16 samples 
were mapped on to obtain 16 distinct MitoModels of primary CRC and liver 
metastases.  
 
3.3.3 CLUSTER ANALYSIS:  
Cluster analysis was implemented to group the 16 different MitoModels of the 
primary CRC’s. Groups of these models was based on the expression values of 563 
mitochondria associated genes participating in the MitoModel from 16 primary CRC 
samples. Hierarchical clustering using euclidean distance as similarity metric was 
used [Maimon & Rokach, 2005]. 
 
 Clustering resulted in  four groups depicted as cluster 1, 2, 3 and 4 (Figure 24).    
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Figure 24: Dendrogram showing 4 distinct clusters derived from 16 primary CRC samples. 
 
3.3.4 REPRESENTATIVE MITOMODELS: 
To achieve the representative MitoModel for a single cluster, individual MitoModels 
from each cluster were combined.  
 
Representative expression data were generated by using the mean value of the 
log2fold change and p-values of individual cluster members for the different 
conditions.  
 
For generating the representative mutations, mutation sites observable in at least 
two members of the cluster were collected.  
 
The representative expression and mutation data for each cluster was mapped to 
the MitoModel to obtain the representative MitoModels.  
 
For liver metastases samples, we took the four clusters based on the CRC expression 
and mutation data and followed the same procedure. 
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3.3.5 CHARACTERIZING REPRESENTATIVE GENES:  
Representative genes that are consistently affected in each and every cluster, and in 
both the primary CRC and the liver metastases were analysed further.  
 
This was achieved by creating tables with the affected genes divided in the 4 
clusters and subdivided into primary CRC and liver metastases (see for instance 
Table 112 for the electron transport chain). Several symbols define the expression 
profile in the table. For example, “ ↑ ”  blue up arrow shows up-regulation,, “ ↓ ” 
green down arrow represents down-regulation and “ X ” red X  is used for no 
change. For mutations, “ + ” black  + represent that the gene is mutated and “ X “ 
light blue X indicates that the gene does not have any mutations (see for instance 
Table 113).  
 
Electron transport chain 
Representative differentially expressed genes and mutated genes in the electron 
transport chain function are defined below in the tables 112 and 113 respectively. 
 
Genes cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastase
s 
Primary 
CRC   
Liver 
Metastases 
COX6B2 ↓  ↓  ↓  ↓  ↓  ↓   X ↓  
COX4I2  X  X  X  X  X  X  X ↓  
 
Table 112: Differentially expressed, representative genes observed in both primary CRC 
and liver metastases of all the clusters in the electron transport chain function.    
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary Liver Primary Liver Primary Liver Primary Liver 
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CRC Metastases CRC Metastases CRC Metastases CRC   Metastases 
MT-ND5 + +  X  X  X  X  X  X 
MT-CO1  X  X + +  X  X  X  X 
MT-CYB  X  X +  X  X  X  X  X 
COX4I1  X  X  X +  X  X  X  X 
MT-CO2  X  X  X  X  X  X  X + 
 
Table 113: Representative genes with mutation sites observed in both the primary CRC 
and the liver metastases of all the clusters in the electron transport chain function.   
 
COX6B2 expression was lower in the primary CRC and liver metastases samples of 
all most all the clusters. COX6B2 is an essential component of cytochrome c 
oxidase, complex IV in the electron transport chain [Hüttemann et al., 2003]. 
COX6B2 was also observed to be down-regulated in the rho(0) cell line 
[Hashiguchi & Zhang-akiyama, 2009] devoid of mitochondrial DNA that exhibit 
Warburg effect [Ayyasamy et al., 2011].  
 
This study also revealed mutations in core subunits of the mitochondrial electron 
transport chain. For example, mutated MT-ND5 was observed in both the primary 
CRC and the liver metastases of cluster 1 and mutated MT-CO1 was observed in both 
the primary CRC and liver metastases of cluster 2. Similarly, mutations in the coding 
regions of MT-ND5 and MT-CO1 was observed in the human colorectal cancer cell 
lines as well as human colon cancer [Chatterjee et al., 2006].   
 
In conclusion, the misregulation of COX6B2 identified in multiple clusters both in 
the primary CRC and the liver metastases and mutations in core subunits of the 
electron transport chain, suggests a reduction in energy production via the electron 
transport chain in most of the patient groups. 
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Beta oxidation of fatty acids 
Representative differentially expressed genes and mutated genes in the Beta 
oxidation of fatty acids function are defined below in the tables 114 and 115 
respectively. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
FABP6 ↑ ↑ ↑ ↑ ↑ ↑  X ↑ 
FABP4 ↓  ↓  ↓  ↓  ↓  ↓   X ↓  
FABP2 ↓  ↓  ↓  ↓   X ↓   X ↓  
ACSL6 ↑ ↑ ↑ ↑  X ↑  X  X 
SLC27A5 ↑ ↑  X ↑  X ↑  X ↑ 
SLC27A6 ↓  ↓  ↓  ↓   X  X  X ↓  
ACADS ↓   X ↓   X ↓  ↓   X ↓  
ACSL1 X  ↑  X ↑  X ↑  X ↑ 
ACSS3  X ↑  X ↑  X ↑  X ↑ 
ACSM5  X ↑  X ↑  X ↑  X ↑ 
ACSM2A  X ↑  X ↑  X ↑  X ↑ 
ACSM2B  X ↑  X ↑  X ↑  X ↑ 
ACADL  X ↑  X ↑  X ↑  X ↑ 
CD36 ↓   X ↓   X ↓   X  X ↓  
ACSM1 ↓   X ↓   X  X ↓   X ↓  
FABP1 ↓   X ↓  ↓   X  X  X  X 
ACAA2  X  X ↓   X  X  X  X ↓  
ACADM  X  X  X  X ↓   X  X  X 
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ACSM3  X  X  X  X  X  X  X ↓  
 
Table 114: Differentially expressed, representative genes observed in both primary CRC 
and liver metastases of all the clusters in the beta oxidation of fatty acids function. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
ACSL3  X  X  X +  X +  X  X 
ACSL5  X  X  X +  X  X  X  X 
ACSL6 +  X  X  X  X  X  X  X 
ACSS3  X  X  X +  X  X  X  X 
FABP6  X  X  X +  X  X  X + 
 
Table 115: Representative genes with mutation sites observed in both the primary CRC 
and the liver metastases of all the clusters in the beta oxidation of fatty acids function. 
 
Observations from this study throws light on the misregulations in multiple fatty 
acid binding proteins such as FABP2 and FABP4, which were down-regulated but 
FABP6, was up-regulated in primary CRC and liver metastases of all the clusters.  
Similarly, it was also reported that FABP6 was overexpressed in the colorectal 
cancer [Ohmachi et al., 2006]. 
 
The two acyl-CoA dehydrogenases showed contradictory behaviour. ACADL, which 
catalyses initial steps of beta oxidation and is  involved in the metabolism of long 
chain fatty acids is up-regulated only in the liver metastases of 4 clusters whereas 
ACADS, which catalyse the final step of beta oxidation and is involved in the 
metabolism of short chain fatty acids is down-regulated in the primary CRC’s of 
almost all the cluster. 
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As a consequence of misregulations in the fatty acid binding proteins in both 
primary CRC and liver metastases, observed in almost all the clusters, we predict a 
shift in lipid metabolism in both the primary CRC as well as liver metastases. AS we 
further observed a misregulations in Acyl-CoA dehydrogenases, such as ACADS, 
observed in primary CRC’s and ACADL only in liver metastases,  we hypothesize that 
fatty acid metabolims changes from primary CRC to liver metastases inside 
mitochondria. 
 
Glycolysis 
Representative differentially expressed genes and mutated genes in the glycolytic 
function are defined below in the tables 116 and 117 respectively. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
ALDOB X ↑ ↑ ↑ X ↓  X ↑ 
ALDOC X X X X X ↑ X ↑ 
SLC2A1 X X X X X ↑ X ↑ 
SLC2A2 X ↑ X ↑ X ↑ X ↑ 
SLC2A3 X X X X X ↑ X ↑ 
SLC2A5 ↓  X X X X X X X 
HK2 X X X ↓  X X X ↓  
HK3 X X X ↑ X X X X 
ENO3 X X X ↑ X X X X 
PGAM2 X X X X X ↓  X X 
PKLR X ↑ X ↑ X X X ↑ 
 137 
 
Table 116: Differentially expressed, representative genes observed in both primary CRC 
and liver metastases of all the clusters in the glycolytic function. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
HK1 X X + X X X X X 
PFKP X X + X X X X X 
ALDOB X X + + X X X X 
SLC2A2 X + X + X X X X 
PKLR X + X + X X X X 
ENO1 X X X + X X X X 
 
Table 117: Representative genes with mutation sites observed in both the primary CRC 
and the liver metastases of all the clusters in the glycolysis function. 
 
This study highlights misregulations in two critical genes in glycolysis: SLC2A2, 
which is a facilitated glucose transporter, was up-regulated only in the liver 
metastases of 4 clusters and was also mutated in the liver metastases of cluster 1 
and 2; PKLR, which catalyses the transphosphorylation of phosphoenolpyruvate 
into pyruvate and ATP was noticed to be up-regulated in the liver metastases of all 
clusters and was also mutated in the liver metastases of cluster 1 and 2.   
 
We propose that due to up-regulation of SLC2A2 and PKLR in the liver metastases of 
all the clusters, there might be an increase in glucose utilization and ATP production 
via glycolytic pathway in the liver metastases compared to primary CRC.      
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Urea cycle 
Representative differentially expressed genes and mutated genes in the urea cycle 
function are defined below in the tables 118 and 119 respectively. 
  
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
CPS1 ↑ ↑ X ↑ X ↑ X ↑ 
OTC X ↑ X ↑ X X X X 
ARG1 X ↑ X ↑ X ↑ X ↑ 
 
Table 118: Differentially expressed, representative genes observed in both primary CRC 
and liver metastases of all the clusters in the Urea cycle function. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
CPS1 X + X + X X X + 
 
Table 119: Representative genes with mutation sites observed in both the primary CRC 
and the liver metastases of all the clusters in the Urea cycle function. 
 
Several genes of the urea cycle were misregulated, including CPS1, which catalyses 
the first step of urea cycle, the formation of carbamoyl phosphate with the available 
free ammonia and bicarbonate, is up-regulated in liver metastases of all the clusters 
and is also mutated in the liver metastases of almost all the clusters. ARG1, which 
catalyses the final step, where arginine is hydrolyzed to form urea and ornithine is 
up-regulated in the liver metastases of all the clusters.  
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Based on our observations in the liver metastases, we hypothesize a build up of 
NH4+  in the blood, which could lead to toxicity due to the absence of alternative 
pathways for the generation of urea. 
 
Mitochondrial dynamics: 
Representative differentially expressed genes and mutated genes in the 
mitochondrial dynamics function are defined below in the tables 120 and 121 
respectively. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
PLD6 ↑ X X X X X X X 
TRAP1 ↑ X X X X X X X 
GDAP1 ↑ X X X X X X X 
BNIP3 X ↑ X ↑ X ↑ X ↑ 
PINK1 ↓  X ↓  X X X X X 
PARK2 X X X X X X X ↓  
PKIA X X X ↓  X X X X 
 
Table 120: Differentially expressed, representative genes observed in both primary CRC 
and liver metastases of all the clusters in the mitochondrial dynamics function. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastase
s 
MFF + X X X X X X X 
SQSTM1 X X X + X X X X 
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Table 121: Representative genes with mutation sites observed in both the primary CRC 
and the liver metastases of all the clusters in the mitochondrial dynamics function. 
 
The most important gene observed to be misregulated is BNIP3, which is up-
regulated in the liver metastases of all the clusters. As a consequence, there might be 
an increase in the permeabilization of the mitochondrial membrane leading to 
mitophagy in the liver metastases. 
 
Apoptosis 
Representative differentially expressed genes and mutated genes in the apoptosis 
function are defined below in the tables 122 and 123 respectively. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
PMAIP1 ↑ X ↑ ↑ X ↑ X X 
CDK1 ↑ X ↑ X X ↑ X ↑ 
CASP7 ↓  ↓  ↓  ↓  X ↓  X ↓  
BCL2 ↓  X ↓  ↓  ↓  X X ↓  
BCL2L11 ↓  X X X X X X X 
 
Table 122: Differentially expressed, representative genes observed in both primary CRC 
and liver metastases of all the clusters in the apoptosis function. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
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BAX + X X X X X X X 
TP53 + X + + X X X + 
 
Table 123: Representative genes with mutation sites observed in both the primary CRC 
and the liver metastases of all the clusters in the apoptosis function. 
 
Critical genes were observed to be misregulated in apoptotic function mediated by 
mitochondria such as CASP7, which is one of the executioner caspase leading to 
apoptosis is down-regulated in both primary CRC and liver metastases. BCL2, which 
is an anti-apoptotic member of Bcl-2 protein family is down-regulated in both 
primary CRC and liver metastases of almost all the clusters.  
 
TP53, which directly binds to Bcl-2 family members propagating apoptosis was 
noticed to be mutated in both the primary CRC and the liver metastases.  
 
Consequently, with misregulations in the crucial genes that prevailed in both 
primary CRC and liver metastases suggests an inability of mitochondria to induce 
the intrinsic apoptotic pathway. 
 
Replication and transcription 
Representative differentially expressed genes and mutated genes in the replication 
and transcription function are defined below in the tables 124 and 125 respectively. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
C10orf2 ↑ X X X X X X ↑ 
TOP1MT ↑ X X X X X X ↑ 
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SLC29A1 ↑ ↑ ↑ ↑ X ↑ X ↑ 
TRMT6 ↑ X X X X X X X 
AK4 X X X X X X X ↑ 
PUS1 X X X X X X X ↑ 
YRDC X X X X X X X ↑ 
PPARGC1A ↓  X ↓  X X X X ↓  
 
Table 124: Differentially expressed, representative genes observed in both primary CRC 
and liver metastases of all the clusters in the replication and transcription function. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
GTPBP3 + + X X X X X X 
C10orf2 X X + + X X X X 
NSUN2 X X X + X X X X 
 
Table 125: Representative genes with mutation sites observed in both the primary CRC 
and the liver metastases of all the clusters in the replication and transcription function. 
 
One  gene, which was up-regulated in both the primary CRC and liver metastases of 
almost all the clusters was SLC29A1, which is involved in the import of recycled 
deoxyribonucleosides from cytoplasm into mitochondria. As a consequence, there 
might be an increase in the synthesis and maintenance of mtDNA. This would be in 
concordance with the observed probable lower efficiency of the electron transport 
chain. Concurrently PPARGC1A, involved in the regulation of mitochondrial 
transcription factors is down-regulated mostly in the primary CRC’s of a few 
clusters suggesting that the transcription machinery might be impaired. 
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ROS defence:  
Representative differentially expressed genes and mutated genes in the ROS defence 
function are defined below in the tables 126 and 127 respectively. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
GSTA1 ↓  ↑ ↓  ↑ X X X ↑ 
 
Table 126: Differentially expressed, representative genes observed in both primary CRC 
and liver metastases of all the clusters in the ROS defence function. 
 
GENES cluster 1 cluster 2  cluster 3 cluster 4 
 Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC 
Liver 
Metastases 
Primary 
CRC   
Liver 
Metastases 
GSR X X + X X X X X 
GSTA2 X X X + X X X X 
SOD2 X X + X X X X + 
 
Table 127: Representative genes with mutation sites observed in both the primary CRC 
and the liver metastases of all the clusters in the ROS defence function. 
 
GSTA1 showed differential expression in primary CRC and liver metastases. In 
primary CRC it was observed to be down-regulated, whereas in the liver metastases 
it was up-regulated. This suggests a potential build up of reactive molecules with the 
progression of the cancer in the metastatic state.       
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CHAPTER 4 
 
DISCUSSION 
 
 
Mitochondria are indispensable organelles present in the eukaryotic cell. They are 
primarily involved in the energy production in the form of ATP through oxidative 
phosphorylation. In addition, they are involved in diverse functions such as 
beta oxidation of fatty acids, apoptosis, biosynthesis of heme, FE-S cluster 
biosynthesis and calcium signalling. Mitochondrial disorders arise from defects in 
mtDNA, encoding essential components of OXPHOS. The nuclear genome also 
contributes the majority of the OXPHOS proteins and hence variations in the 
proteins encoded by nuclear genome can also cause mitochondrial disorders. 
 
The MitoModel server 
In this study we have developed a web-based platform named “MitoModel” that has 
brought together 659 mitochondria associated genes encoded by both mitochondria 
and nuclear genomes. We classified them into 17 functional groups. All the genes in 
the MitoModel are annotated for their role via comprehensive literature survey and 
carefully put into their functional groups. MitoModel is designed as a web server, 
which allows users to map mutation and differential expression data. The advantage 
that MitoModel extends is the fact that it is highly interactive and enables users to 
interpret their data in the functional context of mitochondria.  
 
Compiling the genes to be part of a mitochondrial function included identifying the 
investigated or well reviewed functions related to mitochondria and taking note of 
all the genes and their roles. While the advantage of our approach was that we could 
capture the mitochondria associated genes and their roles at a detailed level in each 
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function, the disadvantage was that it took a lot of time and effort to compile 659 
genes. Though time consuming our approach appropriately pinpoints the roles of 
genes, which was a primary requirement for us to achieve in conducting functional 
studies of mitochondria.  
  
Comparing our approach to other resources hosting mitochondria proteomics data, 
it is evident that the inventory of the genes compiled by us had only literature 
evidence compared to MitoCarta. This resource provides evidence through 
literature, targetP signals for mitochondrial localization prediction, homologs of 
yeast mitochondrial proteins, Rickettsia homologs, domains exclusive for 
mitochondria, induction, coexpression and mass spectrometry, providing GO term 
annotation for the genes [Pagliarini et al., 2008], whereas MitoMiner includes data 
 from 52 large-scale proteomic datasets of mitochondrial localisation from both 
mass spectrometry and green fluorescent protein- (GFP-) tagging studies, providing 
GO term annotations and functions curated by UniProt [Smith & Robinson, 2016].   
 
The inventory of 659 genes was initially generated for Homo sapiens and further 
extended to mouse, deriving 659 mouse orthologous genes from the human gene 
set, using the HCOP’s human orthology prediction [Eyre et al., 2007]. The STRING 
database [Szklarczyk et al. 2015] was used to derive the interactions for our gene 
sets and for human and mouse genes we got 10985 and 12571 interactions, 
respectively. Similar efforts were made to achieve mitochondrial interactome from 
budding yeast, resulting in nearly 10000 interactions for 800 genes extracted from 
24 published datasets [Perocchi et al., 2006].  
 
A database was created for the gene catalog and the interactions of the MitoModel 
web server. This enables the user to interact with user-provided variants data. The 
disadvantage of MitoModel is that users cannot access the gene list and its functions 
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without providing input data from their side. The output text file generated by 
MitoModel returns only the variant genes. This is not the case with MitoCarta and 
MitoMiner, which allows users to query for individual or group of genes. The 
advantages of MitoModel are that it is the only tool known to us until now, which 
maps user-defined variation data of different diseases onto the mitochondria 
associated genes. It is furthermore highly interactive, providing users with simple 
visual cues, appropriate gene information and the mapped variants data 
information. Similar web resource created by another study called MitoInteractome 
allowed users to query for interacting partners, SNPs within proteins, the number of 
SNPs, disease related proteins [Reja et al., 2009] but never allowed the analysis of 
user data.  
 
Though MitoModel is a robust, interactive network, it still lacks several aspects such 
as providing the whole gene set and functions to the user, which limits the user 
knowledge only to the variant genes. Second, the roles of the genes are manually 
curated and are presently static, which means only database administrators can 
curate it. At present MitoModel does not link to any other web resources, which 
make its outcome specific only to variants data of the user-provided disease.  
 
Use cases tested for MitoModel 
We tested MitoModel on three different data sets: First, we used data from 
aneuploid cell lines. In HCT116 5/4 aneuploid cell line, we identified PKM2 up-
regulated, which catalyzes the conversion of phosphoenolpyruvate to pyruvate, 
resulting in the generation of glycolytic ATP.  It was reported that chromosomally-
unstable cancer lines displayed increased glycolytic and TCA-cycle flux [Sheltzer, 
2013], indicating that the generation of glycolytic energy might be higher in HCT116 
5/4 cells compared to its wild type cell line. We also identified several genes down-
regulated, harboring mutation sites in electron transport chain, replication and 
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transcription, and translation functions. Thus we hypothesize that mitochondrial 
biogenesis and energy production inside mitochondria are severely affected in 
HCT116 5/4 cell line compared to its wild type cell line. 
 
In RPE1 5/3 12/3 aneuploid cells, we identified several genes in electron transport 
chain, replication and transcription, and translation up-regulated. In ROS defense, 
we observe that several genes involved in the reducing the ROS elements to be up-
regulated. Thus we hypothesize that increased stress created during energy 
production caused a buildup of ROS in RPE1 5/3 12/3 aneuploidy cell line 
compared to its wild type cell line. 
 
In RPE1H2B 21/3 aneuploidy cell line, we identified two up-regulated genes in 
electron transport chain and two up-regulated genes in ROS defence such as SOD1, 
which removes superoxides in the intermembrane space of mitochondria and GPX1, 
which further reduces the hydrogen peroxide to water. It was reported that the 
superoxide production and oxidative stress were observed to be 3 times higher in 
Down Syndrome fibroblasts [Coskun & Busciglio, 2012], thus we hypothesize that a 
mis-regulated mitochondrial OXPHOS leads to the buildup of mitochondrial ROS in 
the RPE1H2B 21/3 aneuploidy cell line compared to its wild type cell line. 
 
Comparing the MitoModels of three aneuploid cell lines throws light on the fact that 
they were highly different from each other. Though we could observe that the 
functions replication and transcription, translation and electron transport chain 
were the most affected in the HCT116 5/4 and RPE1 5/3 12/3, they were showing 
contradictory behaviors. RPE1H2B 21/3 cells compared to other aneuploidy cell 
lines, accumulating only few variations in the mitochondria associated genes. Thus 
using MitoModels we could show that each aneuploidy cell line behaves individually 
when compared to each other.  
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Second, we tested MitoModel on the expression data of expression of high (HR) and 
low (LR) stress resistance mouse line. Here we identified Atp5h, Atp5o and Atp5e 
from the electron transport chain, which are three essential  subunits of ATP 
synthase complex V to be up-regulated, suggesting that there might be an increased 
conversion of ADP to ATP in the HR mouse line. In glycolysis, Slc2a4, a facilitated 
glucose transporter was up-regulated. In addition Pkm2, which is known to catalyse 
the transphosphorylation of phosphoenolpyruvate into pyruvate and ATP was 
upregulated. The hippocampal proteomic analysis identified several proteins 
differentially expressed in HR and LR mice, including proteins involved in energy 
metabolism [Knapman et al., 2012]. We hypothesize that there might be a increased 
need of energy in HR mouse line, whereby glycolysis is also contributing to this.  
 
Finally, we tested MitoModel on RNA-seq data of  normal colon , primary Colorectal 
cancer (CRC) and liver metastases from 16 patients [Kim et al., 2014]. 16 
MitoModels of primary CRC and liver metastases were reduced to 4 representative 
MitoModels representing clustering patient groups. We analysed those 4 
representative groups for mitochondrial contribution. In the electron transport 
chain, COX6B2 was down-regulated in both primary CRC and liver metastases of 
most clusters. Interestingly, COX6B2 was also observed to be down-regulated in the 
rho(0) cell line [Hashiguchi & Zhang-akiyama, 2009] devoid of mitochondrial DNA 
that exhibit the Warburg effect [Ayyasamy et al., 2011]. This indicates that down-
regulation of COX6B2 may be involved in both the development and progression of 
CRC. Mutations in MT-ND5 and MT-CO1 were observed in the primary CRC and liver 
metastases of cluster 1 and 2. Similarly, mutations in the coding regions of MT-ND5 
and MT-CO1 were observed in the human colorectal cancer cell line as well as 
human colon cancer [Chatterjee et al., 2006]. This suggests that the mutations might 
lead to changes in the OXPHOS process. In the beta oxidation of fatty acids, FABP6, 
was up-regulated in both primary CRC and liver metastases of most clusters and it 
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was also reported to be overexpressed in the colorectal cancer [Ohmachi et al., 
2006]. In addition, we also identified ACADL, which catalyses the metabolism of long 
chain fatty acids. This mRNA was up-regulated only in the liver metastases of all 
clusters. ACADS, which catalyses the metabolism of short chain fatty acids was 
down-regulated in primary CRC of all clusters. We therefore hypothesize that there 
might be an up-regulated first step of beta oxidation in liver metastases due to 
decrease in the catalysing ability of ACADS in primary CRC, which functions at the 
tail end of the beta oxidation. In urea cycle,  ARG1 was up-regulated only in the liver 
metastases of all clusters. ARG1 is involved in catalysing the final step of urea cycle, 
hydrolyzing arginine to urea and ornithine. It has been reported that there was a 
buildup of urea cycle metabolites (purines, pyrimidines and amino acids) in colon 
carcinoma [Denkert et al., 2008]. Thus we hypothesize that there might be an 
increase in the intermediate products of urea cycle in liver metastases. In apoptosis, 
CASP7 which is one of the executioner caspases leading to apoptosis, as well as 
BCL2, which is an anti-apoptotic member of Bcl-2 protein family are down-
regulated in both primary CRC and liver metastases of most clusters. TP53, which 
directly binds to Bcl-2 family members propagating apoptosis was noticed to be 
mutated in both the primary CRC and the liver metastases. A study suggests that 
BCL2 suppresses TP53 dependent apoptosis in colorectal cancer cells [Jiang and 
Milner, 2003], and variations in both, the BCL2 and TP53 gene in both the primary 
CRC and liver metastases indicates, that there might be an inability of mitochondria 
to induce the intrinsic apoptotic pathway. 
 
The above research findings demonstrates that with MitoModel, user can map their 
variant data and efficiently describe mitochondria in a disease state. Thus 
MitoModel is an infrastructure, which enables user to make primary hypothesis of 
mitochondrial biology in the disease of interest. It should be noted that MitoModel 
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only enables hypothesis, which should be verified in the lab before making final 
conclusions. 
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CHAPTER 5 
 
Conclusions and future perspectives 
 
 
5.1 CONCLUSION: 
An array of human diseases are implicated to contain atypical mitochondria, which 
not only have a pivotal role in efficient energy generation but also several other 
important functions in the cell. Mutations in mtDNA and nDNA, both inherited and 
spontaneous, and differential expression patterns of mitochondrial genes encoded 
in mitochondria and the nucleus lead to altered mitochondrial functions, which has 
a critical impact on cell physiology and survival.  
 
The availability of large scale sequencing data of several disease samples has 
opened up avenues to identify variants carried or developed during disease 
progression. The advantage of analysing diseases with RNA-seq data, are two-fold: it 
provides differential expression of genes, as well as efficient capture of mutations.  
 
This study has established a mitochondria-based model in the form of the 
MitoModel web-server, which is an program to efficiently comprehend the variants 
carried by mitochondria in a disease state. This approach allows users to make a 
primary hypothesis about the mitochondrial biology and physiology in disease by 
mapping expression and mutation variants on to the MitoModel.  
 
This work also highlights the applicability of MitoModel to various disease types. We 
have used it to understand mitochondrial variants carried by different aneuploid 
cell lines, highlighting the different mitochondrial variations observed in the 
MitoModels for HCT116 5/4, RPE1 5/3 12/3 and RPE1H2B 21/3 cell lines. In a 
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second comparison, we have used a mouse MitoModel to analyse the differential 
mitochondrial expression between high and low stress reactivity mouse lines. The 
data mapped on the mouse MitoModel revealed that most of the mitochondrial 
functions were up-regulated in the HR stress reactivity mice. It also showed a the 
deviation in the energy production, which was increased in glycolysis due to a 
potential damage to the efficient energy production by mitochondria.  
Analysing the representative MitoModel genes accommodated by the 16 samples of 
CRC and liver metastases identified numerous affected genes, that contribute to the 
tweaking of the metabolic makeup of the mitochondria. For instance, PKLR which 
catalyses the reaction producing glycolytic ATP was up-regulated only in the liver 
samples; ACADS and ACADL contradictory misregulations inside mitochondria in 
primary CRC’s and liver metastases samples might play an important role in 
creating an imbalance in the generation of acetyl CoA. Due to this metabolic 
imbalance, there might be an increased stress to the mitochondria leading to the 
mitochondrial clearance via mitophagy, which was also observed only in the liver 
metastases samples with an up-regulated BNIP3, causing the permeabilization of 
the mitochondrial membrane during mitophagy. 
 
Thus, MitoModel an interactive network with mitochondria associated genes 
provides an infrastructure to the user to understand the biology of mitochondria 
and the changes it accommodates in the different diseases.  
 
5.2 FUTURE PERSPECTIVES: 
Improvements to the existing MitoModel will be achieved by expansion of the model 
to include additional genes and functions. A diverse set of mass-spec studies of 
whole mitochondria from several organisms are available to date [Smith AC et al., 
2012]. One possibility is to built an extended MitoModel based on these 
experimental data.   
 155 
 
At present NCBI gene symbols are accepted by the MitoModel for mapping the 
variants. Since NCBI gene symbols might have several synonyms but only a single 
numeric ID, using in the future the numeric IDs would prevent the mismapping of 
synonyms to their gene symbols in the database.  
 
The MitoModel enables users store and interactively use their data. Hence a 
mitochondrial disease database could prove as an important portal to store and 
catalogue mitochondrial variants in different disease types. Users could control 
public accessibility of their data, enabling a more comprehensive analysis of 
mitochondrial variants.  
 
The network framework of the MitoModel can be further explored. One easy to 
establish improvement would be to give the user the options to view the first 
interacting partners of the genes.   
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APPENDIX C: Mitochondria associated genes, functions and their references    
 
No. Gene Function Reference 
ELECTRON TRANSPORT CHAIN 
1 MT-ND1  
 
 
 
 
 
 
Mitochondrially encoded NADH dehydrogenase, part of enzyme complex I, involved in the reduction of 
ubiquinone by NADH 
 
 
 
 
 
 
[Schaffer & Suleiman, 
2010] 
 
 
 
 
 
 
 
 
 
2 MT-ND2 
3 MT-ND3 
4 MT-ND4 
5 MT-ND4L 
6 MT-ND5 
7 MT-ND6 
8 NDUFA1  
 
 
Nuclear encoded essential components of complex I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
 
 
9 NDUFA2 
10 NDUFA3 
174 
 
11 NDUFA4  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nuclear encoded essential components of complex I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Schaffer & Suleiman, 
2010] 
 
 
 
 
 
 
 
 
 
12 NDUFA5 
13 NDUFA6 
14 NDUFA7 
15 NDUFA8 
16 NDUFA9 
17 NDUFA10 
18 NDUFA11 
19 NDUFA12 
20 NDUFA13 
21 NDUFAB1 
22 NDUFB1 
23 NDUFB2 
175 
 
24 NDUFB3  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nuclear encoded essential components of complex I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Schaffer & Suleiman, 
2010] 
 
 
 
 
 
 
 
 
 
25 NDUFB4 
26 NDUFB5 
27 NDUFB6 
28 NDUFB7 
29 NDUFB8 
30 NDUFB9 
31 NDUFB10 
32 NDUFB11 
33 NDUFC1 
34 NDUFC2 
35 NDUFS1 
36 NDUFS2 
176 
 
37 NDUFS3  
 
 
 
 
 
 
 
 
 
 
 
Nuclear encoded essential components of complex I NADH dehydrogenase, involved in the reduction 
of ubiquinone by NADH 
 
 
 
 
 
 
 
 
 
 
[Schaffer & Suleiman, 
2010] 
38 NDUFS4 
39 NDUFS5 
40 NDUFS6 
41 NDUFS7 
42 NDUFS8 
43 NDUFV1 
44 NDUFV2 
45 NDUFV3 
46 MT-CYB Mitochondria encoded cytochrome b, an essential component of complex III, transfers electrons from 
ubiquinol to cytochrome c 
 
47 
 
CYC1 
 
 
Nuclear encoded essential components of complex III,  transfers electrons from ubiquinol to 
cytochrome c 48 UQCR10 
49 UQCR11 
177 
 
50 UQCRB  
 
 
 
 
Nuclear encoded essential components of complex III,  transfers electrons from ubiquinol to 
cytochrome c 
 
 
 
 
 
 
 
 
 
[Schaffer & Suleiman, 
2010] 
 
 
 
 
 
 
 
 
 
 
 
51 UQCRC1 
52 UQCRC2 
53 UQCRFS1 
54 UQCRH 
55 UQCRQ 
56 MT-CO1  
Mitochondria encoded cytochrome c oxidases, essential components of complex IV, catalyses the 
reduction of oxygen to water by cytochrome c 
 57 MT-CO2 
58 MT-CO3 
59 COX4I1  
 
 
 
 
Nuclear encoded cytochrome c oxidase subunits, essential components of complex IV, catalyses the 
reduction of oxygen to water by cytochrome c 
 
 
60 COX4I2 
61 COX5A 
62 COX5B 
178 
 
63 COX6A1  
 
 
 
 
 
 
 
 
 
 
 
 
 
Nuclear encoded cytochrome c oxidase subunits, essential components of complex IV, catalyses the 
reduction of oxygen to water by cytochrome c 
 
 
 
 
 
 
 
 
 
 
 
 
[Schaffer & Suleiman, 
2010] 
 
 
 
 
 
 
 
 
 
64 COX6A2 
65 COX6B1 
66 COX6B2 
67 COX6C 
68 COX7A1 
69 COX7A2 
70 COX7B 
71 COX7B2 
72 COX7C 
73 COX8A 
74 MT-ATP6 Mitochondria encoded ATP synthases, essential components of complex V, reversible pump of protons 
into matrix with formation of ATP 
75 MT-ATP8 
179 
 
76 ATP5A1  
 
 
 
 
 
Nuclear encoded ATP synthase subunits, essential components of complex V, reversible pump of 
protons into matrix with formation of ATP 
 
 
 
 
 
[Schaffer & Suleiman, 
2010] 
 
 
77 ATP5B 
78 ATP5C1 
79 ATP5D 
80 ATP5E 
81 ATP5F1 
82 ATP5G1 
83 ATP5G2 
84 ATP5G3  
 
 
 
 
 
Nuclear encoded ATP synthase subunits, essential components of complex V, reversible pump of 
protons into matrix with formation of ATP 
 
 
 
 
[Schaffer & Suleiman, 
2010] 
85 ATP5H 
86 ATP5I 
87 ATP5J 
88 ATP5J2 
180 
 
89 ATP5L 
90 ATP5O 
91 ATPIF1 Endogenous inhibitor subunit of ATP synthase, essential component of complex V 
92 ACAD9 Involved in the biogenesis of complex I [Nouws et al., 2010] 
93 FOXRED1 Putative complex I assembly factor [Formosa et al., 2015] 
94 ATPAF1 ATP synthase mitochondrial F1 complex assembly factor 1  
[Wang et al., 2001] 
95 ATPAF2 ATP synthase mitochondrial F1 complex assembly factor 2 
96 BCS1L Involved in the assembly of complex III [Petruzzella et al., 
1998] 
97 C7orf44 Complex IV assembly factor [Szklarczyk et al., 
2012] 
98 CCDC56 Complex IV assembly factor [Szklarczyk et al., 
2012] 
99 CHCHD8 Complex IV assembly factor [Bestwick et al., 2010] 
181 
 
100 COA5 Complex IV assembly factor [Huigsloot et al., 
2011] 
101 SELRC1 Complex IV assembly factor [Kozjak-pavlovic et 
al.,  2014] 
102 C1orf31 Required for the stability of complex IV subunit  [Baertling et al., 2015] 
103 COX10 Complex IV assembly factor [Coenen et al., 2004] 
104 COX11 Complex IV assembly factor [Petruzzella et al., 
1998] 
105 COX14 Complex IV assembly factor [Szklarczyk et al., 
2012] 
106 COX15 Complex IV assembly factor [Petruzzella et al., 
1998] 
107 COX17 Responsible for providing copper ions to the complex IV [Banci et al., 2011] 
108 COX18  
Assembly factors of complex IV 
[Sacconi et al., 2005] 
109 COX19 
182 
 
110 COX20  
Assembly factor of complex IV 
[Szklarczyk et al., 
2013] 
111 ECSIT  
Assembly factor of complex I 
[Vogel et al., 2007] 
112 NDUFAF1 Assembly factor of complex I [Janssen et al., 2002] 
113 NDUFAF2 Assembly factor of complex I [Ogilvie et al., 2005] 
114 NDUFAF3  
Assembly factors of complex I 
 
[Saada et al., 2009] 
115 NDUFAF4 
116 C20orf7 Complex I assembly factor [Sugiana et al., 2008] 
 
117 
 
C8orf38 
 
Complex I assembly factor 
[Mckenzie et al., 
2011] 
 
118 
 
C2orf56 
 
Complex I assembly factor 
[Zurita rendón et al., 
2014] 
119 NUBPL  
Complex I assembly factor 
[Sheftel et al., 2009] 
120 SCO1  [Leary et al., 2007] 
183 
 
121 SCO2 Complex I assembly factors 
122 SDHAF1 Complex II specific assembly factor [Ghezzi et al., 2009] 
123 SDHAF2 Complex II specific assembly factor [Hao et al., 2009] 
124 SURF1 Assembly factor of complex IV [Zhu et al., 1998] 
125 TMEM126B Complex I assembly factor [Heide et al., 2012] 
126 UQCC  
Complex III assembly factor  
 
[Tucker et al., 2013] 
127 MNF1 
128 TTC19 Complex III assembly factor [Ghezzi et al., 2011] 
129 HCCS Complex III assembly factor [Smith et al., 2012] 
130 PTCD2 Complex III assembly factor, process RNA transcripts involving cytochrome b [Xu et al., 2008] 
131 TMEM70 Complex V assembly factor [Torraco et al., 2012] 
GLYCOLYSIS 
132 SLC2A1 Basal glucose uptake, present in all mammalian tissues   [Berg et al., 2002] 
184 
 
133 SLC2A2 Glucose uptake in liver and pancreatic β cells  
 
 
 
 
 
 
 
 
 
 
 
[Berg et al., 2002] 
 
 
 
 
 
 
 
 
 
 
 
134 SLC2A3 Basal glucose uptake, present in all mammalian tissues   
135 SLC2A4 Glucose transport in the muscle and fat cells 
136 SLC2A5 Fructose transporter, present in the small intestine 
137 HK1  
 
 
Glucose is phosphorylated to glucose 6-phosphate catalysed by the hexokinase  138 HK2 
139 HK3 
140 GCK 
141 GPI Isomerization of glucose 6-phosphate to fructose 6-phosphate by the phosphoglucose isomerase 
142 PFKL  
Fructose 6-phosphate is phosphorylated to fructose 1,6-bisphosphate, catalyzed by 
phosphofructokinase 
143 PFKM 
144 PFKP 
145 ALDOA  
185 
 
146 ALDOB  
Fructose 1,6-bisphosphate converted into glyceraldehyde 3-phosphate and dihydroxyacetone 
phosphate catalyzed by aldolase 
 
 
 
 
 
 
 
 
 
 
 
 
[Berg et al., 2002] 
 
 
 
 
 
 
 
 
 
 
147 ALDOC 
148 TPI1 Dihydroxyacetone phosphate is converted into glyceraldehyde 3-phosphate catalyzed by triose 
phosphate isomerase 
149 GAPDH  
Glyceraldehyde 3-phosphate is converted into 1,3-bisphosphoglycerate catalyzed by glyceraldehyde 
3-phosphate dehydrogenase 
150 GAPDHS 
 
151 
 
PGK1 
 
 
1,3-bisphosphoglycerate is converted to 3-phosphoglycerate and ATP is released, catalyzed by 
Phosphoglycerate kinase 
152 PGK2 
153 PGAM1  
3-phosphoglycerate is converted into 2-phosphoglycerate catalyzed by phosphoglycerate mutase 
154 PGAM2 
155 ENO1  
 
2-phosphoglycerate is converted into phosphoenolpyruvate catalyzed by enolase 
156 ENO2 
157 ENO3 
186 
 
158 PKLR  
Phosphoenolpyruvate is converted into pyruvate and ATP is produced, catalyzed by pyruvate kinase  
 
 
 
 
[Berg et al., 2002] 
 
159 PKM2 
160 LDHAL6B  
 
 
 
 
Pyruvate is converted to lactate catalyzed by lactate dehydrogenase 
161 LDHC 
162 LDHB 
163 LDHA 
PYRUVATE TRANSFER 
164 BRP44   
Involved in the transfer of pyruvate inside mitochondria. 
 
[Bricker  et al., 2012] 
165 BRP44L 
FORMATION OF ACETYL COA 
166 PDHA1  
 
 
Pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl CoA 
 
 
 
 
 
[Berg et al., 2002] 
 
 
167 PDHA2 
168 PDHB 
187 
 
169 PDHX  
Pyruvate dehydrogenase complex catalyzes the overall conversion of pyruvate to acetyl CoA 
 
[Berg et al., 2002] 
170 DLAT 
TRICARBOXYLIC ACID CYCLE 
 
171 CS Citrate synthase catalyzes the synthesis of citrate from oxaloacetate and acetyl CoA  
 
 
 
 
 
 
 
[Berg et al., 2002] 
172 ACO2 Aconitase catalyzes the interconversion of citrate to isocitrate 
173 IDH1  
 
 
Isocitrate dehydrogenase catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate 174 IDH2 
175 IDH3A 
176 IDH3B 
177 IDH3G 
178 OGDH Catalyzes the overall conversion of 2-oxoglutarate to succinyl-CoA and CO2 
179 DLST 
180 DLD 
188 
 
181 SUCLG1  
 
Succinyl CoA synthetase catalyzes the conversion of succinyl CoA to succinate 
 
 
 
 
 
 
 
 
[Berg et al., 2002] 
182 SUCLG2 
183 SUCLA2 
184 SDHA  
 
Part of Succinate dehydrogenase complex in oxidative phosphorylation in TCA cycle it catalyzes the 
oxidation of succinate to fumarate 185 SDHB 
186 SDHC 
187 SDHD 
188 FH Fumarase catalyzes the formation of L-malate from fumarate 
189 MDH2 Malate dehydrogenase catalyzes the reversible oxidation of malate to oxaloacetate 
BETA OXIDATION OF FATTY ACIDS 
190 SLC27A1  
 
 
Readily converts the transported very long chain fatty acids to acyl-CoAs 
 
 
 
 
 
[Houten & Wanders, 
2010] 
191 SLC27A2 
192 SLC27A3 
189 
 
193 SLC27A4  
 
 
Readily converts the transported very long chain fatty acids to acyl-CoAs 
 
 
 
 
 
 
 
 
 
 
[Houten & Wanders, 
2010] 
 
 
 
 
 
 
 
 
 
 
194 SLC27A5 
195 SLC27A6 
 
196 
 
 
 
ACSL1 
 
 
 
 
Acyl-CoA synthetase activity for long chain free fatty acids and are also involved in the activation of 
fatty acids 
197 ACSL3 
198 ACSL4 
199 ACSL5 
200 ACSL6 
201 ACSS1  
 
Acyl-CoA synthetase activity for short chain fatty acids 
202 ACSS2 
203 ACSS3 
204 ACSM1  
190 
 
205 ACSM2A  
 
 
 
 
Acyl-CoA synthetase activity for medium chain fatty acids 
 
 
 
 
 
 
 
 
 
 
 
 
[Houten & Wanders, 
2010] 
 
 
 
 
 
 
 
 
206 ACSM2B 
207 ACSM3 
208 ACSM4 
209 ACSM5 
210 C10orf129 ACSM6 Acyl-CoA synthetase activity for medium chain fatty acids 
211 ACSBG1  
Acyl-CoA synthetase activity for bubblegum family members 
212 ACSBG2 
213 FABP1  
 
Fatty acid binding proteins involved in the import and export of fatty acids 
 
 
 
 
 
 
 
 
 
214 FABP2 
215 FABP3 
216 FABP4 
217 FABP5 
191 
 
218 FABP6  
Fatty acid binding proteins involved in the import and export of fatty acids 
 
 
 
 
 
 
 
 
 
 
 
 
[Houten & Wanders, 
2010] 
 
 
 
 
 
 
 
 
 
 
219 FABP7 
220 FABP9 
221 FABP12 
222 CD36 Fatty acid translocase 
223 GOT2 Plasma membrane fatty acid binding protein 
224 CPT1A  
 
Carnitine palmitoyl transferase converts an acyl-CoA into an acylcarnitine 
225 CPT1B 
226 CPT1C 
227 SLC25A20 Carnitine acylcarnitine translocase mediates acylcarnitine entry into mitochondria 
228 CPT2 Acylcarnitines are reconverted to their CoA esters by carnitine palmitoyltransferase 2 
229 CRAT Free carnitine in the mitochondria can be converted into acyl carnitine by the action of carnitine 
acetyltransferase 
230 ACAD8 Involved in the catabolism of fatty acids  
192 
 
231 ACAD10 Involved in the catabolism of fatty acids with significant activity towards branched chains  
 
 
 
 
 
 
 
 
 
[Houten & Wanders, 
2010] 
 
232 ACAD11 May be involved in the catabolism of long chain fatty acids 
233 ACADL Long chain hydroxyacyl-CoA dehydrogenase 
234 ACADVL Very long chain acyl-CoAs are first catalyzed by long chain acyl-CoA dehydrogenase 
235 HADHA  
Mitochondrial trifunctional protein catalyzes very long and long chain fatty acids 
236 HADHB 
237 ACADM Fatty acids are metabolized for 3 to 4 cycles by the medium chain acyl-CoA dehydrogenase 
238 ECHS1 Enoyl-CoA hydratases, short chain, 1, mitochondrial 
239 HADH Medium and short chain hydroxyacyl-CoA dehydrogenase 
240 ACAA2 Medium chain 3-ketoacyl-CoA thiolase 
241 ACADS Short chain acyl-CoA dehydrogenase encoded by ACADS catalyzes the final 1 to 2 cycles 
242 ACADSB Involved in the metabolism of short branched chain fatty acids 
243 DECR1 2,4 dienoyl CoA reductase 1 catalyzes the metabolism of polyunsaturated fatty acids 
193 
 
ROS DEFENCE 
244 GCLC Catalyzes the first step reaction which combines cysteine and glutamate to form glutamylcysteine  
 
 
 
 
 
 
 
 
[Sabharwal & 
Schumacker, 2014] 
 
 
 
 
 
 
 
 
 
 
245 GCLM Catalyzes the first step reaction which combines cysteine and glutamate to form glutamylcysteine 
246 GSS Catalyzes the formation of glutathione from glutamylcysteine by combining it with the glycine 
247 SLC25A11  
 
May be involved in the transport of glutathione into the mitochondria 
248 SLC25A10 
249 SLC25A1 
250 SOD2 Dismutates the superoxide generated in the mitochondrial matrix to hydrogen peroxide 
251 SOD1 May be involved in the removal of superoxides in the inter membrane space of mitochondria 
252 SHC1 Could be involved in the generation of the hydrogen peroxide independent of superoxides in 
mitochondria 
253 BCKDHA  
Involved in the catabolism of amino acids in mitochondria and may also be involved in the production 
of superoxides and hydrogen peroxide 
254 BCKDHB 
255 GPX1 Reduces hydrogen peroxide to water by using reducing equivalents from glutathione 
194 
 
256 GSR Reduces oxidized glutathione which can be re utilized by GPX1  
 
 
 
 
 
 
 
 
[Sabharwal & 
Schumacker, 2014] 
 
 
 
 
 
257 GPX4 Involved in the reduction of the lipid peroxides to their hydroxides 
258 PRDX3 Mitochondrial peroxiredoxin reduces hydrogen peroxide to water 
259 TXN2 Mitochondrial thioredoxin reduces peroxiredoxin to their superoxide scavenging state 
260 TXNRD2 Maintains thioredoxins in their reduced state using NAPDH reducing equivalents 
261 MPV17 May have a role in the metabolism of reactive oxygen species 
262 MPV17L 
263 GLRX2 Involved in the control of mitochondrial protein glutathionylation 
264 GSTA1  
 
 
Mitochondrial glutathione-S-transferases through glutathione conjugation or peroxide reduction 
detoxify harmful byproducts 
265 GSTA2 
266 GSTA4 
267 GSTP1 
 
 
195 
 
APOPTOSIS 
268 APAF1 Binds CASP9 forming an apoptosome and activates it  
 
 
 
 
 
 
 
 
 
 
[Tait & Green, 2010] 
 
 
 
 
 
 
 
 
 
269 CASP3 Executioner caspases leading to apoptosis 
270 MAPK1 Inhibitors of CASP9 activity 
271 CASP7 Executioner caspases leading to apoptosis 
272 DIABLO Acts as caspase activator by inhibiting the inhibitors of apoptotic proteins 
273 XIAP X-linked inhibitor of apoptosis protein inhibits caspase activity by directly binding to CASP9, 3 and 7 
274 BCL2  
 
 
Bcl-2 family member Anti-apoptotic proteins 275 BCL2L1 
276 MCL1 
277 BAX  
 
Bcl-2 family member propagating apoptosis 
 
 
 
 
278 BAK1 
279 BAD 
196 
 
280 BIK  
Bcl-2 family member propagating apoptosis 
 
 
 
 
 
 
 
 
 
 
[Tait & Green, 2010] 
 
 
 
 
 
 
 
 
 
 
 
281 BID 
282 BCL2L11 Bim Bcl-2 family member propagating apoptosis 
283 PMAIP1 Noxa Bcl-2 family member propagating apoptosis 
284 BBC3 Puma Bcl-2 family member propagating apoptosis 
285 TP53 Directly binds both BAK and BAX and activates them 
286 VDAC1  
 
Voltage dependent anion channel forms part of permeability transition pore and is also involved in the 
takeup of calcium ions from the Endoplasmic reticulum 287 VDAC2 
288 VDAC3 
289 SLC25A4  
 
Adenine nucleotide translocator forms part of permeability transition pore 
290 SLC25A5 
291 SLC25A6 
292 APOPT1 Localizes to the mitochondria and stimulates the release of cytochrome c 
197 
 
293 PPIF Cyclophilin D forms part of permeability transition pore  
 
 
 
 
 
 
 
[Tait & Green, 2010] 
294 CYCS Binds to apoptosis inducing factor 1 (APAF1) forming a structure called apoptosome 
295 ANP32A Enhances APAF1 function 
296 CASP9 Initiator caspase recruited by Apoptosome 
297 CDK1 Can Inhibit CASP9 activity and also involved in the phosphorylation of DNM1L to increase fission 
298 DNM1 Recruited to mitochondria can induce cristae remodelling to release cytochrome c and subsequent 
apoptosis 
299 MAPK3 Inhibitors of CASP9 activity 
300 EIF3M PCI domain containing protein 1 can negatively regulate CASP9 activity 
301 AIFM1 Mitochondria associated apoptosis inducing factor translocates to nucleus and degrades DNA 
302 PPIA Cyclophilin A might work with ENDOG in a DNA degradation complex 
303 HTRA2 Mitochondrial serene protease induces cell death by inhibiting Inhibitors of apoptotic proteins 
IMPORT & SORTING 
304 TOMM20   
198 
 
305 TOMM22 Outer membrane translocation, recognize presequences on the mitochondrial outer membrane  
 
 
 
 
 
 
 
 
 
 
 
[Schmidt et al., 2010] 
&  
[Dolezal et al., 2006] 
 
 
 
 
 
 
 
306 TOMM40  
Outer membrane translocation, forms the outer membrane channel forming protein 
307 TOMM40L 
308 TOMM5 Outer membrane translocation, transports preprotein to the import pore formed by TOMM40 
309 TOMM70A Outer membrane translocation, recognizes proteins with internal targeting signals 
310 TOMM6 Outer membrane translocation, required for the assembly and stability of the TOM complex 
311 TOMM7 Outer membrane translocation, required for the assembly and stability of the TOM complex 
312 TIMM50 Inner membrane translocation, guides the pre-proteins to the import channel formed by TIMM23 
313 TIMM17A Inner membrane translocation, might influence the channel activity formed by the TIMM23 
314 TIMM17B Inner membrane translocation, might influence the channel activity formed by the TIMM23 
315 TIMM23 Inner membrane translocation, forms the main channel of TIMM23 complex 
316 TIMM21 Inner membrane translocation, connects TOMM and TIMM complex and may assist in the release of 
preprotein from the TOMM complex 
317 HSPA9 Presequence translocase associated motor, binds to the preprotein and drives it into the matrix in 
association with other chaperones and also involved in the mediation of the interaction between 
199 
 
VDAC1 and Inositol-1,4,5-trisphosphate receptors  
 
 
 
 
 
 
 
 
 
 
 
 
[Schmidt et al., 2010] 
&  
[Dolezal et al., 2006] 
 
 
 
 
 
318 TIMM44 Presequence translocase associated motor, gets associated with the HSPA9 to drive proteins into the 
matrix 
319 DNAJC19 Presequence translocase associated motor, could stimulate the ATPase activity of HSPA9 
320 PAM16 Presequence translocase associated motor, controls the activity of DNAJC19 
321 GRPEL1 Presequence translocase associated motor, acts as a nucleotide exchange factor releasing the ADP 
from HSPA9 
322 GRPEL2 Presequence translocase associated motor, acts as a nucleotide exchange factor releasing the ADP 
from HSPA9 
323 TIMM9 Inner membrane carrier pathway, forms complex with TIMM10 and performs chaperone like activity 
in the intermembrane space 
324 TIMM10 Inner membrane carrier pathway, forms complex with TIMM9 and performs chaperone like activity in 
the intermembrane space 
325 TIMM8A Inner membrane carrier pathway, forms complex with TIMM13 and also performs the transfer of 
inner membrane proteins 
326 TIMM8B Inner membrane carrier pathway, forms complex with TIMM13 and also performs the transfer of 
inner membrane proteins 
327 TIMM13 Inner membrane carrier pathway, forms complex with TIMM8 and performs the transfer of inner 
membrane proteins 
328 TIMM22 Inner membrane carrier pathway, forms the core channel and inserts proteins into inner membrane 
200 
 
329 CHCHD4 Intermembrane transport and assembly, acts as a receptor at the inter membrane space and 
recognizes incoming precursor proteins 
 
 
 
 
 
 
[Schmidt et al., 2010] 
&  
[Dolezal et al., 2006] 
330 GFER Intermembrane transport and assembly, it is known to oxidize CHCHD4 and then the oxidized 
CHCHD4 acts as a receptor for the pre proteins and it also facilitates assembly of cytosolic Fe–S 
proteins 
331 SAMM50 Outer membrane sorting and assembly machinery, central component of SAMM complex and inserts 
beta barrel proteins into the outer membrane 
332 PMPCA Presequence of pre-proteins are removed by proteolytic enzyme mitochondrial processing peptidase 
333 PMPCB Presequence of pre-proteins are removed by proteolytic enzyme mitochondrial processing peptidase 
334 MIPEP Secondary cleavage of the pre proteins processed by the mitochondrial processing peptidase 
335 IMMP1L Inner membrane peptidase that cleaves hydrophobic sorting signal 
336 IMMP2L Inner membrane peptidase that cleaves hydrophobic sorting signal 
FE-S CLUSTER BIOSYNTHESIS 
337 FXN Functions in regulation of mitochondrial iron transport   
[Rouault & Tong, 
2005]  
and 
 [Lill, 2009] 
338 ISCU Iron sulfur cluster assembly enzyme, Fe-S cluster intermediate is formed on it 
339 NFS1 The sulfide for Fe-S clusters originates from cysteine via the action of NFS1 
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340 LYRM4 Assembles with NFS1  
 
 
 
 
 
 
 
 
[Rouault & Tong, 
2005]  
and 
[Lill, 2009] 
 
 
 
 
 
 
 
 
 
341 SLC25A37 Functions as an essential iron importer 
342 SLC25A28 Mitochondrial iron transporter 
343 FDXR Provide reducing equivalents to electron transfer chain and contribute to iron-sulfur cluster 
biogenesis 
344 FDX1 Small iron-sulfur protein, transfers electrons from NADPH to mitochondrial cytochrome P450 
345 FDX1L Transfers electrons from NADPH to mitochondrial cytochrome P450 
346 HSCB Mitochondrial iron-sulfur cluster co-chaperone 
347 GLRX5 Fe-S cluster transfer protein directly to the apoprotein 
348 NFU1 Protein assembles and transfers 4Fe-4S clusters to target apoproteins 
349 BOLA3 Role in the biogenesis of iron-sulfur clusters 
350 FTMT Shows ferroxidase activity and binds iron 
351 ABCB7 Exports a sulfur product (X) from the mitochondrial iron sulfur cluster system to cytosol 
352 NUBP2 Required for the assembly of cytosolic iron-sulfur proteins 
202 
 
353 NUBP1 Essential for both cytosolic iron-sulfur protein assembly and iron homeostasis  
 
 
 
 
[Rouault & Tong, 
2005]  
and 
[Lill, 2009] 
354 CIAPIN1 Facilitates NUBP1 and NUBP2 assembly 
355 ISCA1 Involved in the biogenesis and assembly of iron-sulfur clusters 
356 ISCA2  
Involved in the maturation of mitochondrial iron-sulfur proteins 
357 IBA57 
358 CIAO1 Cytosolic Fe-S cluster biogenesis and maturation 
359 FAM96A  
Components of the cytosolic Fe/S protein assembly (CIA) machinery 
360 FAM96B 
361 MMS19 Cytosolic Fe/S protein assembly targeting factor 
362 NARF Cytosolic Fe-S protein maturation 
REPLICATION AND TRANSCRIPTION 
363 SSBP1 Promotes helical destabilization for the DNA helicases and Polymerase gama (POLG) to support 
mtDNA replication 
 
[Falkenberg et al., 
2007] 364 C10orf2 Mitochondrial DNA (mtDNA) helicase (TWINKLE) plays a important role in the maintenance of 
mtDNA 
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365 RNASEH1 May have role in the removal of RNA primers at the origin of replication on heavy and light strands  
 
 
 
 
 
 
 
 
 
 
[Falkenberg et al., 
2007] 
 
 
 
 
 
 
 
 
366 TOP1MT Suggested to have a role in the removal of positive supercoils created by helicase activity 
367 TOP3A May also be present in mitochondria with the role in the removal of positive supercoils during 
replication 
368 LIG3 Involved in the mitochondrial DNA replication and repair 
369 TERT Role in the protection of mitochondrial integrity with a suggested role in mtDNA replication and/or 
repair 
370 TFAM A key activator of mitochondrial transcription and also functions in replication and repair 
371 TFB1M Regulates the stability of small subunit of mitochondrial ribosome by its methylation activity. It also 
plays a very important role in transcription 
372 TFB2M Essential transcription factor involved in the transcription of mitochondrial genes 
373 NRF1  
 
Regulates the expression of TFB1M and TFB2M which are two mitochondrial transcription factors 
374 NFE2L2 
375 PPARGC1A 
376 POLRMT Provides primers for the initiation of replication of the mitochondria genome 
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377 RMRP RNA component of mitochondrial RNA processing endoribonuclease cleaves mitochondrial RNA at the 
priming site of mitochondrial DNA replication 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Falkenberg et al., 
2007] 
 
 
 
 
 
 
378 UNG Prevent mutagenesis by eliminating uracil from DNA molecules 
379 OGG1 Responsible for the excision of 8-oxoguanine 
380 NTHL1 Involved in the repair of mispairs in DNA 
381 MUTYH  
 
Involved in the mitochondrial DNA base excision repair 
382 APEX1 
383 APEX2 
384 ENDOG Nuclease which processes the RNA primers for heavy strand replication also has a role in apoptosis 
where after release from the mitochondria induces nucleosomal DNA fragmentation 
385 POLG Mitochondrial DNA polymerase, and also shows 3' to 5' exonuclease activity and ensure faithful 
replication 
386 POLG2 Acts as catalytic subunit of mitochondrial DNA polymerase 
387 MTERF1  
 
 
Mitochondrial transcription termination factor 388 MTERF2 
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389 MTERF3  
 
 
 
 
 
 
 
 
 
 
 
 
[Falkenberg et al., 
2007] 
 
 
 
 
 
 
 
390 MTERF4 
391 TRMT10C Cleaves the 5' terminus of mitochondrial tRNAs 
392 KIAA0391  
Human mitochondrial tRNA processing enzyme 
393 HSD17B10 
394 ELAC2 Endolytic processing the 3' end of tRNA 
395 TRNT1 Mitochondrial CCA adding enzyme, adds CCA sequence to the 3' end of tRNA 
396 DGOUK Involved in the phosphorylation of recycled deoxyribonucleosides in mitochondria specific for 
guanosine, adenosine and inosine 
397 TK2 Involved in the phosphorylation of recycled deoxyribonucleosides in mitochondria specific for 
thymidine, cytidine and uridine 
398 NTM5 Pyrimidine 5', 3' deoxyribonucleotidase that dephosphorylates dTMP 
399 AK3  
 
Phosphorylates the deoxyribonucleoside monophosphates specifically on dAMP 
400 AK4 
401 CMPK2 
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402 NME4 Shows mitochondrial nucleoside diphosphate kinase activity  
 
 
 
 
 
 
 
 
 
 
 
 
[Falkenberg et al., 
2007] 
 
 
 
 
 
 
 
403 SLC25A19 Transports thiamine pyrophosphates into mitochondria 
404 SLC25A33 Mitochondrial pyrimidine nucleotide carrier 
405 SLC29A1 Equilibrative nucleoside transporter 1 imports recycled deoxyribonucleosides from cytoplasm into 
mitochondria 
406 NME3  
Shows mitochondrial nucleoside diphosphate kinase activity 
407 NME6 
408 TRMT11  
 
 
 
 
 
 
 
 
 
 
 
Shows posttranscriptional modifications activity in the human mitochondrial tRNAs 
 
 
 
 
409 TRMT112 
410 DUS2L 
411 TRMT1 
412 PUS1 
413 RPUSD2 
414 RPUSD4 
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415 GTPBP3  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shows posttranscriptional modifications activity in the human mitochondrial tRNAs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Falkenberg et al., 
2007] 
 
 
 
 
 
 
 
416 MTO1 
417 TRMU 
418 QTRT1 
419 QTRTD1 
420 TRMT5 
421 YRDC 
422 OSGEPL1 
423 TRIT1 
424 CDK5RAP1 
425 CDKAL1 
426 PUS3 
427 NSUN2 
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428 TRMT2B  
 
 
 
 
 
 
 
Shows posttranscriptional modifications activity in the human mitochondrial tRNAs 
 
 
 
 
 
 
 
[Falkenberg et al., 
2007] 
 
429 TRUB2 
430 TRMT6 
431 TRMT61B 
432 CREB1 Promotes the transcription of mitochondrial genes 
433 SLC25A3 Involved in the transport of phosphate into the mitochondrial matrix 
434 MTPAP Involved in the polyadenylation of mitochondrial tRNAs, rRNAs and mRNAs 
435 RRM2B Required for the de novo deoxyribonucleotide synthesis in non-proliferating cells supplying dNTPs to 
mtDNA synthesis 
 
 
TRANSLATION 
436 RARS2 Involved in the specific attachment of arginine amino acid to its cognate tRNA  
 
 
 
 
 
 
437 CARS2 Involved in the specific attachment of cysteine amino acid to its cognate tRNA 
438 EARS2 Involved in the specific attachment of glutamic acid amino acid to its cognate tRNA 
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439 IARS2 Involved in the specific attachment of isoleucine amino acid to its cognate tRNA  
 
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
 
 
 
 
440 LARS2 Involved in the specific attachment of leucine amino acid to its cognate tRNA 
441 MARS2 Involved in the specific attachment of methionine amino acid to its cognate tRNA 
442 WARS2 Involved in the specific attachment of tryptophan amino acid to its cognate tRNA 
443 YARS2 Involved in the specific attachment of tyrosine amino acid to its cognate tRNA 
444 VARS2 Involved in the specific attachment of valine amino acid to its cognate tRNA 
445 AARS2 Involved in the specific attachment of alanine amino acid to its cognate tRNA 
446 NARS2 Involved in the specific attachment of asparagine amino acid to its cognate tRNA 
447 DARS2 Involved in the specific attachment of aspartic acid amino acid to its cognate tRNA 
448 GARS Involved in the specific attachment of glycine amino acid to its cognate tRNA 
449 HARS2 Involved in the specific attachment of histidine amino acid to its cognate tRNA 
450 KARS Involved in the specific attachment of lysine amino acid to its cognate tRNA 
451 FARS2 Involved in the specific attachment of phenylalanine amino acid to its cognate tRNA 
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452 PARS2 Involved in the specific attachment of proline amino acid to its cognate tRNA  
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
453 SARS2 Involved in the specific attachment of serine amino acid to its cognate tRNA 
454 TARS2 Involved in the specific attachment of threonine amino acid to its cognate tRNA 
455 QRSL1  
 
Involved in the biosynthesis of glutamyl-tRNA 
456 PET112 
457 GATC 
458 MTFMT Involved in the specific attachment of methionine amino acid to its cognate tRNA 
459 TUFM Involved in the elongation and termination phases of the translation process 
460 GFM2 Involved in the elongation and termination phases of the translation process may also be involved in 
the ribosome recycling 
461 GFM1 Involved in the elongation and termination phases of the translation process 
462 TSFM Involved in the elongation and termination phases of the translation process 
463 MTRF1  
Involved in the mitochondrial translation termination, may act as a release factor 
464 MTRF1L 
211 
 
465 MRRF Acts as a mitochondrial ribosome recycling factor during translation process  
 
 
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
 
 
 
466 PTCD3 Associates with mitochondrial small ribosomal subunit and regulates translation 
467 MT-TA mitochondrially encoded tRNA alanine 
468 MT-TC mitochondrially encoded tRNA cysteine 
469 MT-TD mitochondrially encoded tRNA aspartic acid 
470 MT-TE mitochondrially encoded tRNA glutamic acid 
471 MT-TF mitochondrially encoded tRNA phenylalanine 
472 MT-TG mitochondrially encoded tRNA glycine 
473 MT-TH mitochondrially encoded tRNA histidine 
474 MT-TI mitochondrially encoded tRNA isoleucine 
475 MT-TK mitochondrially encoded tRNA lysine 
476 MT-TL1 mitochondrially encoded tRNA leucine 1 (UUA/G) 
477 MT-TL2 mitochondrially encoded tRNA leucine 2 (CUN) 
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478 MT-TM mitochondrially encoded tRNA methionine  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
479 MT-TN mitochondrially encoded tRNA asparagine 
480 MT-TP mitochondrially encoded tRNA proline 
481 MT-TQ mitochondrially encoded tRNA glutamine 
482 MT-TR mitochondrially encoded tRNA arginine 
483 MT-TS1 mitochondrially encoded tRNA serine 1 (UCN) 
484 MT-TS2 mitochondrially encoded tRNA serine 2 (AGU/C) 
485 MT-TT mitochondrially encoded tRNA threonine 
486 MT-TV mitochondrially encoded tRNA valine 
487 MT-TW mitochondrially encoded tRNA tryptophan 
488 MT-TY mitochondrially encoded tRNA tyrosine 
489 MRPL1  
 
Mitoribosome which forms a part of mitochondrial translation machinery 
 490 MRPL2 
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491 MRPL3  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mitoribosome which forms a part of mitochondrial translation machinary 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
 
 
 
492 MRPL4 
493 MRPL9 
494 MRPL10 
495 MRPL11 
496 MRPL12 
497 MRPL13 
498 MRPL14 
499 MRPL15 
500 MRPL16 
501 MRPL17 
502 MRPL18 
503 MRPL19 
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504 MRPL20  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mitoribosome which forms a part of mitochondrial translation machinary 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
 
 
 
 
505 MRPL21 
506 MRPL22 
507 MRPL23 
508 MRPL24 
509 MRPL27 
510 MRPL28 
511 MRPL30 
512 MRPL32 
513 MRPL33 
514 MRPL34 
515 MRPL35 
516 MRPL36 
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517 MRPL37  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mitoribosome which forms a part of mitochondrial translation machinary 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
 
 
 
 
518 MRPL38 
519 MRPL39 
520 MRPL40 
521 MRPL41 
522 MRPL42 
523 MRPL43 
524 MRPL44 
525 MRPL45 
526 MRPL46 
527 MRPL47 
528 MRPL48 
529 MRPL49 
216 
 
530 MRPL50  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mitoribosome which forms a part of mitochondrial translation machinary 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
 
531 MRPL51 
532 MRPL52 
533 MRPL53 
534 MRPL54 
535 MRPL55 
536 MRPL57 
537 MRPS10 
538 MRPS11 
539 MRPS12 
540 MRPS14 
541 MRPS15 
542 MRPS16 
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543 MRPS17  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mitoribosome which forms a part of mitochondrial translation machinary 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
 
 
544 MRPS18A 
545 MRPS18B 
546 MRPS18C 
547 MRPS2 
548 MRPS21 
549 MRPS22 
550 MRPS23 
551 MRPS24 
552 MRPS25 
553 MRPS26 
554 MRPS27 
555 MRPS28 
218 
 
556 DAP3  
 
 
 
 
 
 
 
 
 
 
 
 
Mitoribosome which forms a part of mitochondrial translation machinary 
 
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
 
 
 
 
 
 
 
 
 
 
 
 
557 MRPS30 
558 MRPS31 
559 MRPS33 
560 MRPS34 
561 MRPS35 
562 MRPS36 
563 MRPS5 
564 MRPS6 
565 MRPS7 
566 MRPS9 
567 MTIF3 Translation initiation factor could assist the mRNA to bind to rRNAs 
568 MTIF2 Translation initiation factor could assist the tRNA to bind to rRNAs 
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569 TACO1 Translational activator of complex IV subunit  
 
 
 
 
 
 
 
 
 
 
[Suzuki et al., 2011] 
 
 
[Kenmochi et al., 
2001] 
 
and 
 
[Smits  et al., 2010] 
 
570 LRPPRC Might play a role in the translation and stability of COX subunits 
571 RNASEL Modulate the stability of mitochondrial mRNAs by interacting with MTIF2 
572 LONP1  
Involved in the post translational quality control, has re-solubilization activity of protein aggregates 
573 CLPP 
574 CLPX Quality control of inner membrane proteins 
575 PHB  
Involved in the post translational quality control, stabilizes mitochondrially synthesized proteins 
576 PHB2 
577 OXA1L May have a role in the insertion of proteins into inner membrane and also a complex V assembly factor 
578 ATAD3A  
May interact with mitochondrial proteins and is required mitochondrial protein synthesis 
579 ATAD3B 
580 MPV17L2  
 
May be involved in the biogenesis of mitochondrial ribosomes 
581 DHX30 
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582 DDX28 
 
 
MITOCHONDRIAL DYNAMICS 
583 MFN1 Involved in the mitochondrial fusion, mitofusins dimerize resulting in the tethering of the outer 
membranes of the fusing mitochondria. 
 
 
 
[Palmer  et al., 2011], 
 
 [Hales, 2010] and  
 
[Ranieri et al., 2013] 
 
 
 
 
 
 
 
 
 
 
584 MFN2 
585 OPA1 Involved in the mitochondrial fusion, initiates inner membrane fusion 
586 PHB2 Involved in the mitochondrial fusion, scaffold proteins coordinate stability of the OPA1 
587 STOML2 
588 PINK1 Involved in the mitochondrial fusion, PINK1 phosphorylates PARK2 and consequently PARK2 induced 
ubiquitination of mitofusins 
589 PARK2 Involved in the mitochondrial fusion, PARK2 induces ubiquitination of mitofusins 
590 OPA3 Involved in the mitochondrial fusion, interacts with MFN1 and involved in mitochondrial 
fragmentation 
591 PARL Involved in the mitochondrial fusion, regulates the cleavage of OPA1 
592 SPG7  
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593 AFG3L2 Involved in the mitochondrial fusion, known to maintain the OPA1 isoforms  
 
 
 
 
 
 
 
 
 
 
 
[Palmer  et al., 2011], 
 
 [Hales, 2010] and  
 
[Ranieri et al., 2013] 
 
594 OMA1 Involved in the mitochondrial fusion, known to induce proteolytic inactivation of OPA1 
595 YME1L1 Involved in the mitochondrial fusion, known to cleave OPA1 
596 PLD6 Involved in the mitochondrial fusion, promotes mitofusin-mediated fusion 
597 MARCH5 Involved in the mitochondrial fusion and fission, control of mitochondrial morphology by regulating 
MFN2 and DNM1L 
598 TRAP1 Involved in the mitochondrial fission, known to regulate fission proteins DNM1L and MFF 
599 DNM1L Involved in the mitochondrial fission, mediates the division of mitochondria 
600 MFF  
 
Involved in the mitochondrial fission, suggested to have roles in recruiting DNM1L 
 601 MIEF1 
602 MIEF2 
603 FIS1 Involved in the mitochondrial fission, facilitates binding and assembly of DNM1L 
604 MTFP1 Involved in the mitochondrial fission, role in mitochondrial fragmentation and is dependent on 
DNM1L expression 
605 GDAP1 Involved in the mitochondrial fission, know to have a role in the mitochondrial fragmentation 
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606 SH3GLB1 Involved in the mitochondrial fission, proposed to be involved in the lipid remodeling of the outer 
membrane during fission 
607 PKIA Involved in the mitochondrial fission, is known to inhibit GTPase activity of DNM1L 
608 BECN1 Involved in the mitophagy, involved in the initiation of autophagy  
 
 
 
 
 
[Thomas & 
Gustafsson, 2013] 
609 AMBRA1 Involved in the mitophagy, translocates to the mitochondria and facilitate phagophore formation 
610 BNIP3 Involved in the mitophagy, cause permeabilization of the mitochondrial membrane and also acts as a 
proapoptotic factor 
611 BNIP3L Involved in the mitophagy, cause permeabilization of the mitochondrial membrane and also regulate 
mitophagy 
612 MAP1LC3A Involved in the mitophagy, interacts with BNIP3 and BNIP3L to remove mitochondria via autophagy 
613 GABARAP Involved in the mitophagy, interacts with BNIP3 and BNIP3L to remove mitochondria via autophagy 
614 SQSTM1 Involved in the mitophagy, recruited to mitochondria and binds mitochondrial substrates on the 
autophagosomes 
615 RHOT1 Involved in the mitophagy, tethers mitochondria to the tubulin network but phosphorylation by 
PINK1 results in the detachment of mitochondria 
616 RHOT2 
617 KIF5B Involved in the mitochondrial movement, have role in the mitochondrial distribution in neurons  
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618 KIF1B Involved in the mitochondrial movement, have role in the mitochondrial distribution in neurons  
[Chen & Chan, 2009] 
 
 
 
 
[Chen & Chan, 2009] 
619 DYNLL1 Involved in the mitochondrial movement, have role in the retrograde mitochondrial movement 
620 SYBU Involved in the mitochondrial movement, have a role in linking the mitochondria to KIF5B 
621 TRAK1  
Involved in the mitochondrial movement, acts as an adapter linking kinesin-1 to mitochondria 
622 TRAK2 
623 MSTO1 Involved in the regulation of mitochondrial distribution and morphology 
CALCIUM TRAFFICKING 
624 MCU Involved in the accumulation of calcium ions in the matrix through ion impermeable inner 
mitochondrial membrane 
 
 
 
 
 
 
 
[Rizzuto et al., 2012] 
625 SLC24A6 Involved in the calcium homeostasis by counteracting the calcium accumulation in the mitochondria 
626 LETM1 Might act as calcium ion and hydrogen ion antiporter exchanging hydrogen for calcium 
627 MICU1 Regulates the mitochondrial calcium uniporter by inhibiting and permitting the calcium depending 
upon the cytosolic calcium concentrations 
628 EFHA1 
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629 CCDC90A Mitochondrial calcium uniporter regulator 1 required for the MCU dependent calcium uptake by the 
mitochondria 
630 EFHA2 Regulates the mitochondrial calcium uniporter by inhibiting and permitting the calcium depending 
upon the cytosolic calcium concentrations 
631 CCDC109B  
Forms an important component of mitochondrial calcium uniporter with MCU 
632 C22orf32 
633 ITPR3  
 
Component of the Inositol-1,4,5-trisphosphate receptors channels used for the fluxes of Ca2+ from ER 
to mitochondria 634 ITPR2 
635 ITPR1 
636 TCHP Involved in the regulation of ER mitochondria juxtaposition 
637 SIGMAR1 Stabilises the Inositol-1,4,5-trisphosphate receptors and ensures proper Ca2+ fluxes 
638 PACS2 Involved in the control of ER mitochondria appositions 
639 PML Regulates Inositol-1,4,5-trisphosphate receptor mediated Ca2+ release from the ER 
HEME BIOSYNTHESIS 
640 ALAS2   
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641 ALAS1 Catalyzes the reaction in which glycine and succinyl CoA from TCA cycle condenses to form 
aminolevulinate (ALA) and CO2 
[Dailey, 1997] 
 
 
 
 
 
 
[Dailey, 1997] 
642 ALAD ALA dehydratase catalyzes the reaction where two molecules of ALA condenses to form monopyrrole 
porphobilinogen (PBG) 
643 HMBS Hydroxymethylbilane synthase catalyzes head to tail condensation of four PBG and subsequent 
deamination to form a linear tetrapyrrole, Hydroxymethylbilane 
644 UROS Uroporphyrinogen III synthase catalyzes the linear tetrapyrrole molecule is cyclized or rearranged 
645 UROD Uroporphyrinogen III decarboxylase catalyzes stepwise decarboxylation of the Uroporphyrinogen III 
forming Coproporphyrinogen III 
646 CPOX Coproporphyrinogen III is transported to mitochondria and in the presence of coproporphyrinogen III 
oxidase it is oxidatively decarboxylated 
647 PPOX Protoporphyrinogen oxidase converts Protoporphyrinogen IX to Protoporphyrin IX 
648 FECH Ferrochelatase catalyzes the step involving the addition of Ferrous iron into the protoporphyrin IX to 
form the protoheme IX 
CARDIOLIPIN BIOSYNTHESIS 
649 CDS1 Converts phosphatidic acid to cytidine diphosphate diacylglycerol  
 
[Houtkooper & Vaz, 
2008] 
 
650 PGS1 Phosphatidylglycerol synthase converts cytidine diphosphate diacylglycerol to phosphatidylglycerol 
phosphate 
651 PTPMT1 
 
Phosphatidylglycerophosphatase activity removes phospate from phosphatidylglycerol phosphate to 
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form phosphatidylglycerol  
 
[Houtkooper & Vaz, 
2008] 
652 CRLS1 Catalyzes the condensation of cytidine diphosphate diacylglycerol and phosphatidylglycerol forming a 
nascent cardiolipin 
653 TAZ Converts the nascent cardiolipin to mature cardiolipin 
 
UREA CYCLE 
654 CPS1 Carbamoyl phosphate synthetase catalyzes the formation of  carbamoyl phosphate   
 
 
 
 
 
[Berg et al., 2002] 
 
 
 
 
 
 
655 OTC Ornithine transcarbamoylase catalyzes the formation of citrulline, carbamoyl phosphate combines 
with ornithine to form citrulline  
656 ASS1 Argininosuccinate synthetase catalyzes the formation of argininosuccinate 
657 ASL Argininosuccinate lyase catalyzes the formation of arginine and fumarate 
658 ARG1  
Arginase catalyzes the formation of Urea 
659 ARG2 
 
